Use: Labeled indications
- Pharyngitis/tonsillitis (adults and pediatric patients)
- Acute bacterial otitis media (pediatric patients)
- Acute bacterial maxillary sinusitis (adults and pediatric patients)
- Acute bacterial exacerbations of chronic bronchitis (adults and pediatric patients 13 years and older)
- Uncomplicated skin and skin-structure infections (adults and pediatric patients 13 years and older)
- Uncomplicated urinary tract infections (adults and pediatric patients 13 years and older)
- Uncomplicated gonorrhea (adults and pediatric patients 13 years and older)
- Early Lyme disease (adults and pediatric patients 13 years and older)
Full indications and usage US FDA label
1 INDICATIONS AND USAGE Cefuroxime axetil tablets are a cephalosporin antibacterial drug indicated for the treatment of the following infections due to susceptible bacteria: (1) Pharyngitis/tonsillitis (adults and pediatric patients) (1.1) Acute bacterial otitis media (pediatric patients) (1.2) Acute bacterial maxillary sinusitis (adults and pediatric patients) (1.3) Acute bacterial exacerbations of chronic bronchitis (adults and pediatric patients 13 years and older) (1.4) Uncomplicated skin and skin-structure infections (adults and pediatric patients 13 years and older) (1.5) Uncomplicated urinary tract infections (adults and pediatric patients 13 years and older) (1.6) Uncomplicated gonorrhea (adults and pediatric patients 13 years and older) (1.7) Early Lyme disease (adults and pediatric patients 13 years and older) (1.8) To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets and other antibacterial drugs, cefuroxime axetil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. 1.1 Pharyngitis/Tonsillitis Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of Streptococcus pyogenes. Limitations of Use The efficacy of cefuroxime axetil tablets in the prevention of rheumatic fever was not established in clinical trials.
The efficacy of cefuroxime axetil tablets in the treatment of penicillin-resistant strains of Streptococcus pyogenes has not been demonstrated in clinical trials. 1.2 Acute Bacterial Otitis Media Cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae (including β-lactamase–producing strains), Moraxella catarrhalis (including β-lactamase–producing strains), or Streptococcus pyogenes. 1.3 Acute Bacterial Maxillary Sinusitis Cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacterial maxillary sinusitis caused by susceptible strains of Streptococcus pneumoniae or Haemophilus influenzae (non - β-lactamase–producing strains only). Limitations of Use The effectiveness of cefuroxime axetil tablets for sinus infections caused by β-lactamase–producing Haemophilus influenzae or Moraxella catarrhalis in patients with acute bacterial maxillary sinusitis was not established due to insufficient numbers of these isolates in the clinical trials [see Clinical Studies (14.1)]. 1.4 Acute Bacterial Exacerbations of Chronic Bronchitis Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with mild-to-moderate acute bacterial exacerbations of chronic bronchitis caused by susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae (β-lactamase–negative strains), or Haemophilus parainfluenzae (β-lactamase–negative strains). 1.5 Uncomplicated Skin and Skin-Structure Infections Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with uncomplicated skin and skin-structure infections caused by susceptible strains of Staphylococcus aureus (including β - lactamase–producing strains) or Streptococcus pyogenes. 1.6 Uncomplicated Urinary Tract Infections Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with uncomplicated urinary tract infections caused by susceptible strains of Escherichia coli or Klebsiella pneumoniae. 1.7 Uncomplicated Gonorrhea Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with uncomplicated gonorrhea, urethral and endocervical, caused by penicillinase-producing and non-penicillinase–producing susceptible strains of Neisseria gonorrhoeae and uncomplicated gonorrhea, rectal, in females, caused by non-penicillinase–producing susceptible strains of Neisseria gonorrhoeae. 1.8 Early Lyme Disease (erythema migrans) Cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (aged 13 and older) with early Lyme disease (erythema migrans) caused by susceptible strains of Borrelia burgdorferi. 1.10 Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefuroxime axetil tablets and other antibacterial drugs, cefuroxime axetil tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Contraindications
- Known hypersensitivity (such as anaphylaxis) to cefuroxime or other beta-lactams (penicillins, cephalosporins)
Contraindications (US label) US FDA label
4 CONTRAINDICATIONS Cefuroxime axetil tablets are contraindicated in patients with a known hypersensitivity (e.g., anaphylaxis) to cefuroxime axetil tablets or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). Known hypersensitivity (e.g., anaphylaxis) to cefuroxime axetil tablets or to other β-lactams (e.g., penicillins and cephalosporins). (4)
Dosing: Adult
- Oral: pharyngitis, sinusitis, uncomplicated UTI: 250 mg every 12 hours
- Oral: bronchitis exacerbation, uncomplicated skin infection: 250 or 500 mg every 12 hours
- Oral: early Lyme disease: 500 mg every 12 hours for 20 days
- Oral: uncomplicated gonorrhea: 1,000 mg once
- IV: usual range: 750 mg to 1.5 g every 8 hours (life-threatening: 1.5 g every 6 hours; meningitis up to 3 g every 8 hours)
- IV surgical prophylaxis: 1.5 g before incision, then 750 mg every 8 hours if prolonged
- Tablets and oral suspension are not bioequivalent and are therefore not substitutable on a milligram-per-milligram basis. (2.1)
- Administer tablets with or without food. (2.2)
- Administer cefuroxime axetil tablets as described in the dosage guidelines. (2.2)
- Dosage adjustment is required for patients with impaired renal function. (2.5)
- Adult Patients and Pediatric Patients Dosage Guidelines for Cefuroxime Axetil Tablets Infection Dosage Duration (Days) Adults and Adolescents (13 years and older) Pharyngitis/tonsillitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 250 mg or 500 mg every 12 hours 10 Uncomplicated skin and skin-structure infections 250 mg or 500 mg every 12 hours 10 Uncomplicated urinary tract infections 250 mg every 12 hours 7 to 10 Uncomplicated gonorrhea 1,000 mg single dose Early Lyme disease 500 mg every 12 hours 20 Pediatric Patients younger than 13 years (who can swallow tablets whole) Acute bacterial otitis media 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis 250 mg every 12 hours 10
2.1 Important Administration Instructions
2.1 Important Administration Instructions Cefuroxime axetil tablets and cefuroxime axetil for oral suspension are not bioequivalent and are therefore not substitutable on a milligram-per-milligram basis [see Clinical Pharmacology (12.3)]. Administer cefuroxime axetil tablets as described in the appropriate dosage guidelines [see Dosage and Administration (2.2)].
Administer cefuroxime axetil tablets with or without food. Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole should receive cefuroxime axetil for oral suspension because the tablet has a strong, persistent bitter taste when crushed [see Dosage and Administration (2.2)].
2.2 Dosage for Cefuroxime Axetil Tablets
2.2 Dosage for Cefuroxime Axetil Tablets Administer cefuroxime axetil tablets as described in the dosage guidelines table below with or without food. Table 1. Adult Patients and Pediatric Patients Dosage Guidelines for Cefuroxime Axetil Tablets a The safety and effectiveness of cefuroxime axetil tablets administered for less than 10 days in patients with acute exacerbations of chronic bronchitis have not been established. b When crushed, the tablet has a strong, persistent bitter taste.
Therefore, patients who cannot swallow the tablet whole should receive the oral suspension. Infection Dosage Duration (Days) Adults and Adolescents (13 years and older) Pharyngitis/tonsillitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis (mild to moderate) 250 mg every 12 hours 10 Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 250 mg or 500 mg every 12 hours 10 a Uncomplicated skin and skin-structure infections 250 mg or 500 mg every 12 hours 10 Uncomplicated urinary tract infections 250 mg every 12 hours 7 to 10 Uncomplicated gonorrhea 1,000 mg single dose Early Lyme disease 500 mg every 12 hours 20 Pediatric Patients younger than 13 years (who can swallow tablets whole) b Acute bacterial otitis media 250 mg every 12 hours 10 Acute bacterial maxillary sinusitis 250 mg every 12 hours 10
2.5 Dosage in Patients with Impaired Renal Function
2.5 Dosage in Patients with Impaired Renal Function A dosage interval adjustment is required for patients whose creatinine clearance is less than 30 mL/min, as listed in Table 4 below, because cefuroxime is eliminated primarily by the kidney [see Clinical Pharmacology (12.3)]. Table 4. Dosing in Adults with Renal Impairment Creatinine Clearance (mL/min) Recommended Dosage ≥30 No dosage adjustment 10 to <30 Standard individual dose given every 24 hours <10 (without hemodialysis) Standard individual dose given every 48 hours Hemodialysis A single additional standard dose should be given at the end of each dialysis
Dosing: Altered kidney function
Cefuroxime is excreted unchanged by the kidneys (about 89% of an IV dose in 8 hours). Oral cefuroxime axetil keeps the standard dose but lengthens the interval when creatinine clearance (CrCl) is below 30 mL/min; IV cefuroxime is reduced to 750 mg every 12 hours at CrCl 10–20 and every 24 hours below 10. Both labels give an extra dose at the end of each hemodialysis.
Kidney function measure: Labels use CrCl (mL/min; Cockcroft–Gault). Oral: adjust below 30. IV: adjust at 20 or less.
Show full dosing details
- CrCl ≥60 mL/min
- Oral and IV: usual dose (labels).
- CrCl 30–59 mL/min
- Oral and IV: usual dose (oral: no adjustment at CrCl 30 or more; IV: usual dose above 20) (labels).
- CrCl 15–29 mL/min
- Oral: CrCl 10 to <30, standard dose every 24 hours. IV: CrCl 21–29, usual 750 mg to 1.5 g every 8 hours; CrCl 10–20, 750 mg every 12 hours (labels).
- CrCl <15 mL/min (not on dialysis)
- Oral: CrCl 10–14, standard dose every 24 hours; below 10 (not on HD), every 48 hours. IV: CrCl 10–14, 750 mg every 12 hours; below 10, 750 mg every 24 hours (labels).
- Hemodialysis (intermittent)
- Oral: one extra standard dose at the end of each dialysis. IV: a further dose at the end of dialysis, as cefuroxime is dialyzable (labels).
- Peritoneal dialysis
- No peritoneal dialysis dosing in the labels (serum levels can be reduced by PD, overdose sections). ISPD 2022 gives no intraperitoneal cefuroxime dose. Specialist input.
- CRRT
- Not in label; the cited CRRT review (Li 2020) gives no regimen for this drug. Specialist input.
- Dialyzable? Yes: hemodialysis and peritoneal dialysis reduce serum levels (labels). About 50% protein bound.
- Monitoring CrCl for dose; seizures or encephalopathy with overdose in kidney impairment (label overdose section); diarrhea (CDAD).
Children (kidney dosing)
Show full dosing details
- eGFR ≥60
- Usual dose (labels).
- eGFR 30–59
- Usual dose; adult changes start below CrCl 30 (oral) or at 20 (IV) (labels).
- eGFR 15–29
- IV: modify dosing frequency consistent with the adult table (IV label). Oral pediatric: not stated.
- eGFR <15 (not on dialysis)
- IV: modify dosing frequency consistent with the adult table (IV label). Oral pediatric: not stated.
- Hemodialysis (intermittent)
- IV: frequency consistent with adult recommendations, including the dose after dialysis (IV label). Specialist input.
- Peritoneal dialysis
- No pediatric data. Specialist input.
- CRRT
- No pediatric CRRT data in the cited sources. Specialist input.
Pediatric eGFR: bedside Schwartz equation, 0.413 × height (cm) / serum creatinine (mg/dL). Weight-based doses should not exceed the adult maximum.
renalcarematters.com guidance, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Sources are listed under References. Use with the product's package insert and the patient's current kidney function.
US label text: Renal impairment US FDA label
2.5 Dosage in Patients with Impaired Renal Function A dosage interval adjustment is required for patients whose creatinine clearance is less than 30 mL/min, as listed in Table 4 below, because cefuroxime is eliminated primarily by the kidney [see Clinical Pharmacology (12.3)]. Table 4. Dosing in Adults with Renal Impairment Creatinine Clearance (mL/min) Recommended Dosage ≥30 No dosage adjustment 10 to <30 Standard individual dose given every 24 hours <10 (without hemodialysis) Standard individual dose given every 48 hours Hemodialysis A single additional standard dose should be given at the end of each dialysis
8.6 Renal Impairment Reducing the dosage of cefuroxime axetil is recommended for adult patients with severe renal impairment (creatinine clearance <30 mL/min) [see Dosage and Administration (2.5), Clinical Pharmacology (12.3)].
Patients with Renal Impairment: In a trial of 28 adults with normal renal function or severe renal impairment (creatinine clearance <30 mL/min), the elimination half-life was prolonged in relation to severity of renal impairment. Prolongation of the dosage interval is recommended in adult patients with creatinine clearance <30 mL/min [see Dosage and Administration (2.5)].
Dosing: Pediatric
- Approved ages
- Oral tablets: children who can swallow tablets whole (3 months to 12 years for maxillary sinusitis). IV: over 3 months (labels).
- Usual dose
- Oral tablets under 13 years: 250 mg every 12 hours (otitis media, sinusitis). IV over 3 months: 50 to 100 mg/kg/day divided every 6 to 8 hours; bone and joint 150 mg/kg/day every 8 hours; meningitis 200 to 240 mg/kg/day every 6 to 8 hours (labels).
- Maximum dose
- Not above the maximum adult dose (IV label).
Kidney dosing in children: see Dosing: Altered kidney function.
renalcarematters.com, reviewedPediatric use (US label) US FDA label
8.4 Pediatric Use The safety and effectiveness of cefuroxime axetil have been established for pediatric patients aged 3 months to 12 years for acute bacterial maxillary sinusitis based upon its approval in adults. Use of cefuroxime axetil in pediatric patients is supported by pharmacokinetic and safety data in adults and pediatric patients, and by clinical and microbiological data from adequate and well-controlled trials of the treatment of acute bacterial maxillary sinusitis in adults and of acute otitis media with effusion in pediatric patients.
It is also supported by postmarketing adverse events surveillance [see Indications and Usage (1), Dosage and Administration (2), Adverse Reactions (6), Clinical Pharmacology (12.3)].
Dosing: Older adult
Geriatric use (US label) US FDA label
8.5 Geriatric Use Of the total number of subjects who received cefuroxime axetil in 20 clinical trials, 375 were aged 65 and older while 151 were aged 75 and older. No overall differences in safety or effectiveness were observed between these subjects and younger adult subjects. Reported clinical experience has not identified differences in responses between the elderly and younger adult patients, but greater sensitivity of some older individuals cannot be ruled out.
Cefuroxime is substantially excreted by the kidney, and the risk of adverse reactions may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.
Administration
2.1 Important Administration Instructions Cefuroxime axetil tablets and cefuroxime axetil for oral suspension are not bioequivalent and are therefore not substitutable on a milligram-per-milligram basis [see Clinical Pharmacology (12.3) ] . Administer cefuroxime axetil tablets as described in the appropriate dosage guidelines [see Dosage and Administration (2.2) ]. Administer cefuroxime axetil tablets with or without food. Pediatric patients (aged 13 years and older) who cannot swallow the cefuroxime axetil tablets whole should receive cefuroxime axetil for oral suspension because the tablet has a strong, persistent bitter taste when crushed [see Dosage and Administration (2.2) ].
US FDA labelDosage forms
Philippines
- Powder for injection: 1 g, 1.5 g, 250 mg, 750 mg
- Film-coated tablet: 250 mg, 500 mg
- Granule for suspension: 125 mg/5 mL, 250 mg/5 mL
- Powder for oral suspension: 125 mg, 125 mg/5 mL, 125 mg/mL, 250 mg/5 mL
- Powder for suspension: 125 mg/5 mL, 250 mg/5 mL
- Tablet: 125 mg, 250 mg, 500 mg
- Granule for oral suspension: 125 mg, 125 mg/5 mL, 250 mg/5 mL
- Dry powder for injection: 1.5 g, 750 mg
- Powder for lnjection: 1.5 g
- Sterile powder for injection: 750 mg
and 6 more forms; see the products table.
Registered products in the Philippines
799 products registered with the Food and Drug Administration (FDA) Philippines list Cefuroxime as the generic name (including products registered under a variant spelling). Registration status changes; confirm a product's current status on the FDA portal before relying on it.
Also registered under: Cefuroxim (as sodium) (1 product) · Cefuroxime (as sodium (1 product) · Cefuroxime (as axetil0 (1 product) · Cefuroxime (as sodium) with Sterile Water for Injection (2 products) · Cefuroxine (as axetil) (1 product). Products registered under these spellings are included in the table and marked.
All registered products799
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
2-GenCefuroxime (As Axetil) | 125 mg/5 mL Powder For Suspension30 mL and 60 mL HDPE Bottle with PP Cap and 10 mL PP Measuring Cup and 100 mL HDPE Bottle with PP Cap and 15 mL PP Measuring Cup | Rx | Zim Laboratories Ltd.India | Jjysrinn Trading Inc.Importer: Ambica International CorporationTrader: Rainbow Life Science Pvt. Ltd. | DRP-4045 | Jul 5, 2029 | |
2-Gen 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Speed Cure PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995 | Sep 28, 2027 | |
2-Gen SCPCefuroxime (as axetil) | Film-Coated Tablet 500 mgAlu/Alu Blister Pack x 10’s (Box of 10's) | Rx | Sakar Healthcare LimitedIndia | SPEED CURE PHARMAImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-01 | Jul 14, 2029 | |
2-KingCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 6’s (Box of 12’s) | Rx | Unimax LaboratoriesIndia | Diafarm Inc.Importer: Ambica International CorporationTrader: Mankind Pharma Ltd. | DRP-5786-01 | Jun 14, 2028 | |
AcceCefCefuroxime (As Sodium) | 750mg Powder For InjectionType I Transparent Glass Vial with Gray Butyl Rubber Stopper and Flip-Off Seal Cap x l's (Box of l's) | Rx | Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan | Accesspoint International Trading, Inc. | DRP-11548 | Mar 30, 2027 | |
AcceximeCefuroxime (as axetil) | 125 mg/5 ml Powder for SuspensionHDPE White Plastic Bottle x 50 ml (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Accesspoint International Trading Inc. | DRP-5053 | Sep 30, 2031 | |
AcrocefCefuroxime (as Axetil) | 125 mg / 5 mL Powder for SuspensionBoston Round Amber Bottle x 50 mL, 60 mL, 70 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | — | DRP-3191 | Aug 22, 2028 | |
AcrocefCefuroxime (as Axetil) | 250 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 50 mL, 60 mL and 70 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | — | DRP-3231 | Sep 7, 2028 | |
AdvenximeCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue Flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13459-05 | Feb 23, 2028 | |
AeroxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10’s (Box of 10’s and 100’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | AMB HK Enterprises Inc. | DRP-4975 | Mar 6, 2031 | |
AeroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 10's); USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 50's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK ENTERPRISES INC. | DRP-3600 | Feb 14, 2029 | |
AeruginoxCefuroxime (as Axetil) | 250 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 60 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Dynasty Pharmaceuticals | DRP-3231-17 | Sep 7, 2028 | |
AeruginoxCefuroxime (as axetil) | 250 mg Film-Coated Tablet10 Individually Boxed Alu-Alu Blister Pack x 6's (Box of 60's) | Rx | Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd.China | Dynasty Pharmaceuticals | DRP-7219 | Jan 21, 2031 | |
AeruginoxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Brawn Laboratories LimitedIndia | Dynasty PharmaceuticalsImporter: Ambica International Corporation | DRP-4164-05 | Dec 27, 2027 | |
AeruginoxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 10's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Ambitech Biopharmaceuticals Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-03 | Oct 24, 2028 | |
AeruginoxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10 and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dynasty PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-4975-02 | Apr 16, 2031 | |
AeruginoxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear Colorless Glass Vial (Box of 10's) | Rx | Sinopharm Zhijun (Shenzhen) Pharmaceutical Co., Ltd.China | Dynasty Pharmaceuticals | DRP-7483 | Feb 18, 2031 | |
AjenacefCefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL and 70 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | AJ Research & Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5745-02 | Apr 24, 2029 | |
AlcefurCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Jalmed Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-05 | Sep 28, 2027 | |
AllycefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Little Mary Pharmaceutical Distributor | DRP-4618-10 | Oct 29, 2031 | |
AltacefCefuroxime (as axetil) | 500 mg Film-Coated TabletAluminum Foil Strip x 10's (Box of 50's) | Rx | Maxim Pharmaceuticals Pvt. Ltd.India | Glenmark Philippines, Inc.Trader: Glenmark Pharmaceuticals Limited | DRP-6219 | Aug 22, 2031 | |
AltoximeCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Foramen Products Corporation | DRP-7789-04 | Sep 19, 2031 | |
AltoximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Interhealthcare Pharmaceuticals, Inc. | DRP-2103-01 | Sep 18, 2028 | |
AltoximeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Altomed Pharmaceuticals, Inc. | DRP-7568-01 | Feb 24, 2029 | |
AltoximeCefuroxime (as Sodium) | 750 mg Powder for InjectionType I Clear Glass Vial with Rubber Stopper and Orange Flip-off Seal (Box of 10's) | Rx | Aju Pharm Co., Ltd.Republic of Korea | Altomed Pharmaceuticals, Inc.Importer: Interhealthcare Pharmaceuticals, Inc. | DRP-2356-02 | Dec 6, 2028 | |
AltoximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Altomed Pharmaceuticals, Inc.Importer: D.B. Manix International, Inc. | DRP-076-01 | Dec 21, 2029 | |
AltoximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | Daewon Pharm. Co., Ltd.Republic of Korea | Altomed Pharmaceuticals, Inc.Importer: D.B. Manix International, Inc. | DRP-884-07 | Sep 28, 2032 | |
AmbicaineCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-08 | Jun 30, 2029 | |
AmbifucefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Sanoviz Pharmaceutical Products TradingImporter: Ambica International Corporation | DRP-4164-24 | Dec 27, 2027 | |
AmbiximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear and Colorless Glass Vial with Yellow Flip-Off Seal (Box of 1’s) | Rx | Cadila Pharmaceuticals Ltd.India | Bio Medpro PharmaceuticalsImporter: Ambica International Corporation | DRP-1130-01 | Jul 24, 2029 | |
AmkoximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Amk Pharma International TradingImporter: Pharmakon Biotec Inc. | DRP-4976-01 | Nov 27, 2028 | |
Amkoxime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 20 's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Amk Pharma International TradingImporter: Pharmakon Biotec Inc. | DRP-5017-01 | Dec 18, 2028 | |
ApoximeCefuroxime (as Axetil) | 500 mg TabletAlu-Alu Blister Pack x 10’s per box (Box of 10’s) | Rx | Lark Laboratories (India) Ltd.India | UniGlobal Group Marketing Corp.Importer: Medbridge, Inc. | DRP-3181-01 | Feb 20, 2031 | |
APPEXCEFCEFUROXIME (AS AXETIL) | 250 MG/5 ML GRANULES FOR ORAL SUSPENSIONBOSTON ROUND AMBER GLASS BOTTLE IN 50 ML (NET CONTENT WHEN RECONSTITUTED) BOX OF 1'S | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | APPEX MD'S PHARMACEUTICALS INC. | DRP-7543-05 | Oct 14, 2029 | |
AppexcefCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu - Alu Blister X 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Appex Md's Pharmaceuticals Inc. | DRP-4618-04 | Aug 26, 2031 | |
AppexcefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-Off Seal Cap x 1's (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Appex MD's Pharmaceuticals Inc.Importer: Medinova Pharmaceutical Inc. | DRP-10888-04 | Jan 26, 2028 | |
ArgiximeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | GPC Geo Pharma CorporationImporter: Ambica International Corporation | DRP-4164-02 | Dec 27, 2027 | |
AtoncefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial with white Flip-off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Aton PharmaImporter: Pharmakon Biotec Inc. | DRP-4976-32 | Nov 27, 2028 | |
AxebacCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Medirich Pharma Distribution Corp.Importer: Largen Med Inc. | DRP-4774-05 | Jan 9, 2028 | |
AXEBACCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | Daewon Pharm. Co., Ltd.Republic of Korea | Medirich Pharma Distribution Corp.Importer: Largen Med Inc. | DRP-884-06 | Sep 28, 2027 | |
Axecrest 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Yellow Flip Off Seal (Box of 1's) | Rx | Cadila Pharmaceuticals Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-1130-02 | Jul 24, 2029 | |
AxefimeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 6's (Box of 30's) | Rx | Sinopharm Shantou Jinshi Pharmaceutical Co., Ltd.China | Endure Medical, Inc. | DR-XY43513 | Jul 8, 2029 | |
AxerichCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type III Clear and Colorless Glass Vial (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Medirich Pharma Distribution Corp.Importer: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-4313-03 | Mar 20, 2028 | |
AxetCefuroxime (as Axetil) | 250 mg/5 mL Powder for Suspension50 mL and 70 mL (Net content) filled in 120mL Boston Round Amber Bottle in a box (Box of 1's) | Rx | Sydenham Laboratories, Inc.Philippines | ADP PHARMA CORPORATION | DRP-1181 | Jun 27, 2029 | |
AxetCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 12's) | Rx | Micro Labs LimitedIndia | ADP Pharma CorporationImporter: Brown & Burk Phils., Inc. | DRP-560-01 | Jul 27, 2028 | |
BacefurCefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)Type III Clear Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x l's + Sterile Water for Injection in LDPE Plastic Ampoule x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | GPC Geo Pharma Corporation | DRP-11250 | Feb 17, 2027 | |
Bacefur 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Globela Laboratories Pvt. Ltd.India | GPC Geo Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-12213-06 | Jul 13, 2027 | |
BacximeCefuroxime (as Axetil) | 125 mg/5 mL Powder for Oral SuspensionPolypropylene Bottle x 60 mL (Box of 1's) | Rx | Swiss Parenterals Pvt. Ltd.India | Endure Medical, Inc. | DR-XY43141 | Feb 17, 2029 | |
BacximeCefuroxime (as Axetil) | 250 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Swiss Parenterals Pvt LtdIndia | Endure Medical, Inc. | DR-XY43286 | Mar 5, 2029 | |
BELFURCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's) and with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 Vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | ONICARE PHARMA TRADING & GENERAL MERCHANDISEImporter: AGLOBAL CARE, INC. | DRP-6570-05 | Mar 10, 2029 | |
BELLUROXI-1.5Cefuroxime (As Sodium) | 1.5 g Powder for Injection (IM/IV)Pack in One Box Containing 1-Type III Clear Colourless Glass Vial with Grey Butyl Rubber Stopper and Blue Aluminum Flip-Off Cap + 1 Ampoule x 10 mL Water for Injection (Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL Company LimitedChina | BELLUS LIFE SOLUTIONS, INC.Importer: AGLOBAL CARE, INC. | DRP-9400-01 | Aug 5, 2029 | |
Belluroxi-750Cefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 Vial + 1 Ampoule Diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Co., Ltd.China | Bellus Life Solutions, Inc.Importer: Aglobal Care, Inc. | DRP-6570-07 | Mar 10, 2029 | |
BermucefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear and Colorless Glass Vial with Yellow Flip Off Seal (Box of 1’s) | Rx | Cadila Pharmaceuticals Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International Corporation | DRP-1130-03 | Jul 24, 2029 | |
BetcefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type III clear and colorless glass vial with rubber stopper and white flip-off seal + 10 mL Sterile Water for Injection as diluent (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-02 | Mar 24, 2029 | |
BioroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Stratmed PharmaImporter: Sanimed Pharmaceuticals Inc. | DRP-7126-06 | Mar 29, 2027 | |
BiozefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Bio Erixx Pharma DistributionImporter: AMB HK Enteprises Inc. | DRP-8403-07 | Feb 15, 2028 | |
BizafroxCefuroxime (As Sodium) | 750 mg Powder For Injection (IM/IV)Type II Clear and Colorless Glass Vial (Box of 10's) | Rx | Laboratorio Reig Jofre, S.A.Spain | Penta Labs Australia (Philippines) | DRP-5866 | Mar 6, 2031 | |
BlifoxemeCefuroxime (As Sodium) | 750mg Powder For Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue Flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Afree Pharmaceutical Distribution Corp. | DRP-13459 | Feb 23, 2028 | |
BluecefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Bluecore Philippines Inc.Importer: Greencore Pharma Inc. | DRP-9975-06 | Feb 8, 2032 | |
Bluecef VCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray ( Box of 1's ) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Bluecore Philippines Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-15 | Mar 29, 2027 | |
Brill-CefuroCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 Vial + 1 Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | RCBRILLIANT PHARMA CORPImporter: AGLOBAL CARE, INC. | DRP-6570-16 | Mar 10, 2029 | |
Brilluroxime-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | Ncpc Hebei Huamin Pharmaceutical Co., Ltd.China | Rcbrilliant Pharma and Medical Supplies TradingImporter: Aglobal Care, Inc. | DRP-6570-14 | Mar 10, 2029 | |
BUENAXIMECefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu Strip Foil x 10's (Box of 50's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | BUENAR RESEARCH, INC. | DRP-7568-02 | Feb 24, 2029 | |
C-RoxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10) | Rx | East African (India) OverseasIndia | Airlife International Trading Corporation | DRP-17513 | Jan 15, 2031 | |
C-Tri TCefuroxime (as axetil) | 250mg Film-Coated TabletAluminum Strip x 10's (Box of 100's) | Rx | Emcure Pharmaceuticals LimitedIndia | Emcure Pharma Philippines Inc. | DR-XY31651 | Apr 19, 2031 | |
C-Tri TCefuroxime (as axetil) | 500mg Film-Coated TabletAluminum Strip x 4's (Box of 10's) (Box of 10's) | Rx | Emcure Pharmaceuticals Ltd.India | Emcure Pharma Philippines Inc. | DR-XY31687 | Mar 3, 2031 | |
Cabxime TCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Centurion Remedies Pvt. Ltd.India | Bliss Pharma Distribution and Consultancy Corp.Importer: Philgen Pharmaceuticals Inc. | DRP-5484-02 | Aug 27, 2029 | |
CaresefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box Not Applicable | Rx | Furen Pharmaceutical Group Co., LtdChina | Euro-Care Products Philippines | DRP-11801 | Apr 29, 2032 | |
CasavexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Medico Remedies LimitedIndia | Corbridge Group Phils., Inc.Importer: Medethix, Inc. | DRP-16457-01 | Mar 18, 2030 | |
CaxetilCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Neo-Care PhilippinesImporter: Ambica International Corporation | DRP-1639-07 | Dec 27, 2028 | |
Caxetil-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Neo-Care PhilippinesImporter: Ambica International Corporation | DRP-4164-21 | Dec 27, 2027 | |
Cef-UCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | 228 Pharma TradingImporter: Steinbach Products Inc. | DRP-2018-03 | Feb 1, 2027 | |
Cef-U 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | 228 Pharma TradingImporter: Ambica International Corporation | DRP-4164-10 | Dec 27, 2027 | |
Cefakind-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 6’s (Box of 12’s) | Rx | Unimax LaboratoriesIndia | Ambica International CorporationTrader: Mankind Pharma Ltd. | DRP-5786 | Jun 14, 2028 | |
Cefell-MedCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Pharmalife DistributionImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-03 | Sep 28, 2027 | |
CEFFTABSCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Sakar Healthcare LimitedIndia | SANREICH HEALTHCARE,INC.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-08 | Jul 14, 2029 | |
CefgenCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL Box of 1's | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Southmed Pharma CorporationImporter: AMB HK Enteprises Inc. | DRP-8403-06 | Feb 15, 2028 | |
Cefgen-1500Cefuroxime(as Sodium) | 1.5 g Powder for lnjection (IM/IV)15 mL USP Type III Clear Glass Vial (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | Southmed Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-5947-02 | Jan 21, 2030 | |
Cefgen-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ ALu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. Ltd.India | Southmed Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-12213-05 | Jul 13, 2027 | |
Cefgen-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Southmed Pharma CorporationImporter: AMB HK Enterprises Inc. | DRP-6113-03 | Mar 12, 2030 | |
CefiemCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Glass Vial + 10 mL USP Type I Clear Glass Ampoule Sterile water for injection (as Diluent) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-4515 | Jul 18, 2028 | |
CefijectCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | GJK Pharma DistributorsImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-05 | Dec 27, 2028 | |
CefiqoCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Amediqo Phils., Inc.Importer: Greencore Pharma, Inc. | DRP-9975-03 | Jul 1, 2031 | |
CefnatCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear Glass Vial with Rubber Closure and Tear-off Aluminum Seal with Blue-Flip-off Cap x 7.5 mL (Box of 1's and 10's) | Rx | SYNCOM FORMULATIONS LTD.India | ARVINCARE PHARMA INC.. | DRP-305 | May 12, 2028 | |
CefogenCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear and Colorless Glass Vial with Yellow Flip Off Seal (Box of 1’s) | Rx | Cadila Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-1130 | Jul 24, 2029 | |
CefopsivCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | VISPOMED CORPORATIONImporter: AGLOBAL CARE, INC. | DRP-6570-11 | Mar 10, 2029 | |
CefoptiCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type III Clear and Colorless Glass Vial *Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-4313 | Mar 20, 2028 | |
CefosanCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content as diluent) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd. - Unit IIIIndia | Sanreich Healthcare, Inc.Importer: I.E. Medica, Inc. | DRP-7060 | Feb 17, 2027 | |
CefosanCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type I Clear Glass Vial + 10 mL USP Type I Clear Glass Ampoule containing Sterile Water for Injection (as Diluent) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | Sanreich Healthcare, Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-4515-08 | Jul 18, 2028 | |
Cefovex-250Cefuroxime (as axetil) | 250 mg Film-Coated TabletAlu/Alu Blister Pack x 5's Box of 10's | Rx | Oman Pharmaceutical Products Co., LLCOman | Atlantic Pharmaceuticals, Inc. | DR-XY43728 | Sep 15, 2029 | |
Cefovex-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 5's (Box of 10's and 100's) | Rx | Oman Pharmaceutical Products Co., LLCOman | MG Prime Pharmaceutical, Inc.Importer: Atlantic Pharmaceuticals, Inc. | DRP-7507 | Sep 5, 2029 | |
CefoximaCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | RCT Med Pharma CorporationImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-09 | Mar 24, 2029 | |
CefpuroCefuroxime (as sodium) | 750 mg Powder for Injection (IM / IV)USP Type I Glass Vial with rubber stopper & orange flip off seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Ellebasy Medicale TradingImporter: H & B Pharma International Inc. | DRP-4342-02 | Jun 4, 2027 | |
CefpuroCefuroxime (as sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 10’s) | Rx | Shin Poong Pharm Co., Ltd.Republic of Korea | Ellebasy Medicale TradingImporter: Phil. Shinpoong Pharma Inc. | DRP-3036-08 | Apr 11, 2031 | |
CefreeximeCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue Flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Bliss Pharma Distribution and Consultancy Corp.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13459-01 | Feb 23, 2028 | |
750 mg Powder For Injection (IM/IV)10 ml-capacity USP Type iIII clear glass with grey bromobutyl rubber stopper and aluminum seal with green flip-off cap (Box of 1's) | Rx | Swiss Parenterals LimitedIndia | Applied Pharmaceutical Distribution Inc. | DRP-14141 | Jun 30, 2028 | ||
CefrixxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Type III Glass Vial x 10 mL (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | Bio Erixx Pharma DistributionImporter: AMB HK Enterprises Inc. | DRP-6041-01 | Feb 24, 2031 | |
CefromedCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type II Clear Glass Vial with rubber stopper and yellow flip-off seal + 10mL diluent in plastic ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Elfin Drugs Pvt. Ltd.India | Mandamed Pharma and Medical Supplies TradingImporter: Divjot Enterprises Corp. | DRP-5015-02 | Mar 19, 2029 | |
CefroneCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Type I clear glass vial (Box of 1's) | Rx | Ncpc Hebei Huamin Pharmaceutical Company LimitedChina | Nueva Sunshine Phils., Inc. | DRP-7730 | May 8, 2031 | |
CefroxilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | St. Raphael Archangel Pharmaceutical Product Distribution | DRP-11151-02 | Feb 8, 2027 | |
CefroximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's); 0 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 Vial + 1 Ampoule Diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Co., Ltd.China | Eliset Pharmaceutical, Inc.Importer: Aglobal Care, Inc. | DRP-6570-02 | Mar 10, 2029 | |
CefroxsurCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)20 mL USP Type II glass mould vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-11576 | Mar 31, 2027 | |
Cefroxsur-750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type II mould vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharma-Surrey International, Inc. | DRP-11575 | Mar 31, 2027 | |
CefruximaCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu / Alu Blister Pack X 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Zeutica, Inc. | DRP-4618-06 | Sep 11, 2031 | |
CefsenzCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL Type II Glass Vial Sealed with Gray Butyl Rubber Stopper and Blue Flip-Off Seal Cap x 1's (Box of 10's) | Rx | Reyoung Pharmaceuticals Co., Ltd.China | Pharmaessence Inc. | DRP-14502 | Sep 14, 2028 | |
Cefstal-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s and 100’s( | Rx | Sakar Healthcare Pvt. Ltd.India | GJK Pharma DistributorsImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385 | Jul 14, 2029 | |
CeftCefuroxime (as axetil) | 250 mg/5 ml Granules for Suspension50ml in 120ml Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: D.B. Manix International, Inc. | DRP-8191 | Jan 13, 2030 | |
CeftCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: D.B. Manix International, Inc. | DRP-16629 | Jun 23, 2031 | |
CeftCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister Pack x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: D.B. Manix International, Inc. | DRP-6830 | Feb 17, 2030 | |
CeftCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Medirich Pharma Distribution Corp.Importer: D.B. Manix International, Inc. | DRP-076-02 | Dec 21, 2029 | |
Ceft-AXCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Foramen Products Corporation | DRP-7789-01 | Sep 19, 2031 | |
CeftaxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Ellebasy Medicale TradingImporter: Greencore Pharma, Inc. | DRP-9975-02 | Jul 1, 2031 | |
Ceftrinova 1000Cefuroxime (as sodium) | 1 g Powder for Injection (I.V/I.M)10 mL-Capacity USP Type III Flint Glass Vial with Grey Butyl Rubber Stopper and Red Aluminum Flip- Off Seal (Box of 1's; Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Medinova Pharmaceutical, Inc. | DRP-10960 | Dec 22, 2026 | |
CefubestCefuroxime (as sodium) | 750 mg Powder for Injection(IM/IV)USP Type I Glass vial with rubber stopper and orange flip-off seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | QLap Endoscopics Inc.Importer: H & B Pharma International Inc. | DRP-4342-08 | Jun 4, 2027 | |
Cefubest-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip Off Seal (Box of 1’s and 10's) | Rx | Samjin Pharm. Co., Ltd.Republic of Korea | QLap Endoscopics Inc.Importer: Medbridge, Inc. | DRP-2729-02 | Jul 6, 2027 | |
CefucircCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister Pack x 4's (Box of 20 's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | PharmaCircle Enterprise CorporationImporter: Pharmakon Biotec Inc. | DRP-5017-10 | Dec 18, 2028 | |
CefucoreCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminum plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Bluecore Philippines Inc.Importer: Euro-Care Products Philippines | DRP-11801-04 | Apr 29, 2027 | |
CefucuraCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type III Clear and Colorless Glass Vial (Box of 10's & 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | RVM Pharma & Medical Supplies DistributionImporter: Orange Biotec Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-4313-04 | Mar 20, 2028 | |
CefucyCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Individually Boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10 mL (Box of 10’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Cyden Medicale Trading Inc.Importer: AMB HK Enterprises Inc. | DRP-3600-04 | Feb 14, 2029 | |
CefudecCefuroxime | 750 mg Powder for InjectionUST Type II Glass Vial with rubber stopper and yellow flip-off seal +10 m L diluent in plastic ampoule (Sterile Water for Injection) (Box of 1's) | Rx | Elfin Drugs Pvt Ltd.India | Decamed Pharmaceutical Trading Inc.Importer: Divjot Enterprises Corp | DRP-5015-01 | Mar 19, 2029 | |
CefudecCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Deca Pharmaceutical and Trading Corp.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-13 | Mar 29, 2027 | |
CefudexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 5's Box of 10's | Rx | Oman Pharmaceuticals Products Co., LLCOman | Madecs Pharma CorporationImporter: Atlantic Pharmaceuticals, Inc. | DRP-7507-01 | Sep 5, 2029 | |
1.5 g Powder for Injection (IM/IV)In a box, 15 mL- capacity USP Type I Glass Vial with rubber stopper and flip off cap and USP Type I glass ampoule x 10 mL (diluent) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Largen Med Inc.Importer: Dreamax Incorporated | DRP-14306-01 | Aug 16, 2028 | ||
CefudimeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type III clear and colorless glass vial with rubber stopper and white flip-off seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) | Rx | Inject Care Parenterals Pvt. Ltd.India | Pharmadyme Philippines, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-04 | Mar 24, 2029 | |
Cefudime-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Theon Pharmaceuticals Ltd.India | Pharmadyme Philippines, Inc.Importer: Orange Biotec Inc. | DRP-8203-01 | May 24, 2029 | |
CefudyneCefuroxime (as axetil) | 250 mg / 5 mL Powder for Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 70 mL (Box of 1’s) | Rx | Globela Laboratories Private LimitedIndia | Nurturemed Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12854-04 | Oct 28, 2027 | |
CefudyneCefuroxime (as Axetil) | 250 mg/5 mL Powder for Suspension50 mL (net content) filled in 120 mL Boston Round Amber Bottle; 70 mL (net content) filled in 120 mL Boston Round Amber Bottle | Rx | Sydenham Laboratories, Inc.Philippines | Nurturemed Pharma Inc. | DRP-1181-06 | Jun 27, 2029 | |
CefudyneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Nurturemed Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-05 | Oct 24, 2028 | |
CefueastCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | 228 Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-10 | Sep 28, 2027 | |
CefufarmCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sakar Healthcare Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-02 | Jul 14, 2029 | |
Cefufarm 750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Diafarm Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-04 | Dec 27, 2028 | |
CefuferCefuroxime (as Axetil) | 125 mg/ 5 mL Powder for SuspensionHDPE Plastic Bottle x 50 mL with Plastic Measuring Cup and Spoon (Box of 1's) | Rx | PharmEvo (Pvt.) Ltd.Pakistan | Ferjan Healthlink Philippines, Inc.Importer: Accesspoint International Trading Inc. | DRP-4939-01 | Nov 19, 2028 | |
CefufirstCefuroxime (as Axetil) | 125 mg/5 mL Granules for Oral SuspensionBoston Round Amber Glass Bottle x 50 mL (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | FIRSTMED THERACONCEPT INC. | DRP-7544 | Oct 14, 2029 | |
CefufirstCefuroxime (As Axetil) | 250 mg/5 mL Granules For Oral SuspensionBoston Round Amber Glass Bottle in 50 mL (net content when reconstituted) (Box of 1's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Firstmed Theraconcept Inc. | DRP-7543 | Oct 14, 2029 | |
CefufirstCefuroxime (As Axetil) | 500mg Film-Coated TabletAlu - Alu Blister Pack X 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Firstmed Theraconcept Inc. | DRP-4618-07 | Aug 18, 2031 | |
CefugetCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Getz Pharma (Phils.), Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-5503-01 | Mar 29, 2027 | |
CefugetCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Getz Pharma (Phils.), Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-08 | Sep 28, 2027 | |
CefugoCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-25 | Sep 28, 2027 | |
CefugoldCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 10's, 30's, 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Brilliantmeed, Inc. | DRP-11151-07 | Feb 8, 2027 | |
CefuhilCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionTranslucent white HDPE Bottle with PP cap and measuring cup x 30 mL, 60 mL, and 70 mL (Box of 1's) | Rx | Globela Laboratories Pvt. Ltd.India | Euroasia Pharmaceuticals, Inc.Importer: AMB HK Enterprises Inc. | DRP-12854-05 | Oct 28, 2027 | |
CefuhilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Zim Laboratories LimitedIndia | Euroasia Pharmaceuticals, Inc.Importer: Medinova Pharmaceutical, Inc. | DRP-15901-05 | Sep 27, 2029 | |
CefuhilCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL tubular glass vial with butyl rubber stopper and flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | EuroAsia Pharmaceuticals Inc. | DRP-11928 | May 20, 2032 | |
CefuhilCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | EuroAsia Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-04 | Mar 29, 2027 | |
CefukerCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack of 10's (Box of 10's) | Rx | Innova Captab Ltd.India | Teramedix Pharma Trading, Inc. | DRP-15542 | Aug 7, 2029 | |
Cefukon-750Cefuroxime (As Sodium) | 750 mg Powder For Injection (Im/Iv)Protect from light. : Type III Clear Glass Vial with Gray Bromobutyl Rubber Stopper and Blue Flip-Off Seal Cap x l's (Box of l's) | Rx | Sance Laboratories Private LimitedIndia | Importer: Pharmakon Biotec, Inc. | DRP-10855 | Dec 9, 2026 | |
Cefukon-DSCefuroxime (as axetil) | 125mg/5mL Powder for Oral Suspension60 mL white HDPE bottle with white HDPE cap and transparent plastic measuring cup (box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | Pharmakon Biotec, Inc. | DRP-9477 | Nov 17, 2026Past listed date | |
CefulabCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Labmate Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-4975-07 | Apr 27, 2031 | |
CefulabCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Labmate Pharma Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-12 | Mar 29, 2027 | |
CefulabCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL + 10 mL Sterile Water for Injection as diluent (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Labmate Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-8403-12 | Feb 15, 2028 | |
Cefulev 1.5Cefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc.Importer: Greencore Pharma Inc. | DRP-8746-10 | Mar 6, 2031 | |
Cefulev 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc.Importer: Greencore Pharma Inc. | DRP-9975-12 | Feb 7, 2032 | |
CefulorCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 mL -Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue Flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Loriel PharmaceuticareImporter: Afree Pharmaceutical Distribution Corp. | DRP-13459-03 | Feb 23, 2028 | |
CefumacCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Ma Conglomo Med Corp.Importer: Greencore Pharma Inc. | DRP-8746-09 | Feb 20, 2031 | |
CefumaxCefuroxime (as Axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | Nutramedica Inc. | DRP-3442-01 | Aug 25, 2031 | |
CefumaxCefuroxime (as sodium) | 750 mg Powder for Injection(I.M./I.V.)USP Type I Glass Vial x 10 mL (Box 1's and Box 10's) | Rx | Gentle Pharma Co., Ltd.ROC | Nutramedica, Inc.Importer: Neo Care Philippines, Inc | DRP-2596-01 | Jun 3, 2031 | |
CefumedCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type I Glass Vial with Rubber Stopper and Green Flip-Off Seal (Box of 1's) | Rx | Shanxi Shuguang Pharmaceutical Co. Ltd.China | Importer: Asianmeds, Inc. | DR-XY36367 | Jul 29, 2027 | |
CefuniCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Universal MBF Pharma (UMP), Co.Importer: Pharmakon Biotec Inc. | DRP-4976-07 | Nov 27, 2028 | |
Cefuni 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Universal MBF Pharma (UMP), Co.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-08 | Oct 24, 2028 | |
CefuniumCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule Box of 1 vial + 1 Ampoule Diluent | Rx | NCPC Hebei Huamin Pharmaceutical Co., Ltd.China | Titanium PharmaImporter: Aglobal Care, Inc. | DRP-6570-17 | Mar 10, 2029 | |
CefunovaCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-Off Seal Cap x l's (Box of l’s) | Rx | Yeluri Formulations Pvt. Ltd.India | Importer: Medinova Pharmaceutical, Inc. | DRP-10888 | Dec 14, 2026 | |
CefupakCefuroxime (as Axetil) | 125 mg/ 5ml Powder for SuspensionHDPE White Plastic Bottle x 50 ml (Box of 1's) | Rx | Opal Laboratories (Pvt.) LimitedPakistan | Geo Pak International Trading Corp.Importer: Accesspoint International Trading Inc. | DRP-5053-02 | Sep 30, 2031 | |
Cefupen 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Glass Vial + 10 mL USP Type I Clear Glass Ampoule Sterile water for injection (as Diluent) (Box of 1's) | Rx | Zazen Pharma Pvt. Ltd.India | Planetarium Enterprise, Inc.Importer: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-4515-10 | Jul 18, 2028 | |
Cefupen-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Planetarium Enterprise, Inc.Importer: Greencore Pharma Inc. | DRP-9975-11 | Feb 8, 2032 | |
CefupharmCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Pharmacom DistributionImporter: Ambica International Corporation | DRP-4164-07 | Dec 27, 2027 | |
CefuphilCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | Phil Asia Pharma Inc.Importer: Ambica International Corporation | DRP-4164-11 | Dec 27, 2027 | |
CEFUPLUSCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's) | Rx | Sakar Healthcare LimitedIndia | DIAFARM INC.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-11 | Jul 19, 2029 | |
CefuprimeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass Vial with Halogenated Rubber Stopper and Aluminium Plastic Combination Flip-Off cap + 10 mL Type I Colorless Ampoule (Water for Injection as diluent) in a Box | Rx | Furen Pharmaceutical Group Co., Ltd.China | MedRep Plus Pharmaceuticals Inc.Importer: Euro-Care Products Philippines | DRP-11801-01 | Apr 29, 2027 | |
CefuquestCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Friends Pharma (Pvt.) Ltd.Pakistan | Health-Quest Pharma and Medical SuppliesImporter: Raquel-Abbas Pharmaceuticals & General Merchandise | DRP-9993-02 | Mar 10, 2031 | |
CEFUQUEST 250CEFUROXIME (AS AXETIL) | 250 MG / 5 ML GRANULES FOR ORAL SUSPENSIONBOSTON ROUND AMBER GLASS BOTTLE IN 50 ML (NET CONTENT WHEN RECONSTITUTED) (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | HEALTH-QUEST PHARMA AND MEDICAL SUPPLIES TRADING | DRP-7543-07 | Oct 14, 2029 | |
Cefuquest 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Theon Pharmaceuticals Ltd.India | Health-Quest Pharma and Medical Supplies TradingImporter: Orange Biotec Inc. | DRP-8203-12 | May 24, 2029 | |
CefuraxCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Wecare Pharma Corp.Importer: D.B. Manix International, Inc. | DRP-076-03 | Dec 21, 2029 | |
Cefurax-AxCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | WeCare Pharma Corp.Trader: Foramen Products Corporation | DRP-7789-03 | Aug 17, 2031 | |
CefurexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: The Cathay Drug Company, Inc. | DR-XY40991 | Jun 28, 2027 | |
CefurexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: The Cathay Drug Company, Inc. | DR-XY47052 | Mar 12, 2031 | |
CefurexCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s) | Rx | Theon Pharmaceuticals Ltd.India | The Cathay Drug Co., Inc.Importer: Orange Biotec Inc. | DRP-8203-03 | May 24, 2029 | |
Cefurex 125Cefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 70 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | The Cathay Drug Co., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5745-01 | Apr 24, 2029 | |
Cefurex 250Cefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | The Cathay YSS Distributors Co., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-04 | Jun 30, 2029 | |
CefurexelCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Excelpharm CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-26 | Sep 28, 2027 | |
CefurifeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Rifemedica CorporationImporter: Sanimed Pharmaceuticals Inc. | DRP-7126-11 | Mar 29, 2027 | |
CefurineCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 10’s and 50’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Vintel Med EnterprisesImporter: AMB HK Enterprises | DRP-3600-07 | Feb 14, 2029 | |
CefuringCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-03 | Dec 27, 2028 | |
CefurogenCefuroxime (As Axetil) | 500mg Film-Coated TabletAlu/Alu blister Pack x 8's (Box of 3 blister packs x 8 tablets) | Rx | Azarias Pharmaceutical Laboratories Inc.,Philippines | Trader: Eba Generisch Trading Inc. | DRP-14048 | Jun 8, 2028 | |
Cefurolive 750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-4976-31 | Nov 27, 2028 | |
CefuromaxCefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap x 1's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated | DRP-11361-02 | Mar 4, 2027 | |
CefuronixCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Zim Laboratories LimitedIndia | GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc. | DRP-15901-01 | Sep 27, 2029 | |
CefuroxCefuroxime Axetil | 125 mg /5 mL Powder for SuspensionAmber Glass Bottle x 50 mL and 70 mL (Box of 1's) | Rx | Medicaids Pakistan (Pvt.) Ltd.Pakistan | Sahar International Trading, Inc. | DRP-2563 | Mar 29, 2030 | |
CefuroxCefuroxime (as axetil) | 125 mg TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Medicaids Pakistan (Pvt.) Ltd.Pakistan | Sahar International Trading Inc. | DR-XY37380 | Feb 2, 2027 | |
CEFUROXCefuroxime (as Axetil) | 250 mg Film Coated-TabletALU/ALU BLISTER PACK X 7'S (BOX OF 14's) | Rx | MEDICAIDS PAKSITAN (PVT) LTD.Pakistan | SAHAR INTERNATIONAL TRADING, INC. | DR-XY36892 | Nov 3, 2029 | |
CefuroxCefuroxime (as axetil) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 50mL with measuring cup (Box of 1's) | Rx | Medicaids Pakistan (Pvt.) Ltd.Pakistan | Sahar International Trading, Inc. | DRP-2562 | May 4, 2031 | |
CefuroxCefuroxime (as Axetil) | 500 mg TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Medicaids Pakistan (Pvt.) Ltd.Pakistan | Sahar International Trading Inc. | DRP-3607 | Dec 3, 2031 | |
CefuroxxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | One Technodrug Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-4976-26 | Nov 27, 2028 | |
CefuryCefuroxime (as sodium) | 750 mg Powder For Injection (IM/IV)USP Type II glass vial with flip-off cap and butyl rubber stopper (Box of l's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Aglobal Care, Inc. | DRP-11097 | Jan 28, 2027 | |
CefusaphCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's; Alu/Alu Blister Pack x 10's Box of 30's | Rx | Sunlovis Pharmaceuticals LLPIndia | NELPA LIFESCIENCES, INC.Trader: SAPPHIRE LIFESCIENCES PVT. LTD | DRP-4857 | Oct 24, 2028 | |
Cefusaph-125Cefuroxime (as axetil) | 125 mg/5 mL Powder for SuspensionBoston Round Bottle with White HDPE Cap x 60 mL and 70 mL (Box of 1's) | Rx | Sunlovis Pharmaceutical LLPIndia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8291 | Mar 17, 2031 | |
Cefusaph-1500Cefuroxime (as Sodium) | 1.5 g Powder For Injection (I.M./I.V.)USP Type III Clear Glass Vial with Bromo Butyl rubber stopper and Flip-off Aluminium seal x 20 mL 1's and 10's) | Rx | Kilitch Drugs (India) Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-13148 | Dec 7, 2027 | |
Cefusaph-250Cefuroxime (as axetil) | 250 mg/5 mL Powder for SuspensionBoston Round Bottle with White HDPE Cap x 60 mL (Box of 1's) | Rx | Sunlovis Pharmaceutical LLPindia | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8287 | Mar 17, 2031 | |
Cefusaph-750Cefuroxime (as Sodium) | 750 mg Powder For Injection (IV/IM)Type I Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Blue Flip-Off Seal Cap x l's + Sterile Water for Injection in Clear Glass Ampoule x 10 mL (Box of l's) | Rx | Kilitch Drugs (India) Ltd.India | Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-11017 | Feb 11, 2027 | |
CEFUSAVE-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | SAVELINK PHARMA AND TRADING CO.Importer: AGLOBAL CARE, INC. | DRP-6570-12 | Mar 10, 2029 | |
CefuseaCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear Flint Glass Vial x 10 mL (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | SEA-King Pharma Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5927-02 | Jan 12, 2030 | |
Cefuseth-125Cefuroxime (as Axetil) | 125 mg/5 mL Powder for SuspensionBoston Round Amber Bottle with Alu Screw Pilfer Proof Cap x 60 mL (Box of 1's) | Rx | SAPPHIRE LIFESCIENCES PVT. LTD.India | 777 Red Pharma IncImporter: Nelpa Lifesciences, Inc. | DRP-8291-01 | May 16, 2027 | |
Cefuseth-250Cefuroxime (as Axetil) | 250 mg/ 5 mL Powder for SuspensionBoston Round Bottle with Alu Screw Pilfer Proof Cap x 60 mL Box of 1's | Rx | SAPPHIRE LIFESCIENCES PVT. LTDIndia | 777 Red Pharma IncImporter: Nelpa Lifesciences, Inc. | DRP-8287-01 | May 16, 2027 | |
CefusinaiCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Oro Sinai Pharma and General Merchandise, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-21 | Sep 28, 2027 | |
CefutamCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-Off Seal Cap x 1's (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Tamiga Pharmaceuticals SupplyImporter: Medinova Pharmaceutical Inc. | DRP-10888-03 | Dec 14, 2026 | |
Cefutam 1.5Cefuroxime (as sodium) | 1.5 g Powder for Injection (I.M./I.V.)20 mL USP Type III clear glass vial sealed with grey butyl rubber stopper and flip-off seal (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Tamiga Pharmaceuticals SupplyImporter: Medinova Pharmaceutical Inc. | DRP-12076-01 | Jun 8, 2027 | |
Cefutam 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's & 100's) | Rx | Zim Laboratories LimitedIndia | Tamiga Pharmaceuticals SupplyImporter: Medinova Pharmaceutical Inc. | DRP-15901-02 | Sep 27, 2029 | |
Cefutech 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises Inc. | DRP-4975-11 | May 20, 2031 | |
Cefutech IVCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-Off Seal x 15 ml + 10 ml Sterile Water for Injection as diluent (Box of 1’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | SNV Biotech Medicinal Products WholesalingImporter: AMB HK Enterprises | DRP-8403-11 | Feb 15, 2028 | |
CefutexCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | I.P.S. Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4164-13 | Dec 27, 2027 | |
CefutreveCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s | Rx | Brawn Laboratories LimitedIndia | Tri-Eve Pharmaceutical MarketingImporter: Ambica International Corporation | DRP-4164-31 | Dec 27, 2027 | |
CefuvastCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Clear Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x 1's + Sterile Water for Injection in LDPE Plastic Ampoule x 10 mL (Box of 1's) | Rx | Swiss Parentals Ltd.India | QLap Endoscopics Inc.Importer: GPC Geo Pharma Corporation | DRP-11250-05 | Feb 17, 2027 | |
CefuvexCefuroxime (as sodium) | 1.5g Powder for Injection (I.M/I.V)Type II clear and colorless glass vial (box of 10 vials in individual cartons) | Rx | Zhuhai United Laboratories (Zhongshan) Co., Ltd.China | Sannovex Pharmaceutical Distributor | DRP-6532 | Feb 16, 2031 | |
CefuvexCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)individually boxed Type II Glass Vial with violet flip-off seal (Box of 10's) | Rx | SHANDONG XIERKANGTAI PHARMACEUTICAL CO. LTD.China | Sannovex Pharmaceutical Distributor | DRP-1955 | May 13, 2029 | |
CefuvicCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear Flint Glass Vial x 10 mL (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | NJT EnterprisesImporter: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5927 | Jan 12, 2030 | |
CefuvilCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type II Clear Glass Vial with Blue Flip-Off Seal (Box of 1's) | Rx | Kinhoo Pharmaceutical Co., Ltd.China | Medville Pharma Inc.Importer: Sahar International Trading Inc. | DRP-7062-02 | Sep 1, 2031 | |
CefuvinCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Vincare PharmaTrader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-7160-01 | Oct 24, 2027 | |
CefuwestCefuroxime (as Axetil) | 250 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 50 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Westpoint Pharma Inc. | DRP-3231-16 | Sep 7, 2028 | |
CefuxCefuroxime (as Axetil) | 125 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gold Life Distribution Phils. Inc. | DRP-8431 | Feb 28, 2028 | |
CefuxCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Medirich Pharma Distribution Corp.Trader: Gold Life Distribution Phils. Inc. | DRP-8430 | Jan 19, 2031 | |
CefuxalCefuroxime (as axetll) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Wecare Pharma Corp.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-2103-09 | Sep 18, 2028 | |
CefuxalCefuroxime (as Axetil) | 500 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 50's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | WECARE PHARMA CORP. | DRP-7568-04 | Feb 24, 2029 | |
CefuxanCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Pharmakon Biotec Inc | DRP-14474 | Jul 10, 2030 | |
CefuxcureCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | Ezmeds Pharma Co.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-01 | Jun 30, 2029 | |
CefuxilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister Pack x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Westfield Pharmaceuticals, Inc.Trader: D.B. Manix International, Inc. | DRP-6830-01 | Feb 17, 2030 | |
CefuximCefuroxime (as Axetil) | 250 mg/5 mL Granules for Suspension120 mL Amber Glass Bottle with White Aluminum Cap x 50 mL Net Content (Box of 1's) | Rx | Drugmaker's Laboratories Inc.Philippines | — | DRP-1170 | May 11, 2031 | |
CefuximCefuroxime (as Axetil) | 500mg TabletClear PVC blister pack x 10's (Box of 30's); Clear PVC blister pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | — | DRP-2144 | Nov 12, 2027 | |
CefuzelCefuroxime (As Sodium) | 750 mg Powder For Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule X 10 mL (Diluent) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | Pharmazel, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-15 | Sep 28, 2027 | |
CefuzenCefuroxime (As sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 10's); USP Type I Borosilicate Glass Vial with blue flip-off seal x 10 mL (Box of 50's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Genzen Pharmaceutical TradingImporter: AMB HK Enterprises Inc. | DRP-3600-06 | Feb 14, 2029 | |
CefxifixCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's and 100's | Rx | Brawn Laboratories LimitedIndia | Pharmazel, Inc.Importer: Ambica International Corporation | DRP-4164-04 | Dec 27, 2027 | |
CefzimeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharmacare Products CorporationImporter: AMB HK Enterprises Inc. | DRP-4975-10 | Apr 1, 2031 | |
CefzimeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sakar Healthcare Pvt. Ltd.India | PHARMACARE PRODUCTS CORPORATIONImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-04 | Jul 14, 2029 | |
CemaxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 20's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharmakon Biotec Inc. | DRP-5017 | Jul 16, 2030 | |
CentroximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | The One Bataan Santisimo Rosario Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-02 | Sep 28, 2027 | |
Cephatic-500Cefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Pharma-Surrey International, Inc. | DRP-11034 | Jan 27, 2027 | |
CephaximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL Box of 10's | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Bio Erixx Pharma DistributionImporter: AMB HK Enteprises Inc. | DRP-8403-03 | Feb 15, 2028 | |
CephinCefuroxime (as sodium) | 750 mg Powder for Injection (IM/ IV)Clear and colorless glass vial with rubber stopper and blue flip-off seal (Box of 1’s) | Rx | T.P. Drug Laboratories (1969) Co., Ltd.Thailand | Lordla Pharma Sales | DRP-580 | Feb 17, 2028 | |
CerinCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Globela Laboratories Pvt. Ltd.India | Curecare Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-12213-07 | Jul 13, 2027 | |
Cerin-250Cefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionTranslucent white HDPE Bottle with PP cap and measuring cup x 60 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Curecare Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-12854-03 | Oct 28, 2027 | |
CerosanCefuroxime (As Sodium) | 750mg Powder For Injection (IM/IV)10 mL USP Type II glass vial with butyl rubber stopper and flip-off seal (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Sanimed Pharmaceuticals Inc. | DRP-12005 | May 27, 2027 | |
CervinCefuroxime (as Axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | Lewison Pharmaceutical Corporation | DRP-3442-02 | Aug 6, 2031 | |
CetilCefuroxime (as axetil) | 500 mg Film-Coated TabletBlister pack x l0's (Box of 50's) | Rx | Lupin LimitedIndia | Lupin Philippines, Inc. | DRP-1908 | Oct 9, 2029 | |
CetraximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister pack x 10’s (Box of 10’s) | Rx | Zeiss Pharma Ltd.India | Novocore Pharma Inc.Importer: SRS Life Sciences Inc. | DRP-16691-01 | Nov 14, 2029 | |
Ceurox-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Medley Pharmaceuticals LimitedIndia | Ambica International Corporation | DRP-6459 | Feb 24, 2029 | |
CifremCefuroxime (as axetil) | 125mg/5mL Powder for SuspensionAmber Glass Bottle x 70mL Box of 1's | Rx | Biopharma LimitedBangladesh | Importer: JF Draf Pharmaceuticals Corp. | DRP-3211 | Sep 8, 2027 | |
CifremCefuroxime (As Axetil) | 500 mg TabetAlu/Alu Blister Pack x 4's (Box of 12's and 24's) | Rx | Biopharma Laboratories Ltd.Bangladesh | JF DRAF PHARMACEUTICALS CORPORATION | DRP-2555 | Aug 27, 2030 | |
Cifrem ForteCefuroxime (as axetil) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 50 mL (Box of 1's) | Rx | Biopharma LimitedBangladesh | Importer: JF Draf Pharmaceuticals Corporation | DRP-3210 | Sep 8, 2027 | |
CimexCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper & Orange Flip-off Seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Multicare Pharmaceuticals Phils. Inc.Importer: H & B Pharma International Inc. | DRP-4505 | Jul 30, 2027 | |
CimexCefuroxime (as axetil) | 250 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle w/ Aluminum PP cap x 50 mL in a 120 mL Bottle (Box of 1's) | Rx | Sydenham Laboratories, Inc.Philippines | Trader: Multicare Pharmaceuticals Philippines, Inc. | DRP-4443 | Sep 23, 2028 | |
CimexCefuroxime (as axetil) | 500 mg Film-Coated TabletBlister Pack x 10's Box of 50's | Rx | LUPIN LIMITEDIndia | MULTICARE PHARMACEUTICALS PHILIPPINES, INC.Importer: LUPIN PHILIPPINES, INC. | DRP-1908-01 | Oct 9, 2029 | |
CimexCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass vial with rubber stopper and orange flip-off seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Multicare Pharmaceuticals Phils. Inc.Importer: H & B Pharma International Inc. | DRP-4342 | Jun 4, 2027 | |
Cimex PlusCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Multicare Pharmaceuticals Phils. Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-06 | Sep 28, 2027 | |
Cmaxid 1.5Cefuroxime (as Sodium) | 1.5 g Powder for Injection (IV)15 mL USP Type I Glass Vial with Violet Flip-off Seal + 10 mL Ampoule Sterile Water for Injection x 2' s (Box of 1 's) | Rx | Nectar Lifesciences Limited (Unit IV)India | Hovid Inc.Trader: Hovid Bhd. | DR-XY42301 | Jul 26, 2028 | |
Cmaxid 750Cefuroxime Sodium | 750 mg Powder for Injection (IM/IV)10 mL USP Type I glass vial with grey bromobutyl rubber stopper and orange flip-off seal + 10 mL Sterile Water for Injection, USP, packed in polyethylene plastic ampoule | Rx | Nectar Lifesciences Limited (Unit VI)India | Hovid, Inc.Trader: Hovid Bhd. | DR-XY42892 | Oct 31, 2028 | |
CongloximeCefuroxime(as Sodium) | 1.5 g Powder for lnjection (IM/IV)15mL USP Type III Clear Glass Vial (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | Ma Conglomo Med Corp.Importer: AMB HK Enterprises Inc. | DRP-5947-04 | Jan 21, 2030 | |
Congloxime-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminum plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box (Box of 1's + Diluent) | Rx | Furen Pharmaceutical Group Co., LtdChina | Ma Conglomo Med Corp.Importer: Euro-Care Products Philippines | DRP-11801-08 | Apr 29, 2027 | |
Congloxime-750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Ma Conglomo Med Corp.Importer: AMB HK Enteprises Inc. | DRP-8403-04 | Feb 15, 2028 | |
Congloxime-750Cefuroxime (as sodium) | 750mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | MA Conglomo Med Corp.Importer: Euro-Care Products Philippines | DRP-8837-05 | May 5, 2030 | |
ConneximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminum plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | D'conner PharmaImporter: Euro-Care Products Philippines | DRP-11801-11 | Apr 29, 2027 | |
CordiximeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Brawn Laboratories LimitedIndia | Marti-Lian Pharma LinkImporter: Ambica International Corporation | DRP-4164-26 | Dec 27, 2027 | |
CortumCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4’s (Box of 4’s); Alu/Alu Blister Pack x 4’s (Box of 12’s); Alu/Alu Blister Pack x 4’s (Box of 40’s) | Rx | Akums Drugs & Pharmaceuticals, Inc.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Ambica International CorporationTrader: Unosource Pharma Limited | DRP-2994 | Jun 9, 2029 | |
CuroximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type II Clear Glass Vial with rubber stopper and yellow flip-off seal +10 mL diluent in plastic ampoule (Sterile Water for Injection) Box of 1's | Rx | Elfin Drugs Pvt., Ltd.India | Divjot Enterprises Corp. | DRP-5015 | Mar 19, 2029 | |
DanixcynCefuroxime (as Sodium) | 750 mg Powder For Injection (IM/IV)Clear Glass Vial with Rubber Closure and Tear-off Aluminum Seal with Blue Flip-off Cap x 7.5mL (Box of 1's and 10's) | Rx | Syncom Formulations Ltd.India | JNCS MarketingImporter: Arvincare Pharma Inc. | DRP-305-05 | May 12, 2028 | |
DanoximeCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type II Clear Glass Vial with Blue Flip-Off Seal (Box of 1's) | Rx | Kinhoo Pharmaceutical Co., Ltd.China | Sahar International Trading Inc. | DRP-7062 | Sep 1, 2031 | |
DanoximeCefuroxime sodium | 1g Powder for Injection (IM/IV)USP Type I Glass Vial (Box of 1's) | Rx | Kinhoo Pharmaceutical Co., Ltd.China | Sahar International Trading, Inc. | DRP-3615 | Nov 18, 2030 | |
DanoximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial + 10 mL Clear Ampoule WFI (Diluent) per Box (Box of 1's) | Rx | Kinhoo Pharmaceutical Co., Ltd.P.R. of China | Sahar International Trading Inc. | DRP-5060 | Oct 14, 2031 | |
DecaximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white Flip-off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Decano Drug Distribution ServicesImporter: Pharmakon Biotec Inc. | DRP-4976-28 | Nov 27, 2028 | |
DiacefarmCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | JVZEA Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4164-17 | Dec 27, 2027 | |
Diacefarm 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear and Colorless Glass Vial with Yellow Flip Off Seal Box of 1’s | Rx | Cadila Pharmaceuticals Ltd.India | Diafarm Inc.Importer: Ambica International Corporation | DRP-1130-04 | Jul 24, 2029 | |
DincefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | DNBG Pharmaceuticals Phils.Importer: Steinbach Products Inc. | DRP-2018-05 | Feb 1, 2027 | |
DinoxefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | DNBG Pharmaceuticals Phils.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-10 | Mar 29, 2027 | |
DomicefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack (Box of 10's and 30’s) | Rx | Theon Pharmaceuticals Ltd.India | Domineight Trading Corp.Importer: Orange Biotec Inc. | DRP-8203-08 | May 24, 2029 | |
DucefCefuroxime | 1.5 g Dry Powder for Injection (IM/IV)20 ml moulded clear glass vial USP Type-III with sealed with grey bromobutyl rubber and 20 mm red flip-off seal (Box of 1’s) | Rx | Theon Pharmaceuticals LimitedIndia | Iberica Verheilen Pharmaceuticals Group Corp.Importer: Verheilen Iberica Health Care Company Inc.Trader: Farma Iberica SL | DR-XY46771 | Nov 27, 2029 | |
DucefCefuroxime | 750 mg Powder for Injection (IM/IV)10 ml moulded clear glass vial USP Type-III with sealed with grey bromobutyl rubber and 20 mm red flip-off seal (Box of 1’s) | Rx | Theon Pharmaceuticals LimitedIndia | Iberica Verheilen Pharmaceuticals Group Corp.Importer: Verheilen Iberica Health Care Company Inc.Trader: Farma Iberica SL | DR-XY46770 | Nov 27, 2029 | |
EcozimeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Econo Pharma TradingImporter: Greencore Pharma Inc. | DRP-9975-13 | Feb 8, 2032 | |
EducefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's and 100's) | Rx | Medley Pharmaceuticals LimitedIndia | Edu Pharma EnterpriseImporter: Ambica International Corporation | DRP-6459-02 | Feb 24, 2029 | |
Educef-250Cefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Edu Pharma EnterpriseImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-05 | Jun 30, 2029 | |
Efrox-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M. /I.V.)USP Type I Glass vial with rubber stopper & orange flip-off seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Starpharm Inc.Importer: H & B Pharma International Inc. | DRP-4342-04 | Jun 4, 2027 | |
Efrox™Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Starpharm, Inc. | DRP-11151-05 | Feb 8, 2027 | |
ElbacefCefuroxime (as Sodium) | 1.5 g Powder for Injection (IM / IV)USP Type II Clear Glass Vial with Blue Flip-Off Seal (Box of 1's) | Rx | Kinhoo Pharmaceutical Co., Ltd.China | Ellebasy Medicale TradingImporter: Sahar International Trading Inc. | DRP-7062-01 | Sep 1, 2031 | |
ElicefCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content) as diluent Sterile Water for Injection) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd. - Unit IIIIndia | Elice Pharma CorporationImporter: I.E. Medica, Inc. | DRP-3115-03 | Feb 17, 2027 | |
EliximeCefuroxime (as Axetil) | 500 mg TabletFoil Strip x 4's (Box of 20's) | Rx | EL Laboratories, Inc.Philippines | Trader: Elin Pharmaceuticals, Inc. | DRP-437 | May 9, 2027 | |
EliximeCefuroxime (as sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Elin Pharmaceuticals, Inc.Importer: Phil. Shinpoong Pharma Inc. | DRP-3036-01 | Feb 8, 2032 | |
EmixefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Northmed Pharma and Medical Supplies DistributionImporter: Pharmakon Biotec Inc. | DRP-4976-29 | Nov 27, 2028 | |
Eoroxime-250Cefuroxime (as axetil) | 250 mg/5 mL Powder for Oral Suspension50 mL-net content opaque white PET bottle (Box of 1's) with plastic cap and plastic dose cup | Rx | Zee Laboratories LimitedIndia | Eon Pharmatek, Inc. | DR-XY49013 | Mar 5, 2029 | |
Eoroxime-750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL-Capacity USP Type I Amber colored Glass Vial (Box of 1's) | Rx | Zee Laboratories LimitedIndia | Eon Pharmatek Inc. | DR-XY48427 | Nov 16, 2027 | |
EphaloxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Jazmark PharmaceuticalImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-07 | Sep 28, 2027 | |
EpiroxCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type I Glass Vial with White Flip- off Seal + LDPE ampoule Sterile Water for Injection (Diluent) x 20 mL (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharmakon Biotec Inc. | DRP-4983 | Dec 9, 2028 | |
EpiroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Pharmakon Biotec Inc. | DRP-4976 | Nov 27, 2028 | |
EquiroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with White Flip-off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Healthcare Pharma, Co.Importer: Pharmakon Biotec Inc. | DRP-4976-06 | Nov 27, 2028 | |
ErazeCefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 70 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5745 | Apr 24, 2029 | |
EroximeCefuroxime (as axetil) | 500mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. Ltd.India | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12213 | Jul 13, 2027 | |
EroximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10 mL (Box of 10’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-3600-02 | Feb 14, 2029 | |
Eroxime +Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL + 10 mL Sterile Water for Injection as diluent (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-8403-10 | Feb 15, 2028 | |
Eroxime-1500Cefuroxime (as Sodium) | 1.5 g Powder for Injection (IM/IV)15mL USP Type III Clear Glass Vial (Box of 1 's) | Rx | Sance Laboratories Pvt. Ltd.India | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-5947-01 | Jan 21, 2030 | |
Eroxime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. LtdIndia | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12213-03 | Jul 13, 2027 | |
Eroxime-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Philrx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-4975-05 | May 25, 2031 | |
Eroxime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | PhilRx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-6113-02 | Mar 12, 2030 | |
EroxmitCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./ I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Justright Healthcare Inc.Importer: Largen Med Inc. | DRP-4774-02 | Jan 9, 2028 | |
Eroxmit 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Justright Healthcare Inc. | DR-XY39107 | Aug 27, 2030 | |
Eroxmit IVCefuroxime (as sodium) | 750 mg Powder for Injection (I.M/I.V)USP Type I Glass Vial x 10 mL (Box of 10's) | Rx | Gentle Pharma Co., Ltd.Taiwan | JustRight Healthcare Inc.Importer: Neo Care Philippines Inc. | DRP-2596-02 | Aug 19, 2031 | |
EscaltaCefuroxime (as axetil) | 500 mg Film coated tabletAlu-Alu Blister Pack x 10's (Box of 30's) | Rx | Medico Remedies LimitedIndia | Helande Kidney Care Inc.Importer: Medethix, Inc. | DRP-16457-02 | Mar 18, 2030 | |
EssefuroximeCefuroxime (as sodium) | 750 mg Powder for injection (IM/IV)USP Type I Glass vial with rubber stopper & orange flip-off seal (Box of 10 vials) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Pharmaessence Inc.Importer: H & B Pharma International Inc. | DRP-4342-07 | Jun 4, 2027 | |
EurimaxCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | Scheeling, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-02 | Jun 30, 2029 | |
EurimaxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Scheeling, Inc.Importer: Ambica International Corporation | DRP-4164-15 | Dec 27, 2027 | |
EurimaxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Scheeling, Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-10 | Oct 24, 2028 | |
EurimaxCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Individually boxed clear and colorless glass vial (Box of 10's) | Rx | Flamingo Pharmaceuticals Ltd.India | Scheeling, Inc.Importer: Hexagon Pharmaceuticals | DRP-282-02 | Dec 10, 2027 | |
EurimaxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Scheeling, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-23 | Sep 28, 2027 | |
EuroximeCefuroxime (as axetil) | 125 mg/5 mL Granules for SuspensionBoston Round Amber Glass Bottle x 50 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY43049 | Dec 3, 2028 | |
EuroximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Totalcare Pharma Inc. | DR-XY47308 | Jun 22, 2031 | |
EuroximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Totalcare Pharma, Inc. | DRP-17862 | Jun 22, 2031 | |
EvoroxCefuroxime (as Axetil) | 125 mg/5 mL Powder for SuspensionHDPE Plastic Bottle x 50 mL with Plastic Measuring Cup and Spoon (Box of 1's) | Rx | PharmEvo (Pvt.) Ltd.Pakistan | Accesspoint International Trading Inc. | DRP-4939 | Nov 19, 2028 | |
ExecoreCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Greencore Pharma Inc. | DRP-8746 | Mar 6, 2031 | |
ExecoreCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Greencore Pharma Inc. | DRP-9975 | Jul 1, 2031 | |
ExecoreCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Greencore Pharma Inc. | DRP-8745 | Mar 2, 2031 | |
F-RoxxCefuroxime (as Axetil) | 500 mg TabletAlu/Alu Blister Pack x 7's (Box of 14's) | Rx | Medicaids Pakistan (Pvt), Ltd.Pakistan | Ferma Drug EnterprisesImporter: Sahar International Trading Inc. | DRP-3607-01 | Dec 3, 2026 | |
FarexilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Innova Captab Ltd.India | Pharmakon Biotec, Inc. | DRP-13664 | Mar 23, 2028 | |
FereximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear Glass Vial with Grey Butyl Rubber Stopper and Sealed with Aluminum Flip-Off Seal (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Suhitas Pharmaceuticals Inc. | DRP-8547 | Nov 7, 2029 | |
FeroximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV10 mL-capacity USP Type III clear glass vial with rubber stopper and green flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DR-XY48919 | Nov 16, 2028 | |
FeroximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL- capacity USP Type III clear glass vial with rubber stopper and green flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DRP-14992 | Nov 16, 2028 | |
FetnalCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Ambica International Corporation | DRP-4164 | Dec 27, 2027 | |
Fin-Cfu 750Cefuroxime ( as sodium ) | 750 mg Powder For Injection (IM/IV)10 mL-capacity Type I glass vial with rubber stopper and aluminum seal (Box of 1's) | Rx | Venus Remedies, LimitedIndia | Finstad Inc. | DRP-13990 | Jun 1, 2028 | |
FroxytilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 50's) | Rx | Sunlovis Pharmaceuticals LLPIndia | TGP Pharma Inc.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-06 | Oct 24, 2028 | |
Fucef 750Cefuroxime sodium | 750 mg Powder for Injection (IM/IV)In a box, 10 mL Type-III glass vial with 20 mm grey butyl rubber plug with 20 mm flip off seal and 10 mL Sterile Water for Injection LDPE ampoule (diluent) | Rx | Innova Captab Ltd.India | Airlife International Trading Corporation | DRP-17854 | Mar 25, 2031 | |
Fumerix-250Cefuroxime (as sodium) | 250 mg Powder for Injection (I.V./I.M.)Individually Boxed Type III Clear and Colorless Glass Vial with Green Flip-Off Seal + Type I Clear and Colorless Glass Ampoule x 10 mL (Sterile Water for Injection as diluent) (Box of 1's); Individually Boxed Type III Clear and Colorless Glass Vial with Green Flip-Off Seal + Type I Clear and Colorless Glass Ampoule x 10 mL (Sterile Water for Injection as diluent) (Box of 5's) | Rx | PharmEvo (Pvt.) Ltd.Pakistan | Accesspoint International Trading Inc. | DR-XY35284 | Jan 9, 2029 | |
FumicefCefuroxime (as Sodium) | 1.5g Powder for Injection (I.M./I.V.)20mL Capacity USP Type 1 clear and colorless glass vial (Box of 1's) | Rx | Haikou Pharmaceutical Factory Co., Ltd.China | Endure Medical, Inc. | DRP-16850 | Apr 11, 2031 | |
FurcefCefuroxime (as axetil) | 250 mg / 5mL Granules for Suspension120mL Amber Glass Bottle (net content: 50mL) (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Ivancor Importer | DR-XY37148 | Dec 3, 2029 | |
FurcefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY37711 | Mar 29, 2030 | |
FureximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type I Glass Vial + 10 ml Ampoule as Diluent (Box of 1's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Pharma King DistributorImporter: Largen Med, Inc. | DRP-6703-02 | May 24, 2031 | |
FurimaxCefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap x l's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of l's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-11361 | Mar 4, 2027 | |
Furimax-1500Cefuroxime (as Sodium) | 1.5g Powder for Injection (IM/IV)USP Type II Glass Vial x 15 mL with rubber stopper and flip-off cap (Box of 10's in a plastic tray) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-14311 | Aug 16, 2028 | |
1.5 g Powder for Injection (IM/IV)In a box, 15 mL-capacity USP Type I Glass Vial with rubber stopper and flip-off cap and USP Type I glass ampoule x 10 mL (diluent) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-14306 | Aug 16, 2028 | ||
Furimax-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type II glass mould vial with butyl rubber stopper and aluminum flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Incorporated | DRP-15763 | Sep 11, 2029 | |
FUROCefuroxime (as axetil) | 250mg/5ml powder for suspension70 mL White HDPE Bottle to contain 60 mL reconstituted suspension with 10mL measuring cup (Box of 1's) | Rx | Scott- Edil Advance Research Laboratories & Education LimitedIndia | MEEDPHARMA MEDICAL SUPPLIES & EQUIPMENT DISTRIBUTORImporter: I.E Medica, Inc.Trader: I- Care Formulations | DRP-10073-02 | Jun 16, 2029 | |
FuronixCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ranixx PharmaceuticalsImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-05 | Mar 24, 2029 | |
Furonix-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s) | Rx | Theon Pharmaceuticals Ltd.India | Ranixx PharmaceuticalsImporter: Orange Biotec Inc. | DRP-8203-02 | May 24, 2029 | |
FurosenzCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass vial with rubber stopper & orange flip-off seal (Box of 10's) | Rx | Union Korea Pharm Co., Ltd.Republic of Korea | Farmacia SheenaImporter: H & B Pharma International Inc. | DRP-4342-05 | Jun 4, 2027 | |
FuroxbetCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30’s) | Rx | Theon Pharmaceuticals Ltd.India | Better Option Pharmaceuticals, Inc.Importer: Orange Biotec Inc. | DRP-8203-07 | May 24, 2029 | |
FuroxenCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL in 120 mL Boston Round Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril Internation Co., Inc. | DR-XY40550 | Jan 19, 2027 | |
FuroxenCefuroxime (as axetil) | 500 mg Film-Coated TabletFoil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril International Co., Inc. | DR-XY33319 | May 18, 2027 | |
FuroxenCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril International Co., Inc. | DR-XY47311 | Jun 23, 2031 | |
FuroxenCefuroxime (as axetil) | 500 mg Film-Coated TabletFoil Strip x 10's (Box of 50's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Randril International Co., Inc. | DRP-15170 | May 18, 2027 | |
FuroximedCefuroxime (As Sodium) | 1.5g Powder for Injection (IM/IV)20 mL USP Type III clear glass vial sealed with grey butyl rubber stopper and flip-off seal (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Medinova Pharmaceutical Inc. | DRP-12076 | Jun 8, 2027 | |
FuroximedCefuroxime (As Sodium) | 750mg Powder for Injection (IM/IV)10 mL USP Type III clear glass vial sealed with grey butyl rubber stopper and flip-off seal (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Medinova Pharmaceutical Inc. | DRP-12077 | Jun 8, 2027 | |
FuroxinovaCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 ml USP Type II glass mould vial with butyl rubber stopper and flip-off cap (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Medinova Pharmaceutical Inc. | DRP-11573 | Mar 31, 2027 | |
FuroxveeCefuroxime(As Sodium) | 750mg Powder for Injection (IM/IV)Type I glass vial with butyl rubber stopper, aluminum seal and seal and green flip-off cap + 10 mL Sterile Water for Injection (diluent) in plastic tray (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Asianmeds, Inc. | DRP-13415 | Feb 27, 2028 | |
FurozepCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Triple Tact Import & Export Corp.Importer: Greencore Pharma Inc. | DRP-9975-01 | Feb 4, 2032 | |
FuschelCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Sonchel Pharma DistributorsImporter: Pharmakon Biotec Inc. | DRP-4976-13 | Nov 27, 2028 | |
FuximoxCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | RL Pharma Enterprises Inc.Trader: Foramen Products Corporation | DRP-7789 | Sep 28, 2031 | |
G-RoximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Greentech Life Sciences Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-07 | Mar 29, 2027 | |
GaviximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Ellebasy Medicale TradingImporter: Pharmakon Biotec Inc. | DRP-4976-03 | Nov 27, 2028 | |
GefoxCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Low borosilicate glass vial with stopper and sealed with aluminum plastic cap (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Euro-Care Products Philippines | DRP-8836 | May 5, 2030 | |
GemicefCefuroxime (as Sodium) | 750mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminum plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Asianmeds, Inc.Importer: Euro-Care Products Philippines | DRP-11801-02 | Apr 29, 2027 | |
Geocef 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | GPC Geo Pharma CorporationImporter: Ambica International Corporation | DRP-4164-20 | Dec 27, 2027 | |
GeoroximeCefuroxime (as axetil) | 125 mg/5 mL Powder for Suspension50 mL Amber Colored Glass Bottle (Box of 1's) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DR-XY40539 | Jan 19, 2027 | |
GeoroximeCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionAmber Colored Glass Bottle x 50 mL (Box of 1's) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DR-XY40543 | Jan 19, 2027 | |
GeoroximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial + 5 mL Ampoule for Water for Injection (Box of 1's) | Rx | Geofman PharmaceuticalsPakistan | Sahar International Trading Inc. | DRP-3642 | Jan 3, 2031 | |
Geoxime-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Brawn Laboratories LimitedIndia | Diafarm Inc.Importer: Ambica International Corporation | DRP-4164-27 | Dec 27, 2027 | |
Gidixime 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Gdmed Pharma DistributorImporter: Greencore Pharma, Inc. | DRP-9975-17 | Jul 1, 2031 | |
Gidixime 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | GDMED Pharma DistributorImporter: Greencore Pharma Inc. | DRP-8745-15 | Feb 20, 2031 | |
GinoxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-off Cap x 1's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Dreamax Life Sciences IncorporatedImporter: Dreamax Incorporated | DRP-11361-01 | Mar 4, 2027 | |
GiximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Gijun Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-4976-16 | Nov 27, 2028 | |
Gixime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Gijun Trading Inc.Importer: Greencore Pharma Inc. | DRP-9975-05 | Feb 8, 2032 | |
GlobalfurCefuroxime (As Sodium) | 1.5 g Powder for Injection (IM/IV)15 mL USP Type II transparent tubular glass vial with gray bromobutyl rubber stopper and aluminum blue plastic cap; 1 vial per unit carton packed as 10 vials per box | Rx | Reyoung Pharmaceutical Co., Ltd.China | First Global Trading Corporation | DR-XY47550 | Nov 19, 2026 | |
GlobalfurCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type II transparent tubular glass vial with gray bromobutyl rubber stopper and aluminum blue plastic cap; 1 vial per unit carton packed as 10 vials per box | Rx | Reyoung Pharmaceutical Co., Ltd.China | First Global Trading Corporation | DR-XY47551 | Nov 19, 2031 | |
Gocef IVCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Go Healthcare Pharmaceutical DistributionImporter: Euro-Care Products Philippines | DRP-11801-10 | Apr 29, 2027 | |
Gocef IVCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Go Healthcare Pharmaceutical DistributionImporter: Euro-Care Products Philippines | DRP-8837-04 | May 5, 2030 | |
Gocef IVCefuroxime (As sodium) | 750 mg Powder for Injection (I.V./I.M.)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-off seal cap x 1's (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Go Healthcare Pharmaceutical DistributionImporter: Medinova Pharmaceutical Inc | DRP-10888-01 | Dec 14, 2026 | |
GofuroxCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Applied Pharmaceutical Distribution IncImporter: Greencore Pharma Inc. | DRP-8746-08 | Mar 6, 2031 | |
GofuroxCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Applied Pharmaceutical Distribution IncImporter: Greencore Pharma Inc. | DRP-8745-08 | Mar 2, 2031 | |
GofuroximeCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)20 mL-Capacity USP Type III Clear Glass Vial with Grey Butyl Rubber Stopper and Green colored Aluminum- Plastic Flip-Off Cap (Box of 1's) | Rx | Swiss Parenterals Ltd. (Block-B)India | Applied Pharmaceutical Distribution Inc. | DRP-13198 | Jan 6, 2028 | |
GoldfroxCefuroxime (as Axetil) | 250mg/5mL Suspension Powder for SuspensionBoston Round Amber Glass Bottle x 70 mL (Box of 1's) | Rx | LifeSquare Laboratories Inc.Philippines | JVZEA Pharmaceuticals Inc. | DRP-3231-18 | Sep 7, 2028 | |
GoroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Borosilicate Glass Vial with blue-flip-off seal x 10 mL (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Applied Pharmaceutical Distribution Inc.Importer: AMB HK Enterprises Inc. | DRP-3600-05 | Feb 14, 2029 | |
GoroximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL + 10 mL Sterile Water for Injection as diluent (Box of 1’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Applied Pharmaceutical Distribution IncImporter: AMB HK Enterprises Inc. | DRP-8403-13 | Feb 15, 2028 | |
GoxcefuroCefuroxime (as sodium) | 750 mg Powder for injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-off Cap x 1’s + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Go-Life PharmaImporter: Dreamax Incorporated | DRP-11361-04 | Mar 4, 2027 | |
GoxetilCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's) | Rx | Brawn Laboratories LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation | DRP-4164-25 | Dec 27, 2027 | |
GoximeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Applied Pharmaceutical Distribution Inc.Importer: Ambica International Corporation | DRP-4164-33 | Dec 27, 2027 | |
Goxime IVCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Applied PharmaceuticalImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-01 | Sep 28, 2027 | |
Goxsime IVCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Applied Pharmaceutical Distribution Inc.Importer: Euro-Care Products Philippines | DRP-11801-12 | Apr 29, 2027 | |
Goxsime IVCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Applied Pharmaceutical Distribution IncImporter: Euro-Care Products Philippines | DRP-8837-06 | May 5, 2030 | |
GreenximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (Diluent) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | The One Bataan Santisimo Rosario Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-30 | Sep 28, 2027 | |
GrefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Greentech Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-4976-25 | Nov 27, 2028 | |
Gref-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's) | Rx | Innova Captab Ltd.India | Greentech Life Sciences Inc.Importer: Pharmakon Biotec Inc. | DRP-13664-01 | Mar 23, 2028 | |
GroximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear Glass Vial with pink flip-off seal (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Grovic Pharma Inc. | DRP-4562 | Jul 25, 2031 | |
GroximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type III Glass Vial (Box of 1's and 10's) | Rx | Bharat Parenterals Ltd.India | Grovic Pharma Inc. | DRP-6956 | Dec 16, 2026 | |
GY-RoximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | G.Y. TradingImporter: Greencore Pharma Inc. | DRP-8745-09 | Mar 2, 2031 | |
HaroxCefuroxime (as Sodium) | 1.5 g Powder for Injection (IM/IV)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip Off Seal + USP Type I Clear Glass Ampoule containing 5mL Sterile Water for Injection (as diluent) in a box | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc.Importer: Endure Medical., Inc. | DRP-1032 | Aug 28, 2027 | |
HaroxCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear Glass USP Type 1 vial Box of 10's | Rx | Harbin Pharmaceutical Group Co. Ltd. Gen. Pharm FactoryChina | Endure Medical, Inc. | DRP-1088 | Nov 28, 2027 | |
HaroxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial with rubber stopper and blue-flip off seal + USP Type I Clear Glass ampoule containing 5mL Sterile Water for Injection (as Diluent) Box of 1's | Rx | Harbin Pharmaceutical Group Co., Ltd. General Pharm. FactoryChina | Endure Medical, Inc. | DRP-1011 | Aug 30, 2027 | |
HeraximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-Off Seal Cap x 1's (Box of 1's) | Rx | Yeluri Formulations Pvt Ltd.India | Herald's Pharma and Medical Supplies DistributionImporter: Medinova Pharmaceutical, Inc. | DRP-10888-06 | Dec 14, 2026 | |
HeraximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear Glass Vial with Rubber Closure and Tear-off Aluminum Seal with Blue Flip-off Cap x 7.5 mL (Box of 1's and 10's) | Rx | SYNCOM FORMULATIONS LTD.India | HERALD'S PHARMA AND MEDICAL SUPPLIES DISTRIBUTIONImporter: ARVINCARE PHARMA INC. | DRP-305-06 | May 12, 2028 | |
Hiroxime-125Cefuroxime (As Axetil) | 125 mg/5 mL Powder For Oral SuspensionHDPE white plastic bottle with clear transparent measuring cup x 60 mL (Box of 1's) | Rx | Hiral Labs LimitedIndia | Aglobal Care, Inc. | DRP-12581 | Sep 7, 2027 | |
Hiroxime-250Cefuroxime (as Axetil) | 250 mg/5 mL Powder For Oral SuspensionHDPE white plastic bottle with clear transparent measuring cup x 60 mL (Box of 1's) | Rx | Hiral Labs LimitedIndia | Aglobal Care, Inc. | DRP-12580 | Sep 7, 2027 | |
InfekorCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type III clear glass vial sealed with grey butyl rubber stopper and flip-off seal (Box of 1's) | Rx | Swiss Parenterals Ltd.India | One Pharma Marketing Inc.Importer: Medinova Pharmaceutical Inc. | DRP-12077-01 | Jun 8, 2027 | |
InfekorCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial with rubber stopper and orange flip-off seal (Box of 10's) | Rx | Union Korea Pharm Co., LtdRepublic of Korea | One Pharma Marketing Inc.Importer: H & B Pharma International Inc. | DRP-4342-01 | Jun 4, 2027 | |
IrefurCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Brawn Laboratories LimitedIndia | Irezal TradingImporter: Ambica International Corporation | DRP-4164-19 | Dec 27, 2027 | |
JaximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Jazmark PharmaceuticalImporter: Greencore Pharma Inc. | DRP-9975-08 | Feb 7, 2032 | |
Jaxime 1.5Cefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Jazmark PharmaceuticalImporter: Greencore Pharma Inc. | DRP-8746-07 | Feb 20, 2031 | |
Jaxime 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Jazmark PharmaceuticalImporter: Greencore Pharma Inc. | DRP-8745-13 | Mar 2, 2031 | |
JazcefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's and 100's) | Rx | Reyoung Pharmaceutical Co., LtdChina | Jazmark PharmaceuticalImporter: AMB HK Enterprises Inc. | DRP-4975-04 | Apr 16, 2031 | |
JectocefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass vial with chlorobutyl rubber plug and sealed with blue aluminum flip-off cap x 1's Box of 10's | Rx | DAE HAN NEW PHARM. CO., LTD.Republic of Korea | Lakeside Pharmaceuticals Phil., Inc. | DRP-365 | Feb 7, 2029 | |
JucefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box (Box of 1's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Jusan Pharmaceuticals Distributor & SupplyImporter: Euro-Care Products Philippines | DRP-11801-09 | Apr 29, 2027 | |
JucefCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content as diluent Sterile Water for Injection) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd. - Unit IIIIndia | Jusan Pharmaceuticals Distributor & SupplyImporter: I.E. Medica, Inc. | DRP-3115-06 | Feb 17, 2027 | |
JyscefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Jjysrinn Trading IncImporter: Suhitas Pharmaceuticals Inc. | DRP-1016-01 | Aug 13, 2028 | |
JyscefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu / Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Theon Pharmaceuticals Ltd.India | Jjysrinn Trading Inc.Importer: Orange Biotec Inc. | DRP-8203-13 | May 24, 2029 | |
KabiroximeCefuroxime (as sodium) | 750 mg Powder for Solution for Injection / Infusion15 mL Type II clear glass vial Box of 10 vials | Rx | Labesfal - Laboratòrios Almiro, S.APortugal | Fresenius Kabi Philippines, Inc. | DR-XY46046 | Sep 29, 2027 | |
KaftaxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) | Rx | Inject Care Parenterals Pvt. Ltd.India | Vintel Med EnterprisesImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326 | Mar 24, 2029 | |
KairoxiCefuroxime (as Sodium) | 750mg Powder for Injection (IM/IV)Box of 20mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt. Ltd.India | Pharmacom DistributionImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-12 | Sep 28, 2027 | |
KD-RoximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | King David Pharma DistributorImporter: Greencore Pharma Inc. | DRP-9975-15 | Feb 2, 2032 | |
KefezyCefuroxime ( as axetil) | 500 mg Film Coated TabletAlu/Alu Blister Pack x 4's (Box of 12's); Alu/Alu Blister Pack x 10's (Box of 30's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DRP-560 | Jul 27, 2028 | |
Kefezy-125Cefuroxime (as Axetil ) | 125 Film -Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Micro Labs LimitedIndia | Brown & Burk Philippines Inc. | DR-XY40904 | May 18, 2027 | |
KefroxCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 30 mL, 60 mL, and 70 ml (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc. | DRP-12854-06 | Oct 28, 2027 | |
KEFROXCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10’s (Box of 10’s and 100’s) | Rx | Reyoung Pharmaceutical Co., Ltd.China | CCL Pharmaceuticals (Philippines), Inc.Importer: AMB HK Enterprises Inc. | DRP-4975-14 | Mar 6, 2031 | |
KefsynCefuroxime (as Axetil) | 125 mg/5 mL Granules for SuspensionAmber Bottle x 50 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: GX International, Inc. | DR-XY41111 | Feb 18, 2027 | |
KefsynCefuroxime (as axetil) | 250 mg/5 mL Granules for Oral SuspensionAmber Bottle x 50 mL (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: GX International, Inc. | DR-XY40875 | May 17, 2027 | |
KefsynCefuroxime (As Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | GX International, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-13 | Jun 30, 2029 | |
KefsynCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | GX International, Inc.Importer: Ambica International Corporation | DRP-4164-28 | Dec 27, 2027 | |
Kefsyn 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | GX International, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-16 | Sep 28, 2027 | |
KefuroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL Type II Glass Vial Sealed with Gray Butyl Rubber Stopper and Blue Flip-off Seal Cap x 1's (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Pharmasia-Cuvest IncorporatedImporter: Pharmaessence Inc. | DRP-14502-02 | Sep 14, 2028 | |
KefuroxCefuroxime sodium | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Closure sealed with Tear-off Aluminum Seal and Orange Flip-off Plastic Cap x 10 mL (Box of 10's) | Rx | SAMCHUNDANG PHARM., CO., LTD.Republic of Korea | PHARMASIA-CUVEST INCORPORATED | DRP-5925 | Jul 27, 2031 | |
KeroximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Amber glass vial with rubber stopper and green flip-off seal (Box of 10 vials) | Rx | Yoo Young Pharmaceutical Co., Ltd.Republic of Korea | Unimex, Inc. | DRP-3137 | Oct 15, 2027 | |
KorcefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 10's, 30's, 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories, Inc.Philippines | Konzept Convenience and Drug Store Corp. | DRP-11151-03 | Feb 8, 2027 | |
LargecefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | Daewon Pharm. Co., Ltd.Republic of Korea | Mark Ericson EnterprisesImporter: Largen Med Inc. | DRP-884-05 | Sep 28, 2027 | |
LargeximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | D&G PharmaImporter: Largen Med Inc. | DRP-4774-04 | Jan 9, 2028 | |
LargexoneCefuroxime (as sodium) | 750 mg Powder for injection (I.M./I.V.)USP Type II glass mould vial with butyl rubber stopper, and aluminum flip-off cap (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | D & G PharmaImporter: Dreamax Incorporated | DRP-15763-01 | Sep 11, 2029 | |
LaxinatCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear Glass Vial with Rubber Closure and Tear-off Aluminum Seal with Blue Flip-off Cap x 7.5 mL (Box of 1's) | Rx | SYNCOM FORMULATIONS LTD.India | BANSAN PHARMA DISTRIBUTORImporter: ARVINCARE PHARMA INC. | DRP-305-04 | May 12, 2028 | |
Levecef 1.5Cefuroxime (as sodium) | 1.5 g Powder for Injection (I.V/I.M.)USP Type III Clear Glass Vial (Box of 1’s and 10’s) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc,Importer: Suhitas Pharmaceuticals Inc. | DRP-8006-01 | Oct 19, 2028 | |
Levecef 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.V/I.M.)USP Type III Clear Glass Vial (Box of 1’s and 10’s) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-8005-01 | Oct 19, 2028 | |
Levecef-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30’s) | Rx | Theon Pharmaceuticals Ltd.India | HLM Pharmaceutical Inc.Importer: Orange Biotec Inc. | DRP-8203-06 | May 24, 2029 | |
LeveximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x 1's + Sterile Water for Injection in LDPE Plastic Ampoule x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | HLM Pharmaceutical Inc.Importer: GPC Geo Pharma Corporation | DRP-11250-01 | Feb 17, 2027 | |
Levexime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu / Alu Blister Pack x 10’s (Box of 10’s) | Rx | Globela Laboratories Pvt. Ltd.India | HLM Pharmaceutical Inc.Importer: AMB HK Enterprises Inc. | DRP-12213-08 | Jul 13, 2027 | |
Levexime-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10's, 50's and 100's) | Rx | Brawn Laboratories LimitedIndia | HLM Pharmaceutical Inc.Importer: Ambica International Corporation | DRP-4164-34 | Dec 27, 2027 | |
LiferoxCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Curasave PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-18 | Sep 28, 2027 | |
LourximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10mL Type I colorless ampoule (water for injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Ritegen Inc.Importer: Euro-Care Products Philipppines | DRP-11801-03 | Apr 29, 2027 | |
LoxatrelCefuroxime (as sodium) | 750 mg Powder for Injection (I.M..I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyungdong Pharm Co., Ltd.Republic of Korea | Westfield Pharmaceuticals, Inc.Importer: D.B. Manix International, Inc. | DRP-076 | Dec 21, 2029 | |
MacroximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Clear Glass Vial with pink flip-off seal (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Multigro Healthcare Inc.Importer: GROVIC PHARMA INC. | DRP-4562-04 | May 6, 2031 | |
MakcuroCefuroxime (as axetil) | 750 mg Powder For Injection (IM/IV)10 mL USP Type III clear glass vial with gray butyl rubber stopper and green flip-off seal + 5 mL Sterile Water for Injection as diluent (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Hillcross Prime, Inc. | DRP-11567 | Mar 30, 2027 | |
MarfuroximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Aqua-MaxImporter: Greencore Pharma Inc. | DRP-8745-12 | Feb 2, 2031 | |
MariximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Individually boxed USP Type I Borosilicate Glass Vial with Blue Flip-Off Seal x 10 mL Box of 10’s | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Marilz Pharmaceuticals CorporationImporter: AMB HK Enterprises Inc. | DRP-3600-01 | Feb 14, 2029 | |
MaroxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 10's, 30's, 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories, Inc.Philippines | Triple 888 Medical And Pharma Inc. | DRP-11151-06 | Feb 8, 2027 | |
MaxcefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear, Colorless USP Type III Glass Vial with grey butyl rubber stopper, aluminum seal and red flip-off cap with LDPE Ampoule x 10 mL containing Sterilized Water for Injection (as diluent) in a box (Box of 1's) | Rx | Nitin Lifesciences Ltd.India | Pharma-Surrey International, Inc.Importer: Seapharma International, Inc. | DRP-7088-01 | Mar 10, 2027 | |
MedaximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I glass vial with white flip-off + USP Type I glass ampoule (diluent) x 10 mL (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | MXL Pharma.Importer: Pharmakon Biotec Inc. | DRP-4976-10 | Nov 27, 2028 | |
Medaxime 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 20 's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | MXL PharmaImporter: Pharmakon Biotec Inc. | DRP-5017-02 | Dec 18, 2028 | |
MediroximeCefuroxime (as Axetil) | 500 mg Film-Coated TabletIn a box of 1 Alu-Alu Blister pack x 10's (Box of 10's and 100's) | Rx | Sance Laboratories Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-7317-05 | Sep 11, 2027 | |
MediximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Teramedix Pharma Trading Inc.Importer: Pharmakon Biotec Inc. | DRP-4976-18 | Nov 27, 2028 | |
MedsefCefuroxime (as Axetil) | 250 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vamsler Phils. Inc.Trader: Ultramed Pharma, Inc. | DRP-3958-01 | Dec 22, 2026 | |
MedsefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Vamsler Phils. IncorporatedTrader: Ultramed Pharma, Inc. | DRP-1188-03 | Sep 30, 2028 | |
MeduximeCefuroxime (as axetil) | 500 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Medico Remedies Ltd.India | Medethix, Inc. | DRP-15885 | Sep 27, 2031 | |
MedxilCefuroxime (as Axetil) | 500 mg TabletAlu-Alu Blister Pack x 10’s (Box of 10’s) | Rx | Lark Laboratories (India) Ltd.India | Medbridge, Inc. | DRP-3181 | Feb 20, 2031 | |
MedxilCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip-Off Seal (Box of 1’s and Box of 10’s) | Rx | SAMJIN PHARM. CO., LTD.Republic of Korea | MEDBRIDGE, INC. | DRP-2729-01 | Jul 6, 2027 | |
MedximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Clear Glass Vial with Rubber Stopper and Blue Flip Off Seal Box of 1’s and 10’s | Rx | SAMJIN PHARM. CO., LTD.Republic of Korea | APOTHECON DRUG INT’L CORP.Importer: MEDBRIDGE, INC. | DRP-2729 | Jul 6, 2027 | |
MedzymeCefuroxime (as sodium) | 1.5 g Powder for Injection (I.M./I.V.)Type I Colorless Glass Vial with Butyl Rubber Plug and Aluminum Flip-off Green Cap (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Medhaus Pharma, IncorporatedImporter: Interhealthcare Pharmaceuticals, Inc. | DR-XY42878 | Oct 29, 2028 | |
MedzymeCefuroxime (as axetil) | 125 mg/5 mL Granules for Suspension120 mL Capacity Amber Glass Bottle x 50 mL Net Content (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY35476 | Feb 18, 2029 | |
MedzymeCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension120 mL Capacity Amber Glass Bottle x 50 mL Net Content (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY35471 | Feb 18, 2029 | |
MedzymeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Incorporated | DR-XY35468 | Feb 18, 2029 | |
MedzymeCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Medhaus Pharma, Inc. | DR-XY47957 | Apr 22, 2027 | |
MedzymeCefuroxime (as sodium) | 750 mg Powder for InjectionType I Clear Glass Vial with Rubber Stopper and Orange Flip-Off Seal (Box of 10's) | Rx | Aju Pharma Co., Ltd.Republic of Korea | Medhaus Pharma, IncorporatedImporter: Interhealthcare Pharmaceuticals, Inc. | DRP-2356 | Dec 6, 2028 | |
MedzymeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | Daewon Pharm. Co., Ltd.Republic of Korea | Medhaus Pharma, IncorporatedImporter: D.B. Manix International, Inc. | DRP-884-08 | Sep 28, 2032 | |
MeuroxCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)10 mL-capacity USP Type III clear glass vial with rubber stopper and green flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DR-XY48920 | Nov 16, 2028 | |
MeuroxCefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)10 mL-capacity USP Type III clear glass vial with rubber stopper and green flip-off seal (Box of 1's) | Rx | Vellinton HealthcareIndia | Pranish Inc. | DRP-14993 | Nov 16, 2028 | |
MidroxCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Diafarm Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-11 | Sep 28, 2027 | |
NatricefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (Net Content of Diluent) (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Asianmeds, Inc.Importer: Euro-Care Products Philippines | DRP-8837-02 | May 5, 2030 | |
NaviximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip-off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | JN Carlo Pharmaceuticals DistributorImporter: Pharmakon Biotec Inc. | DRP-4976-27 | Nov 27, 2028 | |
Navixime 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Sunlovis Pharmaceuticals LLPIndia | JN Carlo Pharmaceuticals DistributorImporter: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-07 | Oct 24, 2028 | |
NeocefuximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Neo-Care PhilippinesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-22 | Sep 28, 2027 | |
NeoroximeCefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Maxipharm Co., Ltd.Importer: Phil. Shinpoong Pharma, Inc. | DRP-3036-04 | Apr 11, 2031 | |
NeroximCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Clear, Colorless USP Type III Glass Vial with grey butyl rubber stopper, aluminum seal and red flip-off cap with LDPE Ampoule x 10 mL containing Sterilized Water for Injection (as diluent) in a box (Box of 1's) | Rx | Nitin Lifesciences Ltd.India | Seapharma International, Inc. | DRP-7088 | Mar 10, 2027 | |
NewximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Clear Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x 1's + Sterile for Injection in LDPE Plastic Ampoule x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | United Pharma Plus (UNIPHARMA) Inc.Importer: GPC Geo Pharma Corporation | DRP-11250-02 | Feb 17, 2027 | |
NicocefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Thymed EnterprisesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-24 | Sep 28, 2027 | |
NicoximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Thymed EnterprisesImporter: Greencore Pharma Inc. | DRP-9975-07 | Feb 6, 2032 | |
NjectximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type I Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | NJT EnterprisesImporter: Pharmakon Biotec Inc. | DRP-4976-05 | Nov 27, 2028 | |
Njectxime 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 20 's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | NJT EnterprisesImporter: Pharmakon Biotec Inc. | DRP-5017-05 | Dec 18, 2028 | |
NoneCefuroxime (As Axetil) | 125 mg/5 mL Powder For Suspension30 mL & 60 mL White Colored PET Bottle With Measuring Cup Box of 1's | Rx | Zim Laboratories Ltd.India | Actimed, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4045-01 | Oct 15, 2027 | |
NoneCefuroxime (as Axetil) | 125 mg/5 mL Powder for SuspensionHDPE Plastic Bottle x 50 mL with Plastic Measuring Cup and Spoon (Box of 1's) | Rx | PharmEvo (Pvt.) Ltd.Pakistan | Ferjan Philippines Inc.Importer: Accesspoint International Trading Inc. | DRP-4939-02 | Nov 19, 2028 | |
NoneCefuroxime (as axetil) | 125 mg/5 mL Powder for SuspensionBoston Round Bottle with White HDPE Cap x 60 mL and 70 mL (Box of 1’s) | Rx | Sunlovis Pharmaceutical LLPIndia | PharmaVital Corp.Importer: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-8291-02 | Mar 17, 2031 | |
NoneCefuroxime (as axetil) | 250 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum Foil) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | Icon Healthcare, Inc. | DRP-3392-01 | Jan 12, 2031 | |
NoneCefuroxime (as axetil) | 250 mg TabletAlu/Alu Foil Blister x 4's Box of 100's | Rx | Nectar Lifesciencs Limited (Unit VI)India | Ritemed Phils., Inc. | DRP-8362 | Sep 29, 2030 | |
NoneCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral Suspension70 mL White HDPE bottle to contain 60 mL reconstituted suspension with 10 mL measuring cup (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Medethix, Inc.Importer: I.E. Medica, Inc.Trader: I -Care Formulations | DRP-10073-01 | Oct 10, 2029 | |
NoneCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral Suspension30 mL and 60 mL HDPE Bottle with PP Cap and 10 mL PP Measuring Cup (Box of 1's) | Rx | Zim Laboratories Ltd.India | Actimed, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-4401 | Apr 30, 2028 | |
NoneCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1's) | Rx | Rainbow Life Sciences Pvt. Ltd.India | Actimed, Inc.Importer: Ambica International Corporation | DRP-5367 | Jun 30, 2029 | |
NoneCefuroxime (as Axetil) | 250 mg/5 mL Powder for Suspension70 mL White HDPE bottle to contain 60 mL reconstituted suspension with 10 mL measuring cup (Box of 1's) | Rx | SCOTT- EDIL ADVANCE RESEARCH LABORATORIES & EDUCATION LIMITEDIndia | ACTIMED INC.Importer: I.E MEDICA INC.Trader: I-CARE FORMULATIONS | DRP-10073 | Jun 16, 2029 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Ambica International Corporation | DRP-10336 | Sep 15, 2031 | |
NoneCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 10's, 30's, 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Jaac Healthline Marketing | DRP-11151-08 | Feb 8, 2027 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Foil Strip Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | — | DRP-11824 | Jan 18, 2027 | |
500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | Foramen Products CorporationTrader: Interhealthcare Pharmaceuticals Inc. | DRP-2103-05 | Sep 18, 2028 | ||
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Gamot Philippines, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-2103-07 | Sep 18, 2028 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4’s Box of 4’s, 12’s, 40’s | Rx | Akums Drugs & Pharmaceuticals, Ltd.India | Actimed, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Limited | DRP-2994-03 | Jun 9, 2029 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's and 14's) | Rx | Interphil Laboratories, Inc.Philippines | St. Joseph Drugstore | DRP-3442-08 | Aug 6, 2031 | |
NoneCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu - Alu Blister Pack X 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | — | DRP-4618 | Nov 10, 2030 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's) | Rx | Sunlovis Pharmaceuticals LLPIndia | Ambitech Biopharmaceuticals IncImporter: Nelpa Lifesciences, Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-4857-04 | Oct 24, 2028 | |
NoneCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sakar Healthcare Pvt. Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-03 | Jul 14, 2029 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sakar Healthcare LimitedIndia | HLM PHARMACEUTICAL INC.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-09 | Jul 14, 2029 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Centurion Remedies Pvt. Ltd.India | TGP Pharma Inc.Importer: Philgen Pharmaceuticals Inc. | DRP-5484-01 | Aug 27, 2029 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Solvang Pharmaceuticals, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-5503-03 | Mar 29, 2027 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Dr. Zen's Research, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-5503-04 | Mar 29, 2027 | |
NoneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Qualifirst Health, Inc.Importer: Greencore Pharma, Inc. | DRP-9975-16 | Jul 1, 2031 | |
NoneCefuroxime (as axetil) | 500 mg TabletAlu/Alu Blister Pack x 10’s (Box of 20’s) | Rx | Sandoz GmbHAustria | Philusa CorporationImporter: Sandoz Philippines Corporation | DRP-11865-01 | Sep 19, 2031 | |
NoneCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | International Pharmaceuticals, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-06 | Dec 27, 2028 | |
NoneCefuroxime (as sodium) | 750 mg Powder For Injection (I.M./I.V.)10 mL -Capacity USP Type III clear glass vial with grey rubber stopper and aluminum brown flip-off seal (Box of 1's) | Rx | Swiss Parenterals Ltd.India | One Pharma MarketingImporter: Brightwell Marketing and Distributions Inc. | DRP-19114 | Oct 29, 2031 | |
NoneCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Philgen Pharmaceuticals Inc.Importer: Steinbach Products Inc. | DRP-2018-06 | Feb 1, 2027 | |
NoneCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)15 mL USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | SINOPHARM ZHIJUN (SHENZHEN) PHARMACEUTICAL CO., LTD.China | DYNASTY PHARMACEUTICALS | DRP-7482 | Jun 14, 2028 | |
NoneCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Clear Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x 1's + Sterile Water for Injection in LDPE plastic ampoule x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Tamiga Pharmaceuticals SupplyImporter: GPC Geo Pharma Corporation | DRP-11250-03 | Feb 17, 2027 | |
NoviroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray (Box of 1's and 10's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Sanimed Pharmaceuticals Inc. | DRP-7126 | Mar 29, 2027 | |
OraximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30’s) | Rx | Theon Pharmaceuticals Ltd.India | Suhitas Pharmaceuticals Inc.Importer: Orange Biotec Inc. | DRP-8203-09 | May 24, 2029 | |
OrximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Bio Erixx Pharma DistributionImporter: Greencore Pharma Inc. | DRP-8745-11 | Feb 20, 2031 | |
OxifadzCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Brawn Laboratories LimitedIndia | Fadz Pharma, Inc.Importer: Ambica International Corporation | DRP-4164-29 | Dec 27, 2027 | |
OxifadzCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Fadz Pharma Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-27 | Sep 28, 2027 | |
PediacefCefuroxime (as Axetil) | 250 mg / 5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1’s) | Rx | Zim Laboratories LimitedIndia | Medlink Pharma Phils., Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-11 | Jun 30, 2029 | |
PharmacefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | DAEWON PHARM. CO., LTD.Republic of Korea | PHARMA KING DISTRIBUTORImporter: LARGEN MED INC. | DRP-884-03 | Sep 28, 2027 | |
Philcef-DS 125Cefuroxime (As Axetil) | 125mg/mL Powder For Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 30 mL and 60 mL (Box of 1's) | Rx | NGB Laboratories Pvt. Ltd.India | FSPC Pharmaceuticals, Inc. | DRP-12855 | Oct 28, 2027 | |
Philcef-DS 250Cefuroxime (as axetil) | 250mg/5mL Powder for Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 30 mL, 60 mL, and 70 mL (Box of 1's) | Rx | NGB Laboratories Pvt. Ltd.India | FSPC Pharmaceuticals, Inc. | DRP-12854 | Oct 28, 2027 | |
PhilosporinCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL (Box of 10's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., LtdChina | PhilRx Pharma Inc.Importer: AMB HK Enteprises Inc. | DRP-8403-01 | Feb 15, 2028 | |
PhysicximeCefuroxime (as sodium) | 750 mg Powder for InjectionGlass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Physics Pharmaceutical TradingImporter: Euro-Care Products Philippines | DRP-11801-07 | Apr 29, 2027 | |
PlaximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear Flint Glass Vial x 10 mL (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Central West Medicale Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5927-01 | Jan 12, 2030 | |
PrimuximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Primus Medicus Distributors Inc.Importer: Euro-Care Products Philippines | DRP-11801-15 | Apr 29, 2027 | |
PrimuximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)One (1) box contains Low borosilicate glass vial with stopper and sealed with aluminum plastic cap + Sterile water for Injection in USP Type I glass ampoule x 10 mL (net content of diluent) (Box of 1's) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Primus Medicus Distributors Inc.Importer: Euro-Care Products Philippines | DRP-8837-01 | May 5, 2030 | |
ProfureCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal x 15mL + plastic ampoule (Sterile Water for Injection as solvent) (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Ellebasy Medicale Group Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-03 | Mar 29, 2027 | |
ProfurexCefuroxime (as Sodium) | 750 mg Sterile Powder for Injection (IM/IV)Clear Glass Vial (Box of 1's) | Rx | Biolab Co., Ltd.Thailand | The Cathay Drug Co., Inc. | DR-XY19897 | May 12, 2027 | |
ProviximeCefuroxime (as sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Providencia Medica Inc.Importer: Shin Poong Pharm. Co., Ltd. | DRP-3036-05 | Feb 8, 2032 | |
ProximCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639 | Dec 27, 2028 | |
PurecefCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Medpure Pharmaceutical Company Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13459-02 | Feb 23, 2028 | |
Quadcef 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. LtdIndia | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-12213-01 | Jul 13, 2027 | |
Quadcef 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Quad-Gen PharmaceuticalsImporter: AMB HK Enterprises Inc. | DRP-6113-05 | Mar 12, 2030 | |
Quadcef 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL Box of 1's | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Quad-Gen PharmaceuticalsImporter: AMB HK Enteprises Inc. | DRP-8403-08 | Feb 15, 2028 | |
QUALIFURCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | QUALIFIRST HEALTH INC.Importer: AGLOBAL CARE, INC. | DRP-6570-04 | Mar 10, 2029 | |
QualizefCefuroxime (as Sodium) | 750mg Powder For Injection (IM/IV)Type II Glass Vial x 10 mL (Box of 1's) | Rx | Shandong Xier Kangtai Pharmaceutical Co., LtdChina | Importer: JF Draf Pharmaceuticals Corporation | DRP-111 | May 6, 2027 | |
QUIROXEF 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Sakar Healthcare LimitedIndia | FADZ PHARMA INC.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-06 | Jul 14, 2029 | |
Quiroxef 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | AGB Pharmaceutical Trading and Consultancy CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-14 | Sep 28, 2027 | |
RafurCefuroxime (as sodium) | 750 mg Powder for Injection (I.M. / I.V.)10 mL Capacity USP Type III Clear and Colorless Glass Vial with Grey Bromo Butyl Rubber Stopper and Red Colored Flip-off Seal (Box of 10's) | Rx | Theon Pharmaceuticals LimitedIndia | HEXAGON PHARMACEUTICALS | DR-XY46815 | Jan 24, 2030 | |
RajaCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10's | Rx | Brawn Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4164-01 | Dec 27, 2027 | |
RaxumCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10's (Box of 100's) | Rx | Hiral Labs LimitedIndia | Aglobal Care, Inc. | DRP-12547. | Aug 31, 2027 | |
Redcef 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Theon Pharmaceuticals Ltd.India | Redrocks Pharma and Medical Supplies DistributionImporter: Orange Biotec Inc. | DRP-8203-11 | May 24, 2029 | |
RegiximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Regimed Pharmaceutical Distributor | DRP-11151-04 | Feb 8, 2027 | |
RETACEF-750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's) and with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | RETA DRUGImporter: AGLOBAL CARE, INC. | DRP-6570-10 | Mar 10, 2029 | |
Retaxzen 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10’s) | Rx | Theon Pharmaceuticals Ltd.India | Reta DrugImporter: Orange Biotec Inc. | DRP-8203-10 | May 24, 2029 | |
RetazetCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack of 10’s (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Reta DrugImporter: Greencore Pharma Inc. | DRP-9975-10 | Feb 8, 2032 | |
Retazet-RCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V)Type III Flint Glass Vial with gray butyl rubber stopper and pink aluminum flip-off seal cap x 1's (Box of 1's) | Rx | Yeluri Formulation Pvt. Ltd.India | Reta DrugImporter: Medinova Pharmaceutical Inc. | DRP-10888-02 | Dec 14, 2026 | |
RexofenCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Clear Glass Vial with Rubber Stopper and Blue Flip-off Seal + 10 mL Plastic Ampoule (Water for Injection) [Diluent] (Box of 1's) | Rx | Vysali Pharmaceuticals Ltd.India | Quad-Gen PharmaceuticalsImporter: Euro-Care PRODUCTS PHILIPPINES | DRP-699 | Feb 10, 2028 | |
RexofenCefuroxime (as sodium) | 750mg Powder for Injection (I.M./I.V.)USP Type II glass vial with rubber stopper, aluminum seal and flip-off cap + USP Type I clear glass ampoule x 10 mL (Sterile Water for Injection, as diluent) (Box of 1 finished product and 1 diluent) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Euro-Care Products Philippines | DRP-18701 | Aug 25, 2031 | |
Rezafil IVCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., LtdIndia | Filadams Pharma, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-17 | Sep 28, 2027 | |
Rezafil-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | Filadams Pharma, Inc.Importer: Ambica International Corporation | DRP-4164-08 | Dec 27, 2027 | |
RhyximexCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Belasram Farma TradingImporter: Ambica International Corporation | DRP-4164-30 | Dec 27, 2027 | |
RIFUCEFCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Sakar Healthcare LimitedIndia | RILEM PHARMA CORP.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-07 | Jul 14, 2029 | |
RobecimCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | RSG Pharma TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-13 | Sep 28, 2027 | |
Robecim-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Brawn Laboratories LimitedIndia | RSG Pharma TradingImporter: Ambica International Corporation | DRP-4164-14 | Dec 27, 2027 | |
RobisefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type III clear and colorless glass vial with rubber stopper and white flip-off seal + 10 mL Sterile Water for Injection as diluent Box of 1’s | Rx | Inject Care Parenterals Pvt. Ltd.India | Rx Global Sales and Mktg. Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-01 | Mar 24, 2029 | |
RocefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Brawn Laboratories LimitedIndia | Jjysrinn Trading Inc.Importer: Ambica International Corporation | DRP-4164-06 | Dec 27, 2027 | |
RockcefCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Co., Ltd.China | Redrocks Pharma and Medical Supplies DistributionImporter: Aglobal Care, Inc. | DRP-6570-15 | Mar 10, 2029 | |
RofimCefuroxime(As Sodium) | 750 mg Powder For Injection (IM/IV)Type I Glass Vial + 10 mL Ampoule as Diluent Box of 1's | Rx | Phil Inter Pharma Co., LtdVietnam | Altomed Pharmaceuticals, Inc.Importer: Largen Med Inc. | DRP-6703 | May 24, 2031 | |
RogeximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | HLM Pharmaceutical Inc.Importer: Greencore Pharma Inc. | DRP-8745-14 | Feb 20, 2031 | |
RojacefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./ I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd.Vietnam | Largen Med Inc. | DRP-4774 | Jan 9, 2028 | |
RomicefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Individually boxed clear glass vials with rubber stopper and yellow flip-off seal (Box of 10's) | Rx | Yung Shin Pharm. Ind. Co., Ltd. (Taichung Youth Factory III)Taiwan | Yung Shin (Philippines), Inc. | DR-XY22714 | Mar 12, 2027 | |
RovexidCefuroxime (as sodium) | 750 mg Powder for Injection (IV/IM)10 mL-Capacity USP Type III Clear Glass Vial with Grey Bromobutyl Rubber Stopper and Blue Flip-Off Aluminum Seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Greencore Pharma Inc.Importer: Afree Pharmaceutical Distribution Corp. | DRP-13459-04 | Feb 23, 2028 | |
RovixCefuroxime (as axetil) | 125 mg/5 mL Granules for Suspension | Rx | Lloyd Laboratories, Inc. | Trader: Ultramed Pharma, Inc. | DRP-3959 | Dec 22, 2026 | |
RovixCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension | Rx | Lloyd Laboratories, Inc. | Trader: Ultramed Pharma, Inc. | DRP-3958 | Dec 22, 2026 | |
RovixCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (box of 30 tablets) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DR-XY47956 | Apr 22, 2027 | |
RovixCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Ultramed Pharma, Inc. | DRP-1188 | Sep 30, 2028 | |
RovixCefuroxime (as Sodium) | 750 mg Powder for injectionType I Clear Glass Vial with Rubber Stopper and Orange Flip-off Seal (Box of 10's) | Rx | Aju Pharm Co., Ltd.Republic of Korea | Ultramed Pharma, Inc.Importer: Interhealthcare Pharmaceuticals, Inc. | DRP-2356-01 | Dec 6, 2028 | |
RovixCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyung Dong Pharm Co., Ltd.Republic of Korea | Ultramed Pharma, Inc.Importer: D.B. Manix International, Inc. | DRP-076-07 | Dec 21, 2029 | |
RoxicefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray (Box of 1's) | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | ECE Pharmaceuticals, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-08 | Mar 29, 2027 | |
RoxicefCefuroxime (as Sodium) | 750 mg Powder for Injection (IV/IM)Type I Flint Glass vial with Gray Bromobutyl Rubber Stopper and Blue Flip-Off Seal Cap x 1's + Sterile Water for Injection in Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Kilitch Drugs (India) Ltd.India | ECE Pharmaceuticals, Inc.Importer: Nelpa Lifesciences Inc.Trader: Sapphire Lifesciences Pvt. Ltd. | DRP-11017-01 | Feb 11, 2027 | |
Roxicef S125Cefuroxime (as Axetil) | 125 mg/5 mL Granules for Suspension | Rx | Lloyd Laboratories, Inc. | ECE Pharmaceuticals, Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-5368-01 | Nov 17, 2026Past listed date | |
Roxicef S250Cefuroxime (as Axetil) | 250 mg/5 mL Granules for Suspension | Rx | Lloyd Laboratories, Inc. | ECE Pharmaceuticals, Inc.Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-5422-02 | Nov 17, 2026Past listed date | |
RoxiemCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content as diluent Sterile Water for Injection) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd.India | Medethix, Inc.Importer: I.E. Medica, Inc. | DRP-3115 | Feb 17, 2032 | |
RoximaxCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type II glass vial with butyl rubber stopper and flip-off seal (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Hillcross Prime, Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-12005-01 | May 27, 2027 | |
RoximeCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III Glass Vial (Box of 10's) | Rx | Reyoung Pharmaceutical Co. Ltd.China | Steinbach Products Inc. | DRP-2018 | Feb 1, 2027 | |
Roxime 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's | Rx | Centurion Remedies Pvt. Ltd.India | Philgen Pharmaceuticals Inc. | DRP-5484 | Aug 27, 2029 | |
RoximufCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) | Rx | Inject Care Parenterals Pvt. Ltd.India | Medico Uno Farma Int'l Traders Corp.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-08 | Mar 24, 2029 | |
RoxinovaCefuroxime (as sodium) | 1.5 g Powder for Injection (I.V./I.M.)USP Type III clear and colorless glass vial with Rubber Stopper, Aluminum seal and Blue flip-off cap (Box of 1's) | Rx | Sance Laboratories Private LimitedIndia | Medinova Pharmaceutical Inc. | DRP-6550 | Mar 7, 2031 | |
RoxiprimeCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Primera Pharma CorporationImporter: Ambica International Corporation | DRP-4164-32 | Dec 27, 2027 | |
Roxisan 250Cefuroxime (as axetil) | 250 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Zeiss Pharma Ltd.India | SRS Life Sciences Inc. | DR-XY49357 | Mar 18, 2030 | |
Roxisan 250Cefuroxime (as axetil) | 250 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10's) | Rx | Zeiss Pharma Ltd.India | SRS Life Sciences Inc. | DRP-16937 | Mar 18, 2030 | |
Roxisan 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 10's) | Rx | Zeiss Pharma Ltd.India | SRS Life Sciences Inc. | DR-XY49273 | Nov 14, 2029 | |
Roxisan 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister pack x 10’s (Box of 10's) | Rx | Zeiss Pharma Ltd.India | SRS Life Sciences Inc. | DRP-16691 | Nov 14, 2029 | |
RoxsheenCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip-off + USP Type I Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Farmacia SheenaImporter: Pharmakon Biotec, Inc. | DRP-4976-30 | Nov 27, 2028 | |
RoxurixCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister pack x 10 (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Altor Pharmaceutical Product DistributionImporter: Greencore Pharma Inc. | DRP-9975-14 | Feb 8, 2032 | |
RoxxinCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Clear, Colorless USP Type III Glass Vial with grey butyl rubber stopper, aluminum seal and red flip-off cap with LDPE Ampoule x 10 mL containing Sterilized Water for Injection (as diluent) in a box (Box of 1's) | Rx | Nitin Lifesciences Ltd.India | Starpharm, Inc.Importer: Seapharma International, Inc. | DRP-7088-02 | Mar 10, 2027 | |
RoxxinCefuroxime (as sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Starpharm, Inc.Importer: Phil. Shinpoong Pharma, Inc. | DRP-3036-07 | Apr 11, 2031 | |
ROXXIN-250CEFUROXIME (AS AXETIL) | 250 MG / 5 ML GRANULES FOR ORAL SUSPENSIONBoston Round Amber Glass Bottle in 50 mL (Net Content When Reconstituted) (Box of 1's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | STARPHARM, INC. | DRP-7543-04 | Oct 14, 2029 | |
Roxxin-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10’s) | Rx | Theon Pharmaceuticals Ltd.India | Starpharm, Inc.Importer: Orange Biotec Inc. | DRP-8203-05 | May 24, 2029 | |
Roxxin-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack of 10’s 9Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Starpharm, Inc.Importer: Greencore Pharma Inc. | DRP-9975-09 | Feb 8, 2032 | |
RucefCefuroxime | 125 mg/5 mL Granules for Suspension50 mL in 120 mL Boston Round Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-4349 | Jan 1, 2027 | |
RucefCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension120 mL Amber Boston Bottle (50 mL net content) per Box | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Solvang Pharmaceuticals, Inc. | DRP-4440 | Aug 28, 2027 | |
RucefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Solvang Pharmaceuticals, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-5503-02 | Mar 29, 2027 | |
RusojectCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)10 mL Type III molded glass vial with grey butyl rubber stopper (Box of 1's) | Rx | Innova CaptabIndia | Ambica International Corporation | DRP-16861 | Jul 30, 2030 | |
RuximCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Colorless Glass vial with rubber Stopper and Blue Flip-off Seal (Box of 10's) | Rx | Karnataka Antibiotics & Pharmaceuticals Ltd.India | Phil. Pharmawealth, Inc. | DR-XY27455 | Dec 24, 2028 | |
S-RoxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 10's, 30's, 50's and 100's) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Pharmasilv Trading | DRP-11151-09 | Feb 8, 2027 | |
S-RoxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10’s) | Rx | Theon Pharmaceuticals Ltd.India | Pharmasilv TradingImporter: Orange Biotec Inc. | DRP-8203-04 | May 24, 2029 | |
S-Rox IVCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Pharmasilv TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-28 | Sep 28, 2027 | |
Sanfur DS-125Cefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionHDPE plastic bottle with measuring cup x 70 mL (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-8625 | Jan 15, 2030 | |
Sanfur DS-125Cefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionHDPE plastic bottle x 30 mL with measuring cup (Box of 1's) | Rx | Sance Laboratories Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-8626 | Jan 15, 2030 | |
Sanfur-1500Cefuroxime (as Sodium) | 1.5 g Powder for Injection (IM/IV)15 mL USP Type III Clear Glass Vial (Box of 1’s) | Rx | Sance Laboratories Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-5947 | Jan 21, 2030 | |
Sanfur-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Sance Laboratories Pvt. Ltd.India | AMB HK Enterprises Inc. | DRP-6113 | Mar 12, 2030 | |
Sanfur-750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Type III Glass Vial x 10 mL (Box of 1’s) | Rx | Sance Laboratories Private LimitedIndia | AMB HK Enterprises Inc. | DRP-6041 | Mar 16, 2030 | |
Sanfurox-750Cefuroxime | 750 mg Dry Powder for Injection (IV/IM)10 mL flint glass vial USP Type III with 20 mm grey bromo butyl rubber stopper, sealed with 20 mm aluminum flip off seal dark blue Box of 10's | Rx | Inject Care Parenterals PVT. LTD.India | Importer: BLISS GVS PHARMA LTD.Trader: Bliss GVS Pharma Ltd. | DR-XY46752 | Oct 22, 2029 | |
Sanoxetil-125Cefuroxime (As Axetil) | 125 mg Powder for Oral SuspensionAluminum sachet x 3 g (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Penta Labs Australia (Philippines) | DRP-6426 | Nov 11, 2030 | |
SanoximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III Clear Colorless Glass Vial Sealed with 20mm Grey Bromobutyl Rubber Stopper and White Flip-off Seal + 10 mL LDPE Ampoule (sterile water for injection as solvent) in Plastic Tray Box of 1's | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Sanoviz Pharmaceutical Products TradingImporter: Sanimed Pharmaceuticals Inc. | DRP-7126-14 | Mar 29, 2027 | |
SantecefCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogenated rubber stopper and aluminium plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Santerra TradingImporter: Euro-Care Products Philippines | DRP-11801-05 | Apr 29, 2027 | |
SantecefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Santerra TradingImporter: Euro-Care Products Philippines | DRP-8837-03 | May 5, 2030 | |
Seafurox 1500Cefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)15 mL USP Type III flint clear glass vial sealed with grey butyl stopper and yellow color flip off cap (Box of l's) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-11572 | Mar 31, 2027 | |
Seafurox 750Cefuroxime (as sodium) | 750 mg Powder For Injection (I.M./I.V.)10 mL USP Type III flint clear glass vial sealed with grey butyl rubber stopper and pink color flip off (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Seapharma International, Inc. | DRP-11574 | Mar 30, 2027 | |
SeaximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type III Glass Vial (Box of 1's and 10's) | Rx | Bharat Parenterals Ltd.India | SEA-King Pharma Inc.Importer: Grovic Pharma Inc. | DRP-6956-02 | Dec 16, 2026 | |
SecgecefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV) | Rx | Steril-Gene Life Sciences (P) Ltd. | Lloyd Laboratories, Inc. | DRP-7547 | Dec 1, 2026 | |
SeconximeCefuroxime (as sodium) | 1.5 g Powder For Injection (I.M./I.V.)USP Type I clear glass vial with 20 mm grey bromo butyl rubber stopper sealed with aluminum and green flip-off cap (Box of 1's) | Rx | Swiss Parenterals Pvt. Ltd.India | Excelcare, Inc.Importer: Ambica International Corporation | DRP-9181 | Mar 12, 2037 | |
SecundaCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's Box of 10's, 50's and 100's | Rx | Brawn Laboratories LimitedIndia | Ambicare Pharmaceuticals Inc.Importer: Ambica International Corporation | DRP-4164-23 | Dec 27, 2027 | |
Secunda-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-08 | Dec 27, 2028 | |
ServcefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals, Pvt. Ltd.India | Trueserve Pharmaceutical DistributorImporter: Sanimed Pharmaceuticals Inc. | DRP-7126-09 | Mar 29, 2027 | |
ShafuroxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)15 mL USP Type III clear and colorless glass vial sealed with 20 mm grey bromobutyl rubber stopper and white flip-off seal + 10 mL plastic ampoule (sterile water for injection as solvent) in plastic tray [Box of 1's] | Rx | Zeiss Pharmaceuticals Pvt. Ltd.India | Shalaks Pharmaceuticals Inc.Importer: Sanimed Pharmaceuticals Inc. | DRP-7126-02 | Mar 29, 2027 | |
Shamcef-1500Cefuroxime (as sodium) | 1.5 g Powder for Injection (IM/IV)20 mL-capacity Type III glass vial with rubber stopper and aluminum blue flip-off seal (Box of 1's) | Rx | Shamshree Lifesciences Ltd.India | Khriz Pharma Trading Inc. | DR-XY48915 | Nov 9, 2028 | |
Shamcef-750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.V.)10 mL-Type III glass vial with rubber stopper and dark blue flip-off seal (Box of 1's) | Rx | Shamshree Lifesciences Ltd.India | Khriz Pharma Trading Inc. | DR-XY48916 | Nov 9, 2028 | |
ShincefCefuroxime (as Sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharmaceutical Co., Ltd.Republic of Korea | PHIL. SHINPOONG PHARMA INC. | DRP-3036 | Apr 11, 2031 | |
Sinbact 750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL capacity USP Type III clear glass vial with rubber stopper and aluminum flip-off seal (Box of 1's) | Rx | Makcur Laboratories LimitedIndia | Penta Labs Australia (Philippines)Trader: U Square Lifesciences Pvt. Ltd. | DRP-15180 | May 21, 2029 | |
Sinnat-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Zim Laboratories LimitedIndia | K Pharma Medical Corp.Importer: Medinova Pharmaceutical, Inc. | DRP-15901-06 | Sep 27, 2029 | |
Sinnat-500Cefuroxime (as Axetil) | 500mg Film-Coated TabletIn a box of 1 Alu-Alu Blister pack x 10's (Box of 10's and Box of 100's) | Rx | Sance Laboratories Pvt. Ltd.India | GA2 Pharmaceutical Inc.Importer: Medinova Pharmaceutical Inc. | DRP-7317-04 | Sep 11, 2027 | |
SpeedximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1’s) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | J and C Pharmamed Distributor and Gen. MerchandiseImporter: Pharmakon Biotec Inc. | DRP-4976-21 | Nov 27, 2028 | |
SQcefCefuroxime (as Axetil) | 125 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 50 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Alman Pharmaceuticals, Inc. | DRP-3191-05 | Aug 22, 2028 | |
SQcefCefuroxime (as Axetil) | 250 mg/5 mL powder for SuspensionBoston Round Amber Glass Bottle x 50 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Alman Pharmaceuticals, Inc. | DRP-3231-07 | Sep 7, 2028 | |
StamozefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Medcare PharmaceuticalsImporter: Ambica International Corporation | DRP-4164-22 | Dec 27, 2027 | |
StanximeCefuroxime (as sodium) | 750mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap x 10mL (Box of 1’s and 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Ellebasy Medicale Group Inc.Importer: PHIL. SHINPOONG PHARMA INC. | DRP-3036-02 | Feb 8, 2032 | |
STAXIM 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack X 3's (Box of 6's) | Rx | Delta Pharma Ltd.Bangladesh | Biomed Pharma Inc. | DR-XY41596 | Jan 25, 2031 | |
Suncetin 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Sakar Healthcare LimitedIndia | Biocare Lifesciences, Inc. | DRP-9316 | Feb 20, 2031 | |
Suncetin TabCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Affy ParenteralsIndia | Biocare Lifesciences, Inc.Trader: Austere Pharmaceuticals | DRP-7693 | Mar 27, 2027 | |
Suncetin-IVCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type III Clear and Colorless Glass Vial Box of 10's | Rx | Yeluri Formulations Pvt. Ltd.India | Biocare Lifesciences, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-4313-02 | Mar 20, 2028 | |
SuperoximeCefuroxime (as sodium) | 750 mg Lyophilized Powder for Injection (IM/IV)10 mL USP Type III Flint Glass Vial (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Biotechnica Medical EnterprisesImporter: Ambica International CorporationTrader: Endurance Healthcare Ltd. | DRP-6008-01 | Jan 25, 2029 | |
SuroximCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sance Laboratories Pvt. Ltd.India | Suhitas Pharmaceuticals Inc. | DRP-4993 | Dec 6, 2028 | |
SyfuroxCefuroxime (as axetil) | 125 mg/ 5mL Powder for Suspension50 mL filled in 120 mL Boston Round Amber Glass Bottle Box of 1's; 70 mL filled in 120 mL Boston Round Amber Glass Bottle Box of 1's | Rx | Sydenham Laboratories, Inc.Philippines | Sydenham Pharmaceuticals, Inc. | DRP-1180 | Dec 16, 2028 | |
Teikeden-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100's) | Rx | XL Laboratories Pvt. Ltd.India | Ambica International Corporation | DRP-477 | Oct 7, 2031 | |
TemlexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. Ltd.India | All-Bio Pharma, Inc.Importer: AMB HK Enterprises Inc. | DRP-12213-04 | Jul 13, 2027 | |
TeroximeCefuroxime (as sodium) | 1.5 g Powder For Injection15 mL USP Type III clear glass vial with aluminum seal and blue flip-off plastic cap (Box of 1's) | Rx | Sance Laboratories Pvt.Ltd.India | Teramedix Pharma Trading Inc. | DR-XY47030 | Jan 11, 2027 | |
TerximeCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Rexmed Pharmaceutical SalesImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-12 | Jun 30, 2029 | |
TerximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4's (Box of 20 's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-5017-06 | Dec 18, 2028 | |
TerximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass with white flip- off + USP Type 1 Ampoule (diluent) x 10 mL (Box of 1's) | Rx | Scott-Edil Advance Research Laboratories & Education LimitedIndia | Rexmed Pharmaceutical SalesImporter: Pharmakon Biotec Inc. | DRP-4976-24 | Nov 27, 2028 | |
TeximCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL-capacity USP Type III clear and colorless glass vial with grey bromo butyl rubber stopper and red flip off seal (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Hexagon Pharmaceuticals | DR-XY47570 | Nov 29, 2026 | |
TGCEFCefuroxime (as Axetil) | 250 mg/5 mL Granules for Oral SuspensionBoston Round Amber Glass Bottle in 50 mL (net content when reconstituted) | Rx | J.M. Tolmann Laboratories Inc.Philippines | TGIF Pharmaceutical Trading Inc. | DRP-7543-06 | Oct 14, 2029 | |
TgcefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Zim Laboratories LimitedIndia | TGIF Pharmaceutical Trading, Inc.Importer: Medinova Pharmaceutical, Inc. | DRP-15901-03 | Sep 27, 2029 | |
TGCEFCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister pack x 10's (Box of 1's) | Rx | SANCE LABORATORIES PVT. LTD.India | TGIF Pharmaceutical Trading Inc.Importer: Medinova Pharmaceutical Inc. | DRP-7317-02 | Sep 11, 2027 | |
TGCef IVCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap x 1's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | TGIF Pharmaceutical Trading Inc.Importer: Dreamax Incorporated | DRP-11361-03 | Mar 4, 2027 | |
Theoroxime 1.5Cefuroxime (as sodium) | 1.5 g Powder for Injection (I.V/I.M.)USP Type III Clear Glass Vial (Box of 1’s and 10’s) | Rx | Theon Pharmaceuticals LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-8006 | Oct 19, 2028 | |
Theoroxime 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.V/I.M.)USP Type III clear glass vial (Box of 1’s and 10’s) | Rx | Theon Pharmaceuticals LimitedIndia | Suhitas Pharmaceuticals Inc. | DRP-8005 | Oct 19, 2028 | |
Theoroxime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 30's) | Rx | Theon Pharmaceuticals Ltd.India | Orange Biotec Inc. | DRP-8203 | May 24, 2029 | |
TitacefCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 100’s | Rx | Brawn Laboratories LimitedIndia | Titanium PharmaImporter: Ambica International Corporation | DRP-4164-18 | Dec 27, 2027 | |
TitacefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | Titanium PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-09 | Sep 28, 2027 | |
Titacef DSCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1's) | Rx | Zim Laboratories Ltd.India | Titanium PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-10 | Jun 30, 2029 | |
Togen-CCefuroxime (as Axetil) | 125 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 50 mL and 70 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Seammed Pharma | DRP-3191-10 | Aug 22, 2028 | |
Togen-CCefuroxime (as Axetil) | 250 mg / 5 mL Powder for SuspensionBoston Round Amber Glass Bottle x 50 mL and 70 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Seamed Pharma | DRP-3231-15 | Sep 7, 2028 | |
TrigennaCefuroxime (as axetil) | 125 mg Granules for Oral SuspensionPET Sachet x 6.2 g (Box of 14's) | Rx | Interphil Laboratories, Inc.Philippines | — | DRP-5923 | Jan 20, 2030 | |
TrigennaCefuroxime (as axetil) | 250 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum Foil) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | — | DRP-3392 | Jan 12, 2031 | |
TrigennaCefuroxime (as axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's and 14's) | Rx | Interphil Laboratories, Inc.Philippines | — | DRP-3442 | Nov 5, 2030 | |
TriximeCefuroxime (as axetil) | 250 mg/5 mL Powder for SuspensionAmber Glass Bottle x 50 mL (Box of 1's) | Rx | Biopharma Ltd.Bangladesh | All-Bio Pharma, Inc.Importer: JF Draf Pharmaceuticals Corporation | DRP-3210-04 | Sep 8, 2027 | |
TriximeCefuroxime (as sodium) | 750 mg Powder for InjectionUSP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content as diluent Sterile Water for Injection) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd. - Unit IIIIndia | All-Bio Pharma, Inc.Importer: I.E. Medica, Inc. | DRP-3115-04 | Feb 17, 2027 | |
UnbrandedCefuroxime (as Axetil) | 250mg Film-coated TabletBlister pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories IncPhilippines | — | DRP-1696 | Mar 11, 2031 | |
UnbrandedCefuroxime (As Axetil) | 250mg/5mL Granules for Suspension120mL Amber glass bottle with white Aluminum Cap x 50mL net content (Box of 1's) | Rx | Drugmaker's Laboratories Inc.Philippines | TGP PHARMA INC. | DRP-1170-02 | Jan 23, 2032 | |
UnbrandedCefuroxime (as axetil) | 500 mg Film-coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Medico Remedies LimitedIndia | Patriot Pharmaceuticals CorporationImporter: Medethix, Inc. | DRP-15885-02 | Sep 27, 2031 | |
UnbrandedCefuroxime (as Axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's and 14's) | Rx | Interphil Laboratories, Inc.Philippines | Icon Healthcare, Inc. | DRP-3442-04 | Aug 18, 2031 | |
UnbrandedCefuroxime (as Axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | Rose Pharmacy, Incorporated | DRP-3442-06 | Oct 20, 2031 | |
UnbrandedCefuroxime (as axetil) | 500 mg Film-Coated TabletFoil Strip (Cellophane/Polyethylene/Aluminum) x 4's (Box of 100's) | Rx | Interphil Laboratories, Inc.Philippines | South Star Drug | DRP-3442-07 | Aug 11, 2031 | |
UnbrandedCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10's) | Rx | Brawn Laboratories LimitedIndia | Actimed, Inc.Importer: Ambica International Corporation | DRP-4164-03 | Dec 27, 2027 | |
UnbrandedCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu / Alu Blister Pack X 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Watsons Personal Care Stores (Philippines), Inc. | DRP-4618-09 | Aug 26, 2031 | |
UnbrandedCefuroxime (as axetil) | 500 mg TabletAlu/Alu Foil Blister x 4's Box of 60's | Rx | Nectar Lifesciencs Limited (Unit VI)India | Ritemed Phils., Inc. | DRP-8725 | Oct 6, 2030 | |
UnbrandedCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I transparent flint glass vial with grey rubber stopper and flip-off aluminum seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-8893 | May 29, 2030 | |
UnbrandedCefuroxime (as Sodium) | 750 mg Sterile Powder for Injection (IM/IV) | Rx | Utopian Co. Ltd. | Importer: JustRight Healthcare Inc. | DR-XY32674 | Nov 27, 2026 | |
Uroxime-500Cefuroxime (as axetil) | 500 mg TabletAlu/Alu Blister Pack in 3 Monocarton x 10's (Box of 30's); Alu/Alu Blister Pack in 10 Monocarton x 10's (Box of 100's) | Rx | Umedica Laboratories Pvt. Ltd.India | EON PHARMATEK, INC | DR-XY42095 | Jun 13, 2028 | |
Uroxime-500Cefuroxime (as axetil) | 500 mg TabletAlu/Alu Blister Pack in 3 Monocarton x 10's (Box of 30's); Alu/Alu Blister Pack in 10 Monocarton x 10's (Box of 100's) | Rx | Umedica Laboratories Pvt. Ltd.India | Eon Pharmatek, Inc.Importer: Eon Pharmatek Inc. | DRP-15013 | Jun 13, 2028 | |
UroxineCefuroxime (As Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Clear Glass Vial (Box of 10's) | Rx | Hankook Korus Pharm. Co., Ltd.Republic of Korea | MG Prime Pharmaceutical, Inc. | DR-XY43528 | Jul 9, 2029 | |
Usanfex 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Maxim Pharmaceuticals Pvt. Ltd.India | SRS Life Sciences, Inc. | DRP-14598 | Oct 23, 2028 | |
USOLIVCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Sakar Healthcare LimitedIndia | Ambicare International CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-05 | Jul 14, 2029 | |
UtiroxCefuroxime (As Axetil) | 250 mg/5 mL Granules for Oral SuspensionBoston Round Amber Glass Bottle in 50 mL (net content when reconstituted) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | CHMI PHARMA, INC. | DRP-7543-02 | Oct 14, 2029 | |
ValcefCefuroxime (as sodium) | 750 mg Powder for Injection(IM/IV)Type I Colorless Glass Vial Sealed with Tear-Off Aluminum Seal and Orange Flip-Off Plastic Cap 1 x 10 mL (Box of 10’s) | Rx | Shin Poong Pharm. Co., Ltd.Republic of Korea | Emru TradingImporter: PHIL. SHINPOONG PHARMA INC. | DRP-3036-03 | Feb 1, 2032 | |
VenirexCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Glass vial with halogentaed rubber stopper and aluminum plastic combination flip-off cap + 10 mL Type I colorless ampoule (Water for Injection as diluent) in a box | Rx | Furen Pharmaceutical Group Co., Ltd.China | Immunovacs Ltd. Co.Importer: Euro-Care Products Philippines | DRP-11801-06 | Apr 29, 2027 | |
VenirexCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low borosilicate glass vial with stopper and sealed with aluminum plastic cap + sterile water for injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Immunovacs Ltd. Co.Importer: Euro-Care Products Philippines | DRP-8837-07 | May 5, 2030 | |
VerileCefuroxime (as sodium) | 750mg Powder for Injection(I.M/I.V)USP Type I Glass Vial x 10ml (Box 1's and Box 10's) | Rx | Gentle Pharma Co LtdTaiwan | Neo Care Philippines Inc | DRP-2596 | Aug 19, 2031 | |
Verile 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s, 50’s and 100’s) | Rx | Brawn Laboratories LimitedIndia | Neo-Care PhilippinesImporter: Ambica International Corporation | DRP-4164-16 | Dec 27, 2027 | |
ViacefCefuroxime (as Axetil) | 500 mg Film-Coated TabletClear PVC Blister Pack x 10's (Box of 100's) | Rx | Drugmaker's Laboratories, Inc.Philippines | Terramedic, Inc. | DRP-2144-01 | Nov 12, 2027 | |
ViacefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Terramedic, Inc.Importer: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-20 | Sep 28, 2027 | |
VigocefCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | VIGOROUS HEALTH PHARMA AND MEDICAL SUPPLIES TRADINGImporter: AGLOBAL CARE, INC. | DRP-6570-13 | Mar 10, 2029 | |
VispocefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Schreechem Pharmaceuticals Pvt., Ltd.India | OneGen PharmaImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-04 | Sep 28, 2027 | |
VispoxetilCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | NGB Laboratories Pvt. Ltd.India | Vispomed EnterprisesImporter: AMB HK Enterprises Inc. | DRP-12213-02 | Jul 13, 2027 | |
VitaroximaCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Individually Boxed Type I Clear and Colorless Glass Vial with Green Colored Flip-off Seal (Box of 10's) | Rx | Vitalis S.A.C.I.Colombia | Pan-Ject Pharmaceuticals Corp.Trader: Vitalis S.A.C.I. | DRP-2394 | Jan 5, 2029 | |
ViximeCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 ml USP Type III Glass Vial (Box of 1's and 10's) | Rx | Bharat Parenterals Ltd.India | Multigro Healthcare Inc.Importer: Grovic Pharma Inc. | DRP-6956-01 | Dec 16, 2026 | |
VizefCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Clear Colorless Glass Vial (Box of 10's) | Rx | Phil Inter Pharma Co., Ltd. (Plant 2)Vietnam | Pharma King DistributorImporter: Largen Med Inc. | DRP-4774-01 | Jan 9, 2028 | |
Vycef 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 (Box of 100’s) | Rx | Theon Pharmaceuticals LimitedIndia | Medvybe Pharmaceutical TradingImporter: Greencore Pharma Inc. | DRP-9975-18 | Jul 1, 2031 | |
XefuCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | DAEWON PHARM. CO., LTD.Republic of Korea | D & G PHARMAImporter: LARGEN MED INC. | DRP-884-04 | Sep 28, 2027 | |
750 mg Powder for Injection (IM/IV)Type I Glass Vial + 10 mL Ampoule as Diluent (Box of 1's) | Rx | Phil Inter Pharma Co., LtdVietnam | D&G PharmaImporter: Largen Med Inc | DRP-6703-03 | May 24, 2031 | ||
Xefu 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10's and 100's | Rx | Brawn Laboratories LimitedIndia | D & G PharmaImporter: Ambica International Corporation | DRP-4164-09 | Dec 27, 2027 | |
XefuronovCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's & 100's) | Rx | Zim Laboratories LimitedIndia | Medinova Pharmaceutical Inc. | DRP-15901 | Sep 27, 2029 | |
Xeptin 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Zim Laboratories LimitedIndia | Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical, Inc. | DRP-15901-04 | Sep 27, 2029 | |
Xeptin 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu-Alu Blister pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Cassandras Care Pharmaceutical DistributorImporter: Medinova Pharmaceutical Inc. | DRP-7317-03 | Sep 11, 2027 | |
XimgencefCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Sanoviz Pharmaceutical Products TradingImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-19 | Sep 28, 2027 | |
XinalatCefuroxime (as sodium) | 750 mg Powder For Injection (IM/IV)10ml transparent and colorless USP Type II glass vial with rubber stopper and blue flip-off cap (Box of 10's and 50's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Lakeside Pharmaceuticals Phil., Inc | DRP-14815 | Jan 15, 2029 | |
XinatreneCefuroxime (as Axetil) | 250 mg/5 mL Granules for Oral SuspensionBoston Round Amber Glass Bottle in 50 mL (net content when reconstituted) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Aisec Farma Corporation | DRP-7543-03 | Oct 14, 2029 | |
XinatreneCefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu - Alu Blister Pack 8's (Box of 16's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Aisec Farma Corporation | DRP-4618-05 | Sep 11, 2031 | |
XinatreneCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Sakar Healthcare Ltd.India | Aisec Farma CorporationImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-12 | Jul 14, 2029 | |
XinatreneCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) (Box of 1’s) | Rx | Inject Care Parenterals Pvt. Ltd.India | Aisec Farma CorporationImporter: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-06 | Mar 24, 2029 | |
Xinatrene 250Cefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL Box of 1's | Rx | Zim Laboratories LimitedIndia | Aisec Farma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-03 | Jun 30, 2029 | |
Xinatrene 500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4’s Box of 4’s | Rx | Akums Drugs & Pharmaceuticals, Ltd.India | Aisec Farma CorporationImporter: Ambica International Corporation | DRP-2994-04 | Jun 9, 2029 | |
Xinatrene 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Box of 20 mL USP Type III Clear Glass Vial + Glass Ampoule x 10 mL (Diluent) | Rx | Shreechem Pharmaceuticals Pvt., Ltd.India | Aisec Farma CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-3995-31 | Sep 28, 2027 | |
XonetrimCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Flint Glass Vial with Gray Butyl Rubber Stopper and Pink Aluminum Flip-Off Seal Cap x 1's (Box of 1's) | Rx | Yeluri Formulations Pvt. Ltd.India | Guimhealth Pharmaceutical Distributor and DrugstoreImporter: Medinova Pharmaceutical, Inc. | DRP-10888-05 | Dec 14, 2026 | |
XurocefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Sance Laboratories Pvt. Ltd.India | Greencore Pharma Inc. | DRP-17503 | Jan 14, 2031 | |
XyfroxCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | TGP Pharma Inc.Trader: Interhealthcare Pharmaceuticals, Inc. | DRP-2103 | Sep 18, 2028 | |
XyfroxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAluminum Strip Foil x 10's (Box of 50's) | Rx | J.M. TOLMANN LABORATORIES INC.Philippines | TGP PHARMA INC. | DRP-7568 | Feb 24, 2029 | |
Y-Cef 750Cefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Flint Clear Glass Vial Sealed with Grey Butyl Rubber Stopper and Pink Color Flip Off Seal (Box of 10's) (Box of 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Pharma-Surrey International, Inc. | DRP-8911 | Jun 23, 2031 | |
YuferoxCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL + 10 mL Sterile Water for Injection as diluent (Box of 1's) and USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 10 mL + 10 mL Sterile Water for Injection as diluent (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | AMB HK Enterprises Inc | DRP-8403 | Feb 20, 2030 | |
ZafexCefuroxime (as Axetil) | 125 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Metz Pharmaceuticals, Inc. | DRP-3947 | Jan 13, 2030 | |
ZafexCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension120 mL (net content: 50 mL) Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | WeCare Pharma Corp.Trader: Metz Pharmaceuticals, Inc. | DRP-3948 | Feb 18, 2030 | |
ZafexCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Metz Pharmaceuticals, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-2103-08 | Sep 18, 2028 | |
ZeconcefCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 30 mL, 60 mL, and 70 mL (Box of 1's) | Rx | Globela Laboratories Private LimitedIndia | Bio Erixx Pharma DistributionImporter: AMB HK Enterprises Inc. | DRP-12854-02 | Oct 28, 2027 | |
ZeeteximeCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)10 mL USP Type III Clear Flint Glass Vial (Box of 1's and 10's) | Rx | Yeluri Formulations Pvt. Ltd.India | Multigro Healthcare Inc.Importer: Grovic Pharma Inc.Trader: Sherrington Pharmaceuticals Pvt. Ltd. | DRP-5927-04 | Jan 12, 2030 | |
Zef IVCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear USP Type II Glass Vial with rubber stopper and red flip-off seal (Box of 10's) | Rx | Daewon Pharm. Co., Ltd.Republic of Korea | D.B. Manix International, Inc. | DRP-884 | Sep 28, 2032 | |
ZefcareCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Colorless Glass Vial with Rubber Stopper and Blue Flip-off Seal x 15 mL (Box of 1's) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | MSF Pharmaceutical Products DistributionImporter: AMB HK Enteprises Inc. | DRP-8403-05 | Feb 15, 2028 | |
Zefcare-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | MSF Pharmaceutical Products DistributionImporter: AMB HK Enterprises Inc. | DRP-6113-06 | Mar 12, 2030 | |
Zefcure 750Cefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Blue Flip-off Seal (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Prodrom Nutritionals, IncorporatedImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-1639-01 | Dec 27, 2028 | |
Zefcure-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 100’s) | Rx | Sakar Healthcare Pvt. Ltd.India | Prodrom Nutritionals, IncorporatedImporter: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd. | DRP-5385-10 | Jul 14, 2029 | |
ZeffoxtabCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Ambica International Corporation | DRP-10337 | Sep 15, 2031 | |
ZefimCefuroxime (As Sodium) | 750 mg Powder For InjectionType I Glass Vial + 10 mL Ampoule As Diluent (Box of 1's) | Rx | Phil Inter Pharma Co., LtdVietnam | Clearvue PharmaceuticalImporter: Largen Med Inc | DRP-6703-01 | May 24, 2031 | |
ZefinatCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL-capacity Type I glass vial with rubber stopper and aluminum seal (Box of 1's) | Rx | Venus Remedies LimitedIndia | Merkchem Pharma Inc.Importer: Finstad Inc. | DRP-13990-01 | Jun 1, 2028 | |
Zefriti 750Cefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)10 mL Clear Glass Vial Sealed with Gray Butyl Rubber Stopper and Violet Aluminum Plastic Seal Cap x 1's (Box of 1's) | Rx | Akriti Pharmaceuticals Pvt. Ltd.India | Aglobal Care, Inc. | DRP-14463 | Sep 8, 2028 | |
ZefsolvCefuroxime (as axetil) | 250 mg /5 mL Granules for Suspension120 mL Amber Boston Bottle (50 mL net content) per Box | Rx | Lloyd Laboratories, Inc.Philippines | Dr. Zen's Research, Inc.Trader: Solvang Pharmaceuticals, Inc. | DRP-4440-01 | Aug 28, 2027 | |
Zefsur 1500Cefuroxime (as sodium) | 1.5 g Powder for Injection (I.M./I.V.)USP Type III Flint Glass Vial x 30 mL Box of 1's | Rx | Medchem International LimitedIndia | Importer: Pharma-Surrey International, Inc. | DRP-3918 | Aug 22, 2027 | |
Zefsur-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 1's) | Rx | Medchem International Ltd.India | Pharma-Surrey International, Inc. | DRP-966 | Feb 21, 2028 | |
ZefucareCefuroxime (as Axetil) | 500mg Film coated tabletAlu/Alu Blister Pack of 10's (Box of 10 tablets) | Rx | Sance Laboratories Pvt. Ltd.India | Euro-Care Products, Philippines | DRP-13124 | Dec 5, 2027 | |
ZefucefCefuroxime (As Sodium) | 750 mg Powder For Injection (Im/Iv)10 mL - Capacity Type I Borosilicate Clear Glass Tubular vial Sealed with Blue Butyl Rubber Stopper and Aluminum Seal with Plastic Cap x 1's + 10 mL Sterile Water for Injection in Type-I Clear Glass Ampoule in PVC Tray (as diluent) (Box of 10's and 50's) | Rx | CSPC Zhongnuo Pharmaceutical (Shjiazhuang) Co., Ltd.China | PhilRx Pharma Inc. | DRP-18070 | Apr 30, 2031 | |
ZefucefCefuroxime (As Sodium) | 750 mg Powder For Injection (IM/IV)10 mL capacity Type I Clear Glass Vial sealed with Halogenated Butyl Rubber Stopper and Aluminum Seal with Blue Flip Off Cap x 1’s (Box of 10’s and 50’s) | Rx | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.China | Philrx Pharma Inc. | DRP-18613 | Aug 5, 2031 | |
ZefufedCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type III clear glass vial sealed with grey bromo butyl stopper and red color flip-off (Box of 1's) | Rx | Theon Pharmaceuticals LimitedIndia | Medical Mission Group Hospitals and Health Services Cooperative of the Philippines Federation (MMGHHSCPF)Importer: Greencor Pharma Inc. | DRP-8745-10 | Feb 20, 2031 | |
ZefumedCefuroxime (as Axetil) | 500 mg Film-Coated TabletIn a box of 1 Alu-Alu Blister pack x 10's Box of 10's and 100's | Rx | SANCE LABORATORIES PVT. LTD.India | MEDINOVA PHARMACEUTICAL INC. | DRP-7317 | Sep 11, 2027 | |
ZefurCefuroxime (as axetil) | 125 mg/5 mL Granules for Suspension50 mL net content in 120 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY41090 | Aug 1, 2027 | |
ZefurCefuroxime (as Axetil) | 250 mg/5 mL Granules for SuspensionAmber Boston Bottle x 50 mL (net content) (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-8433 | Dec 7, 2027 | |
ZefurCefuroxime (As Axetil) | 500 mg Film Coated TabletAlu/Alu blister pack x 10 tablets (box of 30 tablets) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DR-XY47958 | Apr 22, 2027 | |
500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Innogen Pharmaceuticals, Inc. | DRP-5503 | Mar 29, 2027 | ||
ZefurCefuroxime (as Sodium) | 750 mg Powder for InjectionType I Clear Glass Vial with Rubber Stopper and Orange Flip-off Seal Box of 10's | Rx | Aju Pharm Co., Ltd.Republic of Korea | Innogen Pharmaceuticals, Inc.Importer: Interhealthcare Pharmaceuticals, Inc. | DRP-2356-04 | Dec 6, 2028 | |
ZefurCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear and Colorless Glass Vial with Orange Flip-off (Box of 10’s) | Rx | Kyungdong Pharm Co., Ltd.Republic of Korea | Innogen Pharmaceuticals, Inc.Importer: D.B. Manix International, Inc. | DRP-076-05 | Dec 21, 2029 | |
Zefur IVCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)USP Type III Clear and Colorless Glass Vial with Rubber Stopper and White Flip-Off Seal + 10 mL Clear Glass Ampoule (Sterile Water for Injection as Diluent) (Box of 1's) | Rx | Inject Care Parenterals Pvt. Ltd.India | Innogen Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc.Trader: Umedica Laboratories Pvt. Ltd. | DRP-1326-07 | Mar 24, 2029 | |
Zefuroz-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Foil x 10's (Box of 10's and 100's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Zion Pharmaceutical Product DistributionImporter: AMB HK Enterprises Inc. | DRP-4975-13 | May 6, 2031 | |
Zefuroz-750Cefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type III Clear Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Green Aluminum Flip-Off Seal Cap x 1's + Sterile Water for Injection in LDPE Plastic Ampoule x 10 mL (Box of 1's) | Rx | Swiss Parenterals Ltd.India | Zion Pharmaceutical Product DistributionImporter: GPC Geo Pharma Corporation | DRP-11250-04 | Feb 17, 2027 | |
ZefurozanCefuroxime (as sodium) | 750mg Powder for Injection (IM/IV)Type II Glass Vial with Butyl Rubber Stopper and Aluminum Flip-Off Cap x l's + Sterile Water for Injection in Type I Clear Glass Ampoule x 10 mL (Box of 1's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Largen Med Inc.Importer: Dreamax Incorporated | DRP-11361-05 | Mar 4, 2027 | |
ZefuveeCefuroxime (As Sodium) | 750mg Powder for Injection (IV/IM)10 mL -Capacity USP Type III Glass vial with Butyl Rubber Stopper and Aluminum Flip-Off Seal (Box of l's) | Rx | Furen Pharmaceutical Group Co., Ltd.China | Eurocare Products Philippines | DRP-12800 | Oct 7, 2027 | |
ZefuximCefuroxime (as Sodium) | 1.5 g Powder for Injection (IV/IM)USP Type II Clear and Colorless Glass Vial with Yellow Flip-off Seal (Box of 10's) | Rx | Singapore Pharmawealth Lifesciences, Inc.Philippines | — | DR-XY35661 | Apr 2, 2029 | |
ZefuximCefuroxime (as sodium) | 250 mg Powder for Injection (IV/IM)USP Type I Vial (Box of 10's) | Rx | SINGAPORE PHARMAWEALTH LIFESCIENCES, INC.Philippines | — | DR-XY36551 | Aug 29, 2028 | |
ZefuximCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)Clear Glass USP Type 1 vial ( Box of 10's) | Rx | Harbin Pharmaceutical Group Co. Ltd. Gen. Pharm FactoryChina | Phil. Pharmawealth, Inc.Importer: Endure Medical, Inc. | DRP-1088-01 | Nov 28, 2027 | |
ZefuximCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Glass Vial with Rubber Stopper and Orange Flip-Off Seal (Box of 10's) | Rx | Singapore Pharmawealth Lifesciences, Inc.Philippines | — | DRP-1657 | Jul 28, 2031 | |
ZefuximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's and 100's) | Rx | Friends Pharma (Pvt.) Ltd.Pakistan | Raquel-Abbas Pharmaceuticals & General Merchandise | DRP-9993 | Feb 20, 2031 | |
Zefxime-500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 20's and 100's) | Rx | Medley Pharmaceuticals LimitedIndia | West Wing Pharma Sales Inc.Importer: Ambica International Corporation | DRP-6459-01 | Feb 24, 2029 | |
ZegecefCefuroxime (as axetil) | 125 mg /5 mL Granules for SuspensionAmber Glass Bottle x 120 mL (50 mL net volume when reconstituted) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-16074 | May 8, 2028 | |
ZegecefCefuroxime (as axetil) | 125 mg/5 mL Granules for SuspensionAmber Glass Bottle x 120 mL (50 mL net volume when reconstituted) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY42017 | May 8, 2028 | |
ZegecefCefuroxime (as axetil) | 250 mg / 5mL Granules for SuspensionAmber Glass Bottle x 120 mL (50 mL net volume when reconstituted) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DRP-16078 | May 8, 2028 | |
ZegecefCefuroxime (as axetil) | 250 mg/5 mL Granules for SuspensionAmber Glass Bottle x 120 mL (50 mL net volume when reconstituted) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Aldril Pharmaceuticals, Inc. | DR-XY42016 | May 8, 2028 | |
ZegecefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 40's) | Rx | Lloyd Laboratories, Inc.Bulacan | Aldril Pharmaceuticals, Inc.Trader: Innogen Pharmaceuticals, Inc. | DRP-5503-05 | Mar 29, 2027 | |
ZegenCefuroxime (as axetil) | 250 mg Film-coated TabletAluminum flex foil x 4's (Box of 100's) | Rx | PT. Darya-Varia Laboratoria TBKlndonesia | United Laboratories, Inc.Trader: UNILAB, Inc. | DR-XY47592 | Dec 9, 2031 | |
ZegenCefuroxime (as axetil) | 500 mg Film-Coated TabletAluminum flex foil x 4's Box of 60's | Rx | PT Darya-Varia Laboratoria TbkIndonesia | UNILAB, Inc. | DR-XY46653 | Jul 24, 2029 | |
ZegenCefuroxime (as Sodium) | 750 mg Powder for Injection (IM/IV)Type I Clear Glass Vial with Blue Flip-Off Cap and Metallic Blue Alucap x 10 mL (Box of 1's) | Rx | PT Darya-Varia Laboratoratoria TBKIndonesia | Unilab, Inc. | DR-XY27790 | Apr 30, 2029 | |
ZekucefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's, 30's and 100's) | Rx | Medico Remedies Ltd.India | Sanreich Healthcare, Inc.Importer: Medethix, Inc. | DRP-15885-01 | Sep 27, 2031 | |
ZenoximCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s (Box of 10’s) | Rx | Indchemie Health Specialities Private LimitedIndia | Better Option Pharmaceuticals, Inc.Importer: Suhitas Pharmaceuticals Inc. | DRP-1016 | Aug 13, 2028 | |
ZenximeCefuroxime (as axetil) | 125 mg/5 mL Granules for Suspension | Rx | Lloyd Laboratories, Inc. | Trader: Eadriex Pharmaceuticals Phils., Inc. | DRP-5368 | Nov 17, 2026Past listed date | |
ZenximeCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Glass Bottle N/A | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-5422 | Nov 17, 2031 | |
ZenximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 30's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DR-XY47307 | Jun 22, 2031 | |
ZenximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's Box of 24's | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Eadriex Pharmaceuticals, Phils., Inc. | DRP-7160 | Oct 24, 2027 | |
ZepreimexCefuroxime Axetil | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 24's) | Rx | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-11151 | Feb 8, 2027 | |
ZerzimeCefuroxime (as Axetil) | 125 mg / 5 mL Powder for SuspensionBoston Round Amber Bottle x 50 mL, 60 mL, 70 mL (Box of 1's) | Rx | LifeSquare Laboratories, Inc.Philippines | Novomed Inc. | DRP-3191-11 | Aug 22, 2028 | |
ZerzimeCefuroxime (as axetil) | 250 mg/5 mL Powder for SuspensionBoston Round Amber Bottle x 50 mL (Box of 1's); Boston Round Amber Bottle x 60 mL (Box of 1's); Boston Round Amber Bottle x 70 mL (Box of 1's) | Rx | LIFESQUARE LABORATORIES, INC.Philippines | NOVOMED INC. | DRP-3231-14 | Sep 7, 2028 | |
ZeximeCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)10 mL Type II Glass Vial Sealed with Gray Butyl Rubber Stopper and Blue Flip-off Seal x 1's (Box of 10's) | Rx | Reyoung Pharmaceutical Co., Ltd.China | Basic Pharmaceutical CorporationImporter: Pharmaessence Inc. | DRP-14502-01 | Sep 14, 2028 | |
Zexime-250Cefuroxime (as axetil) | 250 mg/ 5 mL Granules for Suspension50 mL Amber Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Basic Pharmaceutical CorporationTrader: Foramen Products Corporation | DRP-7789-02 | Sep 12, 2031 | |
Zexime-500Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/ Alu Blister Pack x 8's (Box of 24's) | Rx | Lloyd Laboratories, Inc.Philippines | Basic Pharmaceutical CorporationTrader: D.B. Manix International, Inc. | DRP-6830-02 | Feb 17, 2030 | |
Zillian 500Cefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10’s Box of 10’s | Rx | Brawn Laboratories LimitedIndia | Speed Cure PharmaImporter: Ambica International Corporation | DRP-4164-12 | Dec 27, 2027 | |
ZINACARECefuroxime (As Sodium) | 1.5 g Powder For Injection (IM/IV)Pack in one box containing 1-Type III Clear Colourless Glass vial with grey butyl rubber stopper and blue aluminium flip-off cap + 1 Ampoule x 10 mL water for injection (Diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Aglobal Care, Inc. | DRP-9400 | Aug 5, 2029 | |
ZinacareCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | AGLOBAL CARE, INC. | DRP-6570 | Mar 10, 2029 | |
ZinacefCefuroxime (as axetil) | 500 mg TabletAlu/Alu Blister Pack x 10's (Box of 50's) | Rx | Glaxo Operations UK LimitedUnited Kingdome | Novartis Healthcare Philippines, Inc. | DRP-6747 | Nov 19, 2030 | |
ZinacefCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Clear Glass Vial with Blue Flip-Off Seal x 750 mg Box of 1's | Rx | ACS Dobfar S.p.A.Italy | Importer: Novartis Healthcare Philippines, Inc. | DRP-11855 | Feb 10, 2029 | |
ZinaferCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Type I Transparent Glass Vial with Gray Butyl Rubber Stopper and Flip-Off Seal Cap x 1's (Box of 10's) | Rx | Medisure Laboratories Pakistan (Pvt.) Ltd.Pakistan | Ferjan Healthlink Philippines Inc.Importer: Accesspoint International Trading, Inc. | DRP-11548-01 | Mar 30, 2027 | |
ZinaximeCefuroxime (as axetil) | 125 mg/5 mL Granules for Suspension50 mL in 120 mL Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Vitalink Health Products, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-3947-01 | Jan 13, 2030 | |
ZinaximeCefuroxime (as axetil) | 250 mg/5 mL Granules for Suspension120 mL (net content: 50 mL) Amber Glass Bottle (Box of 1's) | Rx | Lloyd Laboratories, Inc.Philippines | Altomed Pharmaceuticals, Inc.Trader: Metz Pharmaceuticals, Inc. | DRP-3948-01 | Feb 18, 2030 | |
ZinaximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/PVC Blister Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories Inc.Philippines | Vitalink Health Products, Inc.Trader: Interhealthcare Pharmaceuticals Inc. | DRP-2103-06 | Sep 18, 2028 | |
ZinnatCefuroxime (as axetil) | 125 mg/5 mL Granules for SuspensionGlass Amber Bottle x 50 mL and 70 mL with Measuring Cup and Spoon (Box of 1's) | Rx | Glaxo Operations UK Ltd Trading As Glaxo Wellcome OperationsUnited Kingdom | Importer: Sandoz Philippines Corporation | DRP-11854 | Nov 3, 2029 | |
ZinnatCefuroxime (As Axetil) | 250 mg TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 20's) | Rx | Glaxo Operations UK Limited TradingUnited Kingdom | Importer: Sandoz Philippines Corporation | DRP-11864 | Jan 10, 2031 | |
ZinnatCefuroxime (as Axetil) | 250 mg/5 mL Granules for SuspensionAmber Glass Bottle with Measuring Cup and Spoon x 50 mL; Physician's Sample: Amber Glass Bottle x 5 mL (Box of 1’s); Physician's Sample: Amber Glass Bottle x 5 mL (Box of 2’s) | Rx | Glaxo Operations UK Ltd. Trading as Glaxo Wellcome OperationsUnited Kingdom | Importer: Sandoz Philippines Corporation | DRP-11866 | Nov 3, 2029 | |
ZinnatCefuroxime (as axetil) | 500 mg TabletAlu/Alu Blister Pack x 8's (Box of 24's); Alu/Alu Blister Pack x 10's (Box of 20's) | Rx | Glaxo Operations UK LTD Trading as Glaxo Wellcome OperationsUnited Kingdom | Importer: Sandoz Philippines Corporation Unit | DRP-11865 | Sep 25, 2030 | |
ZinoxCefuroxime (as Sodium) | 750 mg Powder for Solution for Injection (IM/IV)12 mL Type II clear glass vial with bromobutyl rubber stopper and yellow alu-plastic flip-off cap (Box of 1's) | Rx | Zhuhai United Laboratories (Zhongshan) Co. Ltd.China | HLM Leverage Pharmaceutical Corp.Importer: AGlobal Care, Inc. | DR-XY45658 | Nov 22, 2026 | |
ZobexelleCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 4’s (Box of 4’s); Alu/Alu Blister Pack x 4’s (Box of 12’s); Alu/Alu Blister Pack x 4’s (Box of 40’s) | Rx | Akums Drugs & Pharmaceuticals, Ltd.India | Phil Asia Pharma, Inc.Importer: Ambica International CorporationTrader: Unosource Pharma Limited | DRP-2994-02 | Jun 9, 2029 | |
ZocefCefuroxime (as Axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE Bottle x 30 mL & 60 mL (Box of 1's) | Rx | Zim Laboratories LimitedIndia | Alkem Laboratories CorporationImporter: Ambica International CorporationTrader: Rainbow Life Sciences Pvt. Ltd. | DRP-5367-07 | Jun 30, 2029 | |
ZocefCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 10's) | Rx | Alkem Laboratories LimitedIndia | Alkem Laboratories Corporation | DRP-5788 | Oct 26, 2030 | |
Zocef 500Cefuroxime (as axetil) | 500 mg Film-coated tabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Sance Laboratories Pvt. Ltd.India | Alkem Laboratories CorporationImporter: Greencore Pharma Inc. | DRP-17503-01 | Jan 14, 2031 | |
Zocef HospiCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's and 10's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 Vial + 1 Ampoule Diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Co., Ltd.China | Alkem Laboratories CorporationImporter: Aglobal Care, Inc. | DRP-6570-09 | Mar 10, 2029 | |
Zocef KidsCefuroxime (as axetil) | 250 mg/5 mL Powder for Oral SuspensionHDPE White Plastic Bottle with clear transparent measuring cup x 60 mL (Box of 1's) | Rx | Hiral Labs LimitedIndia | Alkem Laboratories CorporationImporter: Aglobal Care, Inc. | DRP-12580-01 | Sep 7, 2027 | |
ZoltaxCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 48's) | Rx | Lloyd Laboratories, Inc.Philippines | Trader: Natrapharm, Inc. | DR-XY37463 | Feb 11, 2030 | |
ZoltaxCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)USP Type I Glass Vial x 10 mL in a box Box of 1’s | Rx | SAMJIN PHARMACEUTICAL CO., LTD.Republic of Korea | NATRAPHARM, INC. | DR-XY32247 | Sep 24, 2029 | |
ZufreximCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap (Box of 1's); 10 mL USP Type I Clear Transparent Vial with Butyl Rubber Stopper and Aluminum (Blue) Plastic Cap with 10 mL Sterile Water for Injection in USP Type I Glass Ampoule (Box of 1 vial + 1 Ampoule Diluent) | Rx | NCPC HEBEI HUAMIN PHARMACEUTICAL CO., LTD.China | BERNEST TRADINGImporter: AGLOBAL CARE, INC. | DRP-6570-03 | Mar 10, 2029 | |
ZuregemCefuroxime (as Sodium) | 750 mg Powder for Injection (I.M./I.V.)One (1) Box contains: Low Borosilicate Glass Vial with Stopper and Sealed with Aluminum Plastic Cap + Sterile Water for Injection in USP Type I Glass Ampoule x 10 mL (net content of diluent) | Rx | NCPC Hebei Huamin Pharmaceutical Company LimitedChina | Euro-Care Products Philippines | DRP-8837 | May 5, 2030 | |
ZurenixCefuroxime (as Axetil) | 500 mg Film-Coated TabletAlu-Alu Blister Pack x 10's (Box of 10's and 50's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-455 | Feb 5, 2032 | |
ZurenixCefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)Individually boxed 10mL USP Type III clear and colorless glass vial with rubber stopper and white flip-off seal Box of 10's | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-282 | Dec 10, 2027 | |
Zurenix WFICefuroxime (as sodium) | 750 mg Powder for Injection (IM/IV)1 USP type III clear glass vial with rubber stopper and white flip-off seal and 1 USP type I clear glass ampoule x 10 mL (diluent) (Box of 1's) | Rx | Flamingo Pharmaceuticals Ltd.India | Hexagon Pharmaceuticals | DRP-954 | Jul 12, 2027 | |
ZureveeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box of 100's) | Rx | Theon Pharmaceuticals LimitedIndia | Euro-Care Products PhilippinesImporter: Greencore Pharma Inc. | DRP-9975-04 | Feb 6, 2032 | |
Zuri-125Cefuroxime (as axetil) | 125 mg/5 mL Powder for Oral SuspensionTranslucent white HDPE Bottle with PP cap and measuring cup x 60 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12855-01 | Oct 28, 2027 | |
Zuri-250Cefuroxime (as axetil) | 250 mg / 5 mL Powder for Oral SuspensionTranslucent white HPDE Bottle with PP cap and measuring cup x 60 mL (Box of 1’s) | Rx | Globela Laboratories Pvt. Ltd.India | Kaufmann Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12854-01 | Oct 28, 2027 | |
ZypraximeCefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 8's (Box of 3 blister packs x 8 tablets) | Rx | Azarias Pharmaceutical Laboratories Inc.Philippines | Trader: St. Raphael Archangel Pharmaceutical Product Distribution | DRP-14047 | Jun 8, 2031 | |
ZyrexCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)USP Type I Flint glass vial (as active) + USP Type I flint glass ampoule x 10 mL (net content as diluent Sterile Water for Injection) (Box of 1's) | Rx | Samrudh Pharmaceuticals Pvt. Ltd. - Unit IIIIndia | Zyre Pharmaceuticals CorporationImporter: I.E. Medica, Inc. | DRP-3115-02 | Feb 17, 2027 | |
ZyrexCefuroxime (as sodium) | 750 mg Powder for Injection (I.M./I.V.)10 mL USP Type I Clear Glass Vial + 10 mL USP Type I Clear Glass Ampoule Sterile water for injection (as Diluent) Box of 1's | Rx | Zazen Pharma Pvt. Ltd.India | Zyre Pharmaceuticals CorportaionImporter: I.E. Medica, Inc.Trader: Stratgen Healthcare Pvt. Ltd. | DRP-4515-07 | Jul 18, 2028 | |
(no brand name)Cefuroxime | 250 mg Film Coated TabletAlu-Alu Blister Pack x 10 (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Penta Labs Australia (Philippines) | DRP-11686 | Apr 13, 2027 | |
(no brand name)Cefuroxime (as axetil) | 250 mg Film Coated TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix Inc. | DRP-16458 | Mar 18, 2030 | |
(no brand name)Cefuroxime | 500 mg Film Coated TabletAlu-Alu Blister Pack x 10 (Box of 10's) | Rx | Sance Laboratories Pvt. Ltd.India | Penta Labs Australia (Philippines) | DRP-11687 | Apr 13, 2027 | |
(no brand name)Cefuroxime (As Axetil) | 500 mg Film-Coated TabletAlu/Alu Foil Strip Pack x 10's (Box of 50's) | Rx | J.M. Tolmann Laboratories, Inc.Philippines | — | DR-XY47614 | Jan 18, 2027 | |
(no brand name)Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu blister pack x 10 tablets (box of 30 tablets) | Rx | Lloyd Laboratories, Inc.Philippines | — | DR-XY47955 | Apr 22, 2027 | |
(no brand name)Cefuroxime (as axetil) | 500 mg Film-Coated TabletAlu/Alu Blister Pack x 10's (Box Tablets) | Rx | Pharmavision San. Ve Tic. A.S.Turkey | Onesource Pharma Solutions, Inc.Trader: Bilim Ilac San Ve Tic. A.S. | DRP-13649 | Mar 23, 2028 | |
(no brand name)Cefuroxime (as axetil) | 500 mg TabletAlu/PVC Blister Pack x 10's (Box of 100's) | Rx | Medico Remedies LimitedIndia | Medethix | DRP-16457 | Mar 18, 2030 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
United States (label)
Dosage forms and strengths (US label) US FDA label
3 DOSAGE FORMS AND STRENGTHS Cefuroxime Axetil Tablets USP, 250 mg of cefuroxime (as cefuroxime axetil), are white to off-white, film-coated, capsule shaped tablets with ‘A33’ debossed on one side and plain on the other side. Cefuroxime Axetil Tablets USP, 500 mg of cefuroxime (as cefuroxime axetil), are white to off-white, film-coated, capsule shaped tablets with ‘A34’ debossed on one side and plain on the other side. Tablets: 250 mg and 500 mg (3)
Warnings/Precautions
- Serious hypersensitivity (anaphylactic) reactions: In the event of a serious reaction, discontinue cefuroxime axetil and institute appropriate therapy. (5.1)
- Clostridioides difficile- associated diarrhea (CDAD): If diarrhea occurs, evaluate patients for CDAD. (5.2)
5.1 Anaphylactic Reactions
5.1 Anaphylactic Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on β-lactam antibacterials, including cefuroxime axetil [see Adverse Reactions (6.2)]. These reactions are more likely to occur in individuals with a history of β-lactam hypersensitivity and/or a history of sensitivity to multiple allergens.
There have been reports of individuals with a history of penicillin hypersensitivity who have experienced severe reactions when treated with cephalosporins. Cefuroxime axetil is contraindicated in patients with a known hypersensitivity to cefuroxime axetil or other β-lactam antibacterial drugs [see Contraindications (4)].
Before initiating therapy with cefuroxime axetil, inquire about previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. If an allergic reaction occurs, discontinue cefuroxime axetil and institute appropriate therapy.
5.2 Clostridioides difficile
5.2 Clostridioides difficile -Associated Diarrhea Clostridioides difficile- associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including cefuroxime axetil, and may range in severity from mild diarrhea to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.
C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must be considered in all patients who present with diarrhea following antibiotic use.
Careful medical history is necessary since CDAD has been reported to occur over 2 months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued. Appropriate fluid and electrolyte management, protein supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
5.3 Potential for Microbial Overgrowth
5.3 Potential for Microbial Overgrowth The possibility of superinfections with fungal or bacterial pathogens should be considered during therapy.
5.4 Development of Drug-Resistant Bacteria
5.4 Development of Drug-Resistant Bacteria Prescribing cefuroxime axetil either in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
5.6 Interference with Glucose Tests
5.6 Interference with Glucose Tests A false-positive result for glucose in the urine may occur with copper reduction tests, and a false-negative result for blood/plasma glucose may occur with ferricyanide tests in subjects receiving cefuroxime axetil [see Drug Interactions (7.3)].
Drug interactions
| Drug or class | Severity | Effect | What to do |
|---|---|---|---|
| Probenecid | Avoid | Blocks tubular secretion; higher and longer drug levels (label). | Coadministration not recommended. |
| Antacids, H2 blockers, proton pump inhibitors (oral) | Adjust or monitor | Lower bioavailability of cefuroxime axetil; may cancel the food effect on absorption (label 7.1). | Give at least 1 hour before or 2 hours after short-acting antacids; avoid H2 blockers and proton pump inhibitors (label 7.1). |
Severity scale (renalcarematters.com): Avoid: do not combine; Adjust or monitor: change the dose or monitor closely; Minor: usually no action.
renalcarematters.com, reviewed- Drugs that reduce gastric acidity may lower the bioavailability of cefuroxime axetil. (7.1)
- Coadministration with probenecid increases systemic exposure to cefuroxime axetil and is therefore not recommended. (7.2)
7.1 Drugs
7.1 Drugs that Reduce Gastric Acidity Drugs that reduce gastric acidity may result in a lower bioavailability of cefuroxime axetil compared with administration in the fasting state. Administration of drugs that reduce gastric acidity may negate the food effect of increased absorption of cefuroxime axetil when administered in the postprandial state.
Administer cefuroxime axetil at least 1 hour before or 2 hours after administration of short-acting antacids. Histamine-2 (H 2) antagonists and proton pump inhibitors should be avoided.
7.2 Probenecid
7.2 Probenecid Concomitant administration of probenecid with cefuroxime axetil tablets increases serum concentrations of cefuroxime [see Clinical Pharmacology (12.3)]. Coadministration of probenecid with cefuroxime axetil is not recommended.
7.3 Drug/Laboratory Test Interactions
7.3 Drug/Laboratory Test Interactions A false-positive reaction for glucose in the urine may occur with copper reduction tests (e.g., Benedict's or Fehling's solution), but not with enzyme-based tests for glycosuria. As a false-negative result may occur in the ferricyanide test, it is recommended that either the glucose oxidase or hexokinase method be used to determine blood/plasma glucose levels in patients receiving cefuroxime axetil.
The presence of cefuroxime does not interfere with the assay of serum and urine creatinine by the alkaline picrate method.
Adverse reactions
Common
- Diarrhea, nausea, vomiting
- Vaginitis; Jarisch-Herxheimer reaction (Lyme disease)
- IV: local infusion reactions
Serious
- Anaphylaxis
- Clostridioides difficile-associated diarrhea
- Seizures or encephalopathy with overdose
- The following serious and otherwise important adverse reaction is described in greater detail in the Warnings and Precautions section of the label: Anaphylactic Reactions [see Warnings and Precautions (5.1)]. The most common adverse reactions (≥3%) for cefuroxime axetil tablets are diarrhea, nausea/vomiting, Jarisch-Herxheimer reaction, and vaginitis (early Lyme disease). (6.1)
- To report SUSPECTED ADVERSE REACTIONS, contact Rising Health, LLC at 1-833-395-6928 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
6.1 Clinical Trials Experience
6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in practice. Tablets Multiple-Dose Dosing Regimens with 7 to 10 Days’ Duration: In multiple-dose clinical trials, 912 subjects were treated with cefuroxime axetil (125 to 500 mg twice daily).
It is noted that 125 mg twice daily is not an approved dosage. Twenty (2.2%) subjects discontinued medication due to adverse reactions. Seventeen (85%) of the 20 subjects who discontinued therapy did so because of gastrointestinal disturbances, including diarrhea, nausea, vomiting, and abdominal pain. The percentage of subjects treated with cefuroxime axetil who discontinued study drug because of adverse reactions was similar at daily doses of 1,000, 500, and 250 mg (2.3%, 2.1%, and 2.2%, respectively).
However, the incidence of gastrointestinal adverse reactions increased with the higher recommended doses. The adverse reactions in Table 5 are for subjects (n = 912) treated with cefuroxime axetil in multiple-dose clinical trials. Table 5. Adverse Reactions (≥1%) after Multiple-Dose Regimens with Cefuroxime Axetil Tablets Adverse Reaction Cefuroxime Axetil (n = 912) Blood and lymphatic system disorders Eosinophilia 1% Gastrointestinal disorders Diarrhea 4% Nausea/Vomiting 3% Investigations Transient elevation in AST 2% Transient elevation in ALT 2% Transient elevation in LDH 1% The following adverse reactions occurred in less than 1% but greater than 0.1% of subjects (n = 912) treated with cefuroxime axetil in multiple-dose clinical trials.
Immune System Disorders: Hives, swollen tongue. Metabolism and Nutrition Disorders: Anorexia. Nervous System Disorders: Headache. Cardiac Disorders: Chest pain. Respiratory Disorders: Shortness of breath. Gastrointestinal Disorders: Abdominal pain, abdominal cramps, flatulence, indigestion, mouth ulcers. Skin and Subcutaneous Tissue Disorders: Rash, itch.
Renal and Urinary Disorders: Dysuria. Reproductive System and Breast Disorders: Vaginitis, vulvar itch. General Disorders and Administration Site Conditions: Chills, sleepiness, thirst. Investigations: Positive Coombs’ test. Early Lyme Disease with 20-Day Regimen: Two multicenter trials assessed cefuroxime axetil 500 mg twice daily for 20 days.
The most common drug-related adverse experiences were diarrhea (10.6%), Jarisch-Herxheimer reaction (5.6%), and vaginitis (5.4%). Other adverse experiences occurred with frequencies comparable to those reported with 7 to 10 days’ dosing. Single-Dose Regimen for Uncomplicated Gonorrhea: In clinical trials using a single 1,000 mg dose of cefuroxime axetil, 1,061 subjects were treated for uncomplicated gonorrhea.
The adverse reactions in Table 6 were for subjects treated with a single dose of 1,000 mg cefuroxime axetil in U.S. clinical trials. Table 6. Adverse Reactions (≥1%) after Single-Dose Regimen with 1,000 mg Cefuroxime Axetil Tablets for Uncomplicated Gonorrhea Adverse Reaction Cefuroxime Axetil (n = 1,061) Gastrointestinal disorders Nausea/Vomiting 7% Diarrhea 4% The following adverse reactions occurred in less than 1% but greater than 0.1% of subjects (n = 1,061) treated with a single dose of cefuroxime axetil 1,000 mg for uncomplicated gonorrhea in U.S. clinical trials.
Infections and Infestations: Vaginal candidiasis. Nervous System Disorders: Headache, dizziness, somnolence. Cardiac Disorders: Tightness/pain in chest, tachycardia. Gastrointestinal Disorders: Abdominal pain, dyspepsia. Skin and Subcutaneous Tissue Disorders: Erythema, rash, pruritus. Musculoskeletal and Connective Tissue Disorders: Muscle cramps, muscle stiffness, muscle spasm of neck, lockjaw-type reaction.
Renal and Urinary Disorders: Bleeding/pain in urethra, kidney pain. Reproductive System and Breast Disorders: Vaginal itch, vaginal discharge.
6.2 Postmarketing Experience
6.2 Postmarketing Experience The following adverse reactions have been identified during post-approval use of cefuroxime axetil. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.
Blood and Lymphatic System Disorders Hemolytic anemia, leukopenia, pancytopenia, thrombocytopenia. Gastrointestinal Disorders Pseudomembranous colitis [see Warnings and Precautions (5.2)]. Hepatobiliary Disorders Hepatic impairment including hepatitis and cholestasis, jaundice. Immune System Disorders Anaphylaxis, serum sickness-like reaction, acute myocardial ischemia with or without myocardial infarction may occur as part of an allergic reaction.
Investigations Increased prothrombin time. Nervous System Disorders Seizure, encephalopathy. Renal and Urinary Disorders Renal dysfunction. Skin and Subcutaneous Tissue Disorders Angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria.
Adverse reaction frequency tables (US label) US FDA label
| Adverse Reaction | Cefuroxime Axetil (n = 912) |
| Blood and lymphatic system disorders | |
| Eosinophilia | 1% |
| Gastrointestinal disorders | |
| Diarrhea | 4% |
| Nausea/Vomiting | 3% |
| Investigations | |
| Transient elevation in AST | 2% |
| Transient elevation in ALT | 2% |
| Transient elevation in LDH | 1% |
| Adverse Reaction | Cefuroxime Axetil (n = 1,061) |
| Gastrointestinal disorders | |
| Nausea/Vomiting | 7% |
| Diarrhea | 4% |
Monitoring parameters
- CrCl for dose; seizures or encephalopathy with overdose in kidney impairment (label overdose section); diarrhea (CDAD). Kidney
- CrCl for dose
- Diarrhea
Pregnancy considerations
Pregnancy (US label) US FDA label
8.1 Pregnancy Risk Summary Available data from published epidemiologic studies, case series, and case reports over several decades with cephalosporin use, including cefuroxime axetil, in pregnant women have not established drug-associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes (see Data). In studies in pregnant mice and rats administered oral cefuroxime axetil during organogenesis at 14 and 9 times the maximum recommended human dose (MRHD) based on body surface area, respectively, there were no adverse developmental outcomes (see Data).
The estimated background risk of major birth defects and miscarriage for the indicated populations are unknown. All pregnancies have a background risk of birth defects, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.
Clinical Considerations Disease-Associated Maternal and/or Embryo/Fetal Risk: Maternal gonorrhea may be associated with preterm birth, low neonatal birth weight, chorioamnionitis, intrauterine growth restriction, small for gestational age, and premature rupture of membranes. Perinatal transmission of gonorrhea to the offspring can result in infant blindness, joint infections, and bloodstream infections.
Data Human Data: While available studies cannot definitively establish the absence of risk, published data from epidemiologic studies, case series, and case reports over several decades have not identified an association with cephalosporin use (including cefuroxime axetil) during pregnancy and major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Available studies have methodologic limitations, including small sample size, retrospective data collection, and inconsistent comparator groups.
Animal Data: Studies performed with oral cefuroxime axetil administered to pregnant mice during organogenesis (Gestation Days 7 through 16) at doses up to 3,200 mg/kg/day (14 times the MRHD based on body surface area); and in rats dosed during organogenesis and lactation (Gestation Days 7 through 16 and Gestation Days 17 through Lactation Day 21, respectively) at doses up to 1,000 mg/kg/day (9 times the MRHD based on body surface area) have revealed no adverse developmental outcomes.
Mechanism of action
12.1 Mechanism of Action Cefuroxime axetil is an antibacterial drug [see Microbiology (12.4)].
US FDA labelPharmacokinetics
Key PK parameters
| Bioavailability | Oral tablet 37% fasting, 52% after food |
|---|---|
| Time to peak | Oral about 2 to 3 hours |
| Half-life | About 1.2 hours (oral); about 80 minutes (IV) |
| Half-life in kidney failure (ESKD) kidney | Prolonged in severe kidney impairment (label; no value given) |
| Protein binding | About 50% |
| Metabolism (CYP, transporters) | Axetil ester hydrolyzed to cefuroxime |
| Active metabolites | Cefuroxime (from the axetil prodrug) |
| Renal excretion kidney | About 89% of an IV dose unchanged in urine in 8 hours |
| Dialyzability kidney | Yes (hemodialysis and peritoneal dialysis) |
Dose b (Cefuroxime Equivalent) Peak Plasma Concentration (mcg/mL) Time of Peak Plasma Concentration (h) Mean Elimination Half-life (h) AUC (mcg·h/mL) 125 mg 2.1 2.2 1.2 6.7 250 mg 4.1 2.5 1.2 12.9 500 mg 7 3 1.2 27.4 1,000 mg 13.6 2.5 1.3 50 Effect of Food: Absorption of the tablet is greater when taken after food (absolute bioavailability increases from 37% to 52%).
Excretion Cefuroxime is excreted unchanged in the urine; in adults, approximately 50% of the administered dose is recovered in the urine within 12 hours.
Specific Populations Patients with Renal Impairment: In a trial of 28 adults with normal renal function or severe renal impairment (creatinine clearance <30 mL/min), the elimination half-life was prolonged in relation to severity of renal impairment.
Geriatric Patients: In a trial of 20 elderly subjects (mean age = 83.9 years) having a mean creatinine clearance of 34.9 mL/min, the mean serum elimination half-life was prolonged to 3.5 hours; however, despite the lower elimination of cefuroxime in geriatric patients, dosage adjustment based on age is not necessary [see Use in Specific Populations (8.5) ] .
Pharmacokinetics (US label) US FDA label
12.3 Pharmacokinetics Absorption After oral administration, cefuroxime axetil is absorbed from the gastrointestinal tract and rapidly hydrolyzed by nonspecific esterases in the intestinal mucosa and blood to cefuroxime. Serum pharmacokinetic parameters for cefuroxime following administration of cefuroxime axetil tablets to adults are shown in Table 8.
Table 8. Pharmacokinetics of Cefuroxime Administered in the Postprandial State as Cefuroxime Axetil Tablets to Adults a a Mean values of 12 healthy adult volunteers. b Drug administered immediately after a meal. Dose b (Cefuroxime Equivalent) Peak Plasma Concentration (mcg/mL) Time of Peak Plasma Concentration (h) Mean Elimination Half-life (h) AUC (mcg·h/mL) 125 mg 2.1 2.2 1.2 6.7 250 mg 4.1 2.5 1.2 12.9 500 mg 7 3 1.2 27.4 1,000 mg 13.6 2.5 1.3 50 Effect of Food: Absorption of the tablet is greater when taken after food (absolute bioavailability increases from 37% to 52%).
Despite this difference in absorption, the clinical and bacteriologic responses of subjects were independent of food intake at the time of tablet administration in 2 trials where this was assessed. Lack of Bioequivalence: Oral suspension was not bioequivalent to tablets when tested in healthy adults. The tablet and oral suspension formulations are NOT substitutable on a milligram-per-milligram basis.
The area under the curve for the suspension averaged 91% of that for the tablet, and the peak plasma concentration for the suspension averaged 71% of the peak plasma concentration of the tablets. Therefore, the safety and effectiveness of both the tablet and oral suspension formulations were established in separate clinical trials.
Distribution Cefuroxime is distributed throughout the extracellular fluids. Approximately 50% of serum cefuroxime is bound to protein. Metabolism The axetil moiety is metabolized to acetaldehyde and acetic acid. Excretion Cefuroxime is excreted unchanged in the urine; in adults, approximately 50% of the administered dose is recovered in the urine within 12 hours.
The pharmacokinetics of cefuroxime in pediatric subjects have not been studied. Until further data are available, the renal elimination of cefuroxime axetil established in adults should not be extrapolated to pediatric subjects. Specific Populations Patients with Renal Impairment: In a trial of 28 adults with normal renal function or severe renal impairment (creatinine clearance <30 mL/min), the elimination half-life was prolonged in relation to severity of renal impairment.
Prolongation of the dosage interval is recommended in adult patients with creatinine clearance <30 mL/min [see Dosage and Administration (2.5)]. Geriatric Patients: In a trial of 20 elderly subjects (mean age = 83.9 years) having a mean creatinine clearance of 34.9 mL/min, the mean serum elimination half-life was prolonged to 3.5 hours; however, despite the lower elimination of cefuroxime in geriatric patients, dosage adjustment based on age is not necessary [see Use in Specific Populations (8.5)].
Drug Interaction Studies Concomitant administration of probenecid with cefuroxime axetil tablets increases the cefuroxime area under the serum concentration versus time curve and maximum serum concentration by 50% and 21%, respectively [see Drug Interactions (7.2)].
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Cefuroxime 1.5 g Vial | ₱38.00–₱138.33Reference ₱96.44 | per vial | DPRI procurement range |
| Cefuroxime 125 mg/5 mL, 70 mL Suspension | ₱122.00–₱188.50Reference ₱169.75 | per unit | DPRI procurement range |
| Cefuroxime 250 mg/5 mL, 120 mL Granule for suspension | ₱150.00–₱200.00Reference ₱199.00 | per unit | DPRI procurement range |
| Cefuroxime 250 mg/5 mL, 50 mL Bottle | ₱120.00–₱210.90Reference ₱154.00 | per bottle | DPRI procurement range |
| Cefuroxime 500 mg Tablet | ₱5.07–₱18.78Reference ₱9.00 | per tablet | DPRI procurement range |
| Cefuroxime 750 mg Vial | ₱13.22–₱90.00Reference ₱16.30 | per vial | DPRI procurement range |
| 125 mg/5 mL (as axetil) granules for suspension in 70 mL | ₱309.00 | per unit | PhilHealth GAMOT fixed fee |
| 250 mg/5 mL granules for suspension in (50 mL content) in 120 mL bottle | ₱320.25 | per bottle | PhilHealth GAMOT fixed fee |
| 500 mg (as axetil) tablet | ₱37.25 | per tablet | PhilHealth GAMOT fixed fee |
PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf, as of October 13, 2026
Formulary and coverage
| Philippine National Formulary | Listed as Cefuroxime |
| PNF listing | Oral: 500 mg tablet (as axetil) |
| PNF listing | Oral: 125 mg/5 mL granules for suspension, 70 mL (as axetil) |
| PNF listing | Oral: 250 mg/5 mL granules for suspension, 50 mL content in 120 mL bottle |
| PNF listing | Inj.: 250 mg and 750 mg vial (IM, IV) |
| PNF listing | Inj.: 1.5 g vial (IV infusion) (as sodium salt) |
| PhilHealth GAMOT | Yes (listed since July 28, 2025) |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Cefuroxime Axetil · Redpharm Drug [US FDA-approved label, version 1, September 11, 2026]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b2e7ec0-7c68-4d62-e063-6294a90a7bd5
- U.S. Food and Drug Administration. Cefuroxime and Dextrose · B. Braun Medical Inc. [US FDA-approved label, version 16, December 5, 2020]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07170ee3-1a24-424f-a2a2-00bc92e98f85
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
- Redpharm Drug. (2026). Cefuroxime axetil tablets, USP [Prescribing information; US FDA-approved label, ANDA065308, set ID 5b2e7ec0-7c68-4d62-e063-6294a90a7bd5, version effective September 11, 2026]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b2e7ec0-7c68-4d62-e063-6294a90a7bd5
- B. Braun Medical Inc. (2020). Cefuroxime for injection USP and dextrose injection USP, DUPLEX container (cefuroxime sodium) [IV label used for the injectable kidney table] [Prescribing information; US FDA-approved label, NDA050780, set ID 07170ee3-1a24-424f-a2a2-00bc92e98f85, version effective December 5, 2020]. DailyMed, U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07170ee3-1a24-424f-a2a2-00bc92e98f85
renalcarematters.com content: Kidney and pediatric dosing: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Dosing, interaction, adverse-effect and monitoring summary: reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026.
Last updated: .
US label: intravenous
Indications and usage (US label) US FDA label
INDICATIONS AND USAGE Cefuroxime for Injection USP and Dextrose Injection USP is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: Lower Respiratory Tract Infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Klebsiella spp., Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, and Escherichia coli. Urinary Tract Infections caused by Escherichia coli and Klebsiella spp.
Skin and Skin-Structure Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pyogenes, Escherichia coli, Klebsiella spp., and Enterobacter spp. Septicemia caused by Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae (including ampicillin-resistant strains), and Klebsiella spp.
Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including ampicillin-resistant strains), Neisseria meningitidis, and Staphylococcus aureus (penicillinase- and non-penicillinase-producing strains). Gonorrhea: Uncomplicated and disseminated gonococcal infections due to Neisseria gonorrhoeae (penicillinase- and non-penicillinase-producing strains) in both males and females.
Bone and Joint Infections caused by Staphylococcus aureus (penicillinase- and non-penicillinase producing strains). Clinical microbiological studies in skin and skin-structure infections frequently reveal the growth of susceptible strains of both aerobic and anaerobic organisms. Cefuroxime has been used successfully in these mixed infections in which several organisms have been isolated.
In certain cases of confirmed or suspected gram-positive or gram-negative sepsis or in patients with other serious infections in which the causative organism has not been identified, cefuroxime may be used concomitantly with an aminoglycoside (see PRECAUTIONS). The recommended doses of both antibacterials may be given depending on the severity of the infection and the patient's condition.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefuroxime for Injection USP and Dextrose Injection USP and other antibacterial drugs, Cefuroxime for Injection USP and Dextrose Injection USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy.
In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Prevention: The preoperative prophylactic administration of Cefuroxime for Injection USP and Dextrose Injection USP may prevent the growth of susceptible disease-causing bacteria and thereby may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures (e.g., vaginal hysterectomy) that are classified as clean-contaminated or potentially contaminated procedures.
Effective prophylactic use of antibacterials in surgery depends on the time of administration. Cefuroxime for Injection USP and Dextrose Injection USP should usually be given one-half to 1 hour before the operation to allow sufficient time to achieve effective antibacterial concentrations in the wound tissues during the procedure.
The dose should be repeated intraoperatively if the surgical procedure is lengthy. Prophylactic administration is usually not required after the surgical procedure ends and should be stopped within 24 hours. In the majority of surgical procedures, continuing prophylactic administration of any antibacterial does not reduce the incidence of subsequent infections but will increase the possibility of adverse reactions and the development of bacterial resistance.
The perioperative use of Cefuroxime for Injection USP and Dextrose Injection USP has also been effective during open heart surgery for surgical patients in whom infections at the operative site would present a serious risk. For these patients it is recommended that cefuroxime therapy be continued for at least 48 hours after the surgical procedure ends.
If an infection is present, specimens for culture should be obtained for the identification of the causative organism, and appropriate antimicrobial therapy should be instituted.
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION This product is intended for intravenous administration only. Dosage: Adults: The usual adult dosage range for cefuroxime is 750 mg to 1.5 grams every 8 hours, usually for 5 to 10 days. In uncomplicated urinary tract infections, skin and skin-structure infections, disseminated gonococcal infections, and uncomplicated pneumonia, a 750 mg dose every 8 hours is recommended.
In severe or complicated infections, a 1.5 gram dose every 8 hours is recommended. In bone and joint infections, a 1.5 gram dose every 8 hours is recommended. In clinical trials, surgical intervention was performed when indicated as an adjunct to cefuroxime therapy. A course of oral antibacterials was administered when appropriate following the completion of parenteral administration of cefuroxime.
In life-threatening infections or infections due to less susceptible organisms, 1.5 grams every 6 hours may be required. In bacterial meningitis, the dosage should not exceed 3 grams every 8 hours. For preventive use for clean-contaminated or potentially contaminated surgical procedures, a 1.5 gram dose administered intravenously just before surgery (approximately one-half to 1 hour before the initial incision) is recommended.
Thereafter, give 750 mg intravenously every 8 hours when the procedure is prolonged. For preventive use during open heart surgery, a 1.5 gram dose administered intravenously at the induction of anesthesia and every 12 hours thereafter for a total of 6 grams is recommended. Impaired Renal Function: A reduced dosage must be employed when renal function is impaired.
Dosage should be determined by the degree of renal impairment and the susceptibility of the causative organism (see Table 2). Table 2: Dosage of Cefuroxime in Adults with Reduced Renal Function Creatinine Clearance (mL/min) Dose Frequency >20 750 mg–1.5 grams q8h 10–20 750 mg q12h <10 750 mg q24h Since cefuroxime is dialyzable, patients on hemodialysis should be given a further dose at the end of the dialysis.
When only serum creatinine is available, the following formula 1 (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal function. Males: Creatinine clearance (mL/min) = Weight (kg) × (140 - age) 72 × serum creatinine (mg/dL) Females: 0.85 × male value Note: As with antibacterial therapy in general, administration of Cefuroxime for Injection USP and Dextrose Injection USP should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or after evidence of bacterial eradication has been obtained; a minimum of 10 days of treatment is recommended in infections caused by Streptococcus pyogenes in order to guard against the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical appraisal is necessary during therapy of chronic urinary tract infection and may be required for several months after therapy has been completed; persistent infections may require treatment for several weeks; and doses smaller than those indicated above should not be used.
In staphylococcal and other infections involving a collection of pus, surgical drainage should be carried out where indicated. Pediatric Patients Above 3 Months of Age: Administration of 50 to 100 mg/kg/day in equally divided doses every 6 to 8 hours has been successful for most infections susceptible to cefuroxime. The higher dosage of 100 mg/kg/day (not to exceed the maximum adult dosage) should be used for the more severe or serious infections.
In bone and joint infections, 150 mg/kg/day (not to exceed the maximum adult dosage) is recommended in equally divided doses every 8 hours. In clinical trials, a course of oral antibacterials was administered to pediatric patients following the completion of parenteral administration of cefuroxime. In cases of bacterial meningitis, a larger dosage of cefuroxime is recommended, 200 to 240 mg/kg/day intravenously in divided doses every 6 to 8 hours.
In pediatric patients with renal insufficiency, the frequency of dosing should be modified consistent with the recommendations for adults. Cefuroxime for Injection USP and Dextrose for Injection USP in the DUPLEX® Container is designed to deliver a 750 mg or 1.5 g dose of cefuroxime. To prevent unintentional overdose, this product should not be used in pediatric patients who require less than the full adult dose.
For intermittent IV infusion with a Y-type administration set, dosing can be accomplished through the tubing system by which the patient may be receiving other IV solutions. However, during infusion of the solution containing Cefuroxime, it is advisable to temporarily discontinue administration of any other solutions at the same site.
Solutions of cefuroxime, like those of most beta-lactam antibacterials, should not be added to solutions of aminoglycoside antibacterials because of potential interaction. However, if concurrent therapy with cefuroxime and an aminoglycoside is indicated, each of these antibacterials can be administered separately to the same patient.
Use sterile equipment. Caution: Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is complete. DUPLEX® Container Directions for Use To avoid inadvertent activation, DUPLEX® Container should remain in the folded position until activation is intended.
Patient Labeling and Drug Powder/Diluent Inspection Apply patient-specific label on foil side of container. USE CARE to avoid activation. Do not cover any portion of foil strip with patient label. Unlatch side tab and unfold DUPLEX® Container. (See Diagram 1.) Visually inspect diluent chamber for particulate matter. Use only if container and seals are intact.
To inspect the drug powder for foreign matter or discoloration, peel foil strip from drug chamber. (See Diagram 2.) Protect from light after removal of foil strip. Note: If foil strip is removed, product must be used within 7 days, but not beyond the labeled expiration date. The product should be re-folded and the side tab latched until ready to activate.
Reconstitution (Activation) Do not use directly after storage by refrigeration, allow the product to equilibrate to room temperature before patient use. Unfold the DUPLEX® Container and point the set port in a downward direction. Starting at the hanger tab end, fold the DUPLEX® Container just below the diluent meniscus trapping all air above the fold.
To activate, squeeze the folded diluent chamber until the seal between the diluent and powder opens, releasing diluent into the drug powder chamber. (See Diagram 3.) Agitate the liquid-powder mixture until the drug powder is completely dissolved. Note: Following reconstitution (activation), product must be used within 24 hours if stored at room temperature or within 7 days if stored under refrigeration.
Administration Visually inspect the reconstituted solution for particulate matter. Point the set port in a downwards direction. Starting at the hanger tab end, fold the DUPLEX® Container just below the solution meniscus trapping all air above the fold. Squeeze the folded DUPLEX® Container until the seal between reconstituted drug solution and set port opens, releasing liquid to set port.
(See Diagram 4.) Prior to attaching the IV set, check for minute leaks by squeezing container firmly. If leaks are found, discard container and solution as sterility may be impaired. Using aseptic technique, peel foil cover from the set port and attach sterile administration set. (See Diagram 5.) Refer to Directions for Use accompanying the administration set.
Precautions As with other cephalosporins, reconstituted Cefuroxime for Injection USP and Dextrose Injection USP tends to darken depending on storage conditions, within the stated recommendations. However, product potency is not adversely affected. Use only if prepared solution is clear and free from particulate matter. Do not use in series connection.
Do not introduce additives into the DUPLEX® Container. Do not freeze. Diagram 1 Diagram 2 Diagram 3 Diagram 4 Diagram 5
Kidney dosing: Renal impairment (US label) US FDA label
Impaired Renal Function: A reduced dosage must be employed when renal function is impaired. Dosage should be determined by the degree of renal impairment and the susceptibility of the causative organism (see Table 2). Table 2: Dosage of Cefuroxime in Adults with Reduced Renal Function Creatinine Clearance (mL/min) Dose Frequency >20 750 mg–1.5 grams q8h 10–20 750 mg q12h <10 750 mg q24h Since cefuroxime is dialyzable, patients on hemodialysis should be given a further dose at the end of the dialysis.
When only serum creatinine is available, the following formula 1 (based on sex, weight, and age of the patient) may be used to convert this value into creatinine clearance. The serum creatinine should represent a steady state of renal function. Males: Creatinine clearance (mL/min) = Weight (kg) × (140 - age) 72 × serum creatinine (mg/dL) Females: 0.85 × male value Note: As with antibacterial therapy in general, administration of Cefuroxime for Injection USP and Dextrose Injection USP should be continued for a minimum of 48 to 72 hours after the patient becomes asymptomatic or after evidence of bacterial eradication has been obtained; a minimum of 10 days of treatment is recommended in infections caused by Streptococcus pyogenes in order to guard against the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical appraisal is necessary during therapy of chronic urinary tract infection and may be required for several months after therapy has been completed; persistent infections may require treatment for several weeks; and doses smaller than those indicated above should not be used.
In staphylococcal and other infections involving a collection of pus, surgical drainage should be carried out where indicated.
Warnings and precautions (US label) US FDA label
WARNINGS BEFORE THERAPY WITH CEFUROXIME FOR INJECTION USP AND DEXTROSE INJECTION USP IS INSTITUTED, CAREFUL INQUIRY SHOULD BE MADE TO DETERMINE WHETHER THE PATIENT HAS HAD PREVIOUS HYPERSENSITIVITY REACTIONS TO CEPHALOSPORINS, PENICILLINS OR OTHER DRUGS. THIS PRODUCT SHOULD BE GIVEN CAUTIOUSLY TO PENICILLIN-SENSITIVE PATIENTS.
ANTIBACTERIALS SHOULD BE ADMINISTERED WITH CAUTION TO ANY PATIENT WHO HAS DEMONSTRATED SOME FORM OF ALLERGY, PARTICULARLY TO DRUGS. IF AN ALLERGIC REACTION TO CEFUROXIME OCCURS, DISCONTINUE THE DRUG. SERIOUS ACUTE HYPERSENSITIVITY REACTIONS MAY REQUIRE EPINEPHRINE AND OTHER EMERGENCY MEASURES. Clostridioides difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including Cefuroxime for Injection USP and Dextrose Injection USP, and may range in severity from mild diarrhea to fatal colitis.
Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the development of CDAD. Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy.
CDAD must be considered in all patients who present with diarrhea following antibacterial use. Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents. If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile may need to be discontinued.
Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated.
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Cefuroxime is generally well tolerated. The most common adverse effects have been local reactions following IV administration. Other adverse reactions have been encountered only rarely. Local Reactions: Thrombophlebitis has occurred with IV administration in 1 in 60 patients. Gastrointestinal: Gastrointestinal symptoms occurred in 1 in 150 patients and included diarrhea (1 in 220 patients) and nausea (1 in 440 patients).
The onset of pseudomembranous colitis may occur during or after antibacterial treatment (see WARNINGS). Hypersensitivity Reactions: Hypersensitivity reactions have been reported in fewer than 1% of the patients treated with cefuroxime and include rash (1 in 125). Pruritus, urticaria, and positive Coombs' test each occurred in fewer than 1 in 250 patients, and, as with other cephalosporins, rare cases of anaphylaxis, drug fever, erythema multiforme, interstitial nephritis, toxic epidermal necrolysis, and Stevens-Johnson syndrome have occurred.
Blood: A decrease in hemoglobin and hematocrit has been observed in 1 in 10 patients and transient eosinophilia in 1 in 14 patients. Less common reactions seen were transient neutropenia (fewer than 1 in 100 patients) and leukopenia (1 in 750 patients). A similar pattern and incidence were seen with other cephalosporins used in controlled studies.
As with other cephalosporins, there have been rare reports of thrombocytopenia. Hepatic: Transient rise in SGOT and SGPT (1 in 25 patients), alkaline phosphatase (1 in 50 patients), LDH (1 in 75 patients), and bilirubin (1 in 500 patients) levels has been noted. Kidney: Elevations in serum creatinine and/or blood urea nitrogen and a decreased creatinine clearance have been observed, but their relationship to cefuroxime is unknown.
Postmarketing Experience with Cefuroxime: In addition to the adverse events reported during clinical trials, the following events have been observed during clinical practice in patients treated with cefuroxime and were reported spontaneously. Data are generally insufficient to allow an estimate of incidence or to establish causation.
Immune System Disorders: Angioedema, acute myocardial ischemia with or without myocardial infarction may occur as part of an allergic reaction. Neurologic System Disorders: Seizure. Cephalosporin-class Adverse Reactions: In addition to the adverse reactions listed above that have been observed in patients treated with cefuroxime, the following adverse reactions and altered laboratory tests have been reported for cephalosporin-class antibacterials: Adverse Reactions: Vomiting, abdominal pain, colitis, vaginitis including vaginal candidiasis, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemolytic anemia, and hemorrhage.
Several cephalosporins, including cefuroxime, have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced (see DOSAGE AND ADMINISTRATION). If seizures associated with drug therapy should occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated.
Altered Laboratory Tests: Prolonged prothrombin time, pancytopenia, agranulocytosis.
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Following IV doses of 750 mg and 1.5 g, serum concentrations were approximately 50 and 100 mcg/mL, respectively, at 15 minutes. Therapeutic serum concentrations of approximately 2 mcg/mL or more were maintained for 5.3 hours and 8 hours or more, respectively. There was no evidence of accumulation of cefuroxime in the serum following IV administration of 1.5 g doses every 8 hours to normal volunteers.
The serum half-life after IV injection is approximately 80 minutes. Approximately 89% of a dose of cefuroxime is excreted by the kidneys over an 8-hour period, resulting in high urinary concentrations. Intravenous doses of 750 mg and 1.5 g produced urinary levels averaging 1,150 and 2,500 mcg/mL, respectively, during the first 8-hour period.
The concomitant oral administration of probenecid with cefuroxime slows tubular secretion, decreases renal clearance by approximately 40%, increases the peak serum level by approximately 30%, and increases the serum half-life by approximately 30%. Cefuroxime is detectable in therapeutic concentrations in pleural fluid, joint fluid, bile, sputum, bone, and aqueous humor.
Cefuroxime is detectable in therapeutic concentrations in cerebrospinal fluid (CSF) of adults and pediatric patients with meningitis. The following table shows the concentrations of cefuroxime achieved in cerebrospinal fluid during multiple dosing of patients with meningitis. Table 1. Concentrations of Cefuroxime Achieved in Cerebrospinal Fluid During Multiple Dosing of Patients with Meningitis Patients Dose Number of Patients Mean (Range) CSF Cefuroxime Concentrations (mcg/mL) Achieved Within 8 Hours Post Dose Pediatric patients (4 weeks to 6.5 years) 200 mg/kg/day, divided q 6 hours 5 6.6 (0.9–17.3) Pediatric patients (7 months to 9 years) 200 to 230 mg/kg/day, divided q 8 hours 6 8.3 (<2–22.5) Adults 1.5 grams q 8 hours 2 5.2 (2.7–8.9) Adults 1.5 grams q 6 hours 10 6.0 (1.5–13.5) Cefuroxime is approximately 50% bound to serum protein.
Microbiology Mechanism of Action Cefuroxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefuroxime has activity in the presence of some beta-Iactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria. Resistance Resistance to cefuroxime is primarily through hydrolysis by beta-Iactamase, alteration of penicillin-binding proteins (PBPs), and decreased permeability.
Interaction with Other Antimicrobials In an in vitro study antagonistic effects have been observed with the combination of chloramphenicol and cefuroxime. Antimicrobial Activity Cefuroxime has been shown to be active against most isolates of the following bacteria, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section: Gram-negative bacteria Enterobacter spp.
Escherichia coli Klebsiella spp. Haemophilus influenzae Neisseria meningitidis Neisseria gonorrhoeae Gram-positive bacteria Staphylococcus aureus Streptococcus pneumoniae Streptococcus pyogenes The following in vitro data are available, but their clinical significance is unknown. At least 90 percent of the following bacteria exhibit an in vitro minimum inhibitory concentration (MIC) less than or equal to the susceptible breakpoint for cefuroxime against isolates of similar genus or organism group.
However, the efficacy of cefuroxime in treating clinical infections caused by these bacteria has not been established in adequate and well-controlled clinical trials. Gram-negative bacteria Citrobacter spp. Providencia rettgeri Haemophilus parainfluenzae Proteus mirabilis Moraxella catarrhalis Morganella morganii Salmonella spp.
Shigella spp. Gram-positive bacteria Staphylococcus epidermidis Susceptibility Testing For specific information regarding susceptibility test interpretive criteria, and associated test methods and quality control standards recognized by FDA for this drug, please see: https://www.fda.gov/STIC.